<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0, user-scalable=yes">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-status-bar-style" content="default">
<meta name="mobile-web-app-capable" content="yes">
<meta name="theme-color" content="#0A5C8F">
<title>CAMP EMS â€” Medication Reference</title>
<style>
/* â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
   APPLE HIG LIGHT MODE â€” iOS 17+ DESIGN SYSTEM
   â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â• */
:root{
  /* â”€â”€ iOS System Backgrounds (Light) â”€â”€ */
  --bg: #F0F4F8;
  --bg2: #FFFFFF;
  --bg3: #F6F9FB;
  --bg-elevated: #FFFFFF;
  --bg-bar: rgba(249,251,253,0.92);
  --fill: rgba(14,60,100,0.18);
  --fill2: rgba(14,60,100,0.14);
  --fill3: rgba(14,60,100,0.08);
  --fill4: rgba(14,60,100,0.05);
  --separator: rgba(14,60,100,0.10);
  --separator-opaque: #C8D6E0;

  /* â”€â”€ Label Hierarchy (Ocean Blue) â”€â”€ */
  --label: #0B2942;
  --label2: rgba(11,41,66,0.68);
  --label3: rgba(11,41,66,0.42);
  --label4: rgba(11,41,66,0.22);

  /* â”€â”€ Hero Colors â”€â”€ */
  --ocean: #0A5C8F;
  --ocean-deep: #083D5A;
  --ocean-light: #1B7DB5;
  --seafoam: #2EC4A4;
  --seafoam-deep: #1FA88B;
  --seafoam-light: #5DD9BF;
  --header-bg: linear-gradient(135deg, #0A5C8F 0%, #0E7490 55%, #17948A 100%);
  --header-shadow: rgba(10,92,143,0.35);

  /* â”€â”€ iOS System Colors (Vibrant) â”€â”€ */
  --blue: #007AFF;
  --green: #34C759;
  --red: #FF3B30;
  --orange: #FF9500;
  --yellow: #FFCC00;
  --purple: #AF52DE;
  --pink: #FF2D55;
  --teal: #5AC8FA;
  --indigo: #5856D6;
  --mint: #00C7BE;
  --cyan: #32ADE6;
  --brown: #A2845E;

  /* â”€â”€ Tinted Fills (Light, Vibrant) â”€â”€ */
  --blue-fill: rgba(0,122,255,0.10); --blue-b: rgba(0,122,255,0.20);
  --green-fill: rgba(52,199,89,0.10); --green-b: rgba(52,199,89,0.20);
  --red-fill: rgba(255,59,48,0.10); --red-b: rgba(255,59,48,0.20);
  --orange-fill: rgba(255,149,0,0.10); --orange-b: rgba(255,149,0,0.22);
  --purple-fill: rgba(175,82,222,0.10); --purple-b: rgba(175,82,222,0.20);
  --pink-fill: rgba(255,45,85,0.10); --pink-b: rgba(255,45,85,0.20);
  --teal-fill: rgba(90,200,250,0.10); --teal-b: rgba(90,200,250,0.22);
  --indigo-fill: rgba(88,86,214,0.10); --indigo-b: rgba(88,86,214,0.20);
  --mint-fill: rgba(0,199,190,0.10); --mint-b: rgba(0,199,190,0.22);
  --cyan-fill: rgba(50,173,230,0.10); --cyan-b: rgba(50,173,230,0.22);
  --yellow-fill: rgba(255,204,0,0.12); --yellow-b: rgba(255,204,0,0.28);
  --brown-fill: rgba(162,132,94,0.10); --brown-b: rgba(162,132,94,0.20);

  /* â”€â”€ Safe Areas â”€â”€ */
  --safe-t: env(safe-area-inset-top, 0px);
  --safe-b: env(safe-area-inset-bottom, 0px);

  /* â”€â”€ Radius â”€â”€ */
  --r-sm: 8px;
  --r-md: 12px;
  --r-lg: 16px;
  --r-card: 14px;
}

/* â•â•â•â•â•â•â• RESET â•â•â•â•â•â•â• */
*{margin:0;padding:0;box-sizing:border-box;-webkit-tap-highlight-color:transparent}
html{scroll-behavior:smooth;overscroll-behavior-y:none;-webkit-text-size-adjust:100%}
body{
  font-family:-apple-system,BlinkMacSystemFont,"SF Pro Text","SF Pro Display","Helvetica Neue",Arial,sans-serif;
  background:var(--bg);color:var(--label);
  min-height:100vh;min-height:100dvh;
  overflow-x:hidden;-webkit-font-smoothing:antialiased;
  font-size:17px;line-height:1.47;
  padding-bottom:calc(90px + var(--safe-b));
}

/* â•â•â•â•â•â•â• NAVIGATION BAR â•â•â•â•â•â•â• */
.nav{position:sticky;top:0;z-index:100;
  background:var(--header-bg);
  padding-top:var(--safe-t);
  border-bottom:none;
  box-shadow:0 4px 20px var(--header-shadow);
  transition:box-shadow .2s}
.nav.scrolled{box-shadow:0 4px 24px var(--header-shadow)}
.nav-inner{padding:6px 16px 0;max-width:700px;margin:0 auto}

/* Large Title (iOS-style collapse) */
.lg-title{
  font-size:34px;font-weight:700;letter-spacing:.37px;line-height:41px;
  padding:2px 0 2px;color:#FFFFFF;
  max-height:48px;opacity:1;overflow:hidden;
  transition:max-height .28s ease,opacity .18s,padding .28s}
.nav.mini .lg-title{max-height:0;opacity:0;padding:0;pointer-events:none}

/* Inline title */
.inline-title{
  font-size:17px;font-weight:600;text-align:center;color:#FFFFFF;
  max-height:0;opacity:0;overflow:hidden;
  transition:max-height .28s,opacity .2s;line-height:44px}
.nav.mini .inline-title{max-height:44px;opacity:1}

/* Subtitle row */
.nav-sub{display:flex;align-items:center;gap:8px;padding:0 0 4px;
  max-height:26px;opacity:1;overflow:hidden;
  transition:max-height .25s,opacity .15s}
.nav.mini .nav-sub{max-height:0;opacity:0;padding:0}
.nav-badge{font-size:14px;color:var(--seafoam-light);font-weight:600}
.nav-credit{font-size:14px;color:rgba(255,255,255,0.75);font-weight:500;margin-left:auto}

/* Scope toggle */
.top-acts{display:flex;gap:6px;align-items:center;padding-bottom:2px;
  max-height:38px;opacity:1;overflow:hidden;
  transition:max-height .25s,opacity .15s}
.nav.mini .top-acts{max-height:0;opacity:0;padding:0}
.top-btn{width:36px;height:36px;border-radius:var(--r-sm);
  border:none;background:rgba(255,255,255,0.18);
  color:#fff;cursor:pointer;font-size:16px;
  display:flex;align-items:center;justify-content:center;margin-left:auto;
  min-width:44px;min-height:44px}
.top-btn:active{background:rgba(255,255,255,0.28)}

/* Scope segmented control */
.scope-wrap{display:none;padding:4px 0}
.scope-wrap.show{display:block}
.scope-seg{display:flex;background:rgba(255,255,255,0.15);border-radius:var(--r-sm);padding:2px;gap:0}
.scope-seg button{flex:1;padding:7px 2px;border:none;border-radius:7px;background:transparent;
  color:rgba(255,255,255,0.75);font-family:inherit;font-size:12px;font-weight:600;
  cursor:pointer;transition:all .15s;min-height:34px}
.scope-seg button.on{background:rgba(255,255,255,0.95);color:var(--ocean-deep);
  box-shadow:0 1px 4px rgba(0,0,0,.12)}

/* Search Bar */
.search-wrap{padding:6px 0 6px;position:relative}
.search-bar{
  width:100%;padding:10px 38px 10px 38px;
  border-radius:10px;border:none;
  background:rgba(255,255,255,0.20);
  color:#fff;font-family:inherit;font-size:17px;
  outline:none;transition:all .2s;min-height:36px}
.search-bar:focus{background:rgba(255,255,255,0.30);box-shadow:0 0 0 3.5px rgba(255,255,255,.18)}
.search-bar::placeholder{color:rgba(255,255,255,0.55)}
.s-icon{position:absolute;left:12px;top:50%;transform:translateY(-50%);
  color:rgba(255,255,255,0.55);font-size:15px;pointer-events:none}
.s-clear{position:absolute;right:10px;top:50%;transform:translateY(-50%);
  width:22px;height:22px;border-radius:50%;background:rgba(255,255,255,.35);
  border:none;color:#fff;font-size:12px;cursor:pointer;
  display:none;align-items:center;justify-content:center;font-weight:700;
  min-width:44px;min-height:44px}
.s-clear.show{display:flex}
.s-count{position:absolute;right:40px;top:50%;transform:translateY(-50%);
  font-size:13px;color:rgba(255,255,255,0.7);pointer-events:none}

/* Filter Chips */
.chips-outer{padding:2px 16px 10px;max-width:732px;margin:0 auto}
.chips-wrap{overflow-x:auto;-webkit-overflow-scrolling:touch;
  scrollbar-width:none;display:flex;gap:8px}
.chips-wrap::-webkit-scrollbar{display:none}
.chip{padding:8px 16px;border-radius:20px;
  background:rgba(255,255,255,0.22);
  border:1px solid rgba(255,255,255,0.15);
  color:rgba(255,255,255,0.85);cursor:pointer;
  font-family:inherit;font-size:14px;font-weight:600;
  transition:all .15s;white-space:nowrap;flex-shrink:0;
  display:flex;align-items:center;gap:5px;min-height:36px}
.chip:active{transform:scale(.95)}
.chip.on{background:var(--seafoam);color:#fff;border-color:var(--seafoam);box-shadow:0 2px 10px rgba(46,196,164,.35)}
.chip .cc{font-size:11px;opacity:.6;font-weight:700}
.chip.on .cc{opacity:.9}

/* â•â•â•â•â•â•â• CARD LIST â•â•â•â•â•â•â• */
.list{padding:0 16px;max-width:700px;margin:0 auto}
.section-hd{font-size:13px;font-weight:700;color:var(--ocean);
  text-transform:uppercase;letter-spacing:.6px;padding:20px 4px 10px}

.card-group{background:var(--bg2);border-radius:var(--r-card);overflow:hidden;
  box-shadow:0 .5px 1px rgba(0,0,0,.04),0 1px 3px rgba(0,0,0,.03)}

.card{display:flex;align-items:center;gap:14px;
  padding:14px 16px;min-height:64px;cursor:pointer;
  position:relative;transition:background .1s;
  border-bottom:.33px solid var(--separator)}
.card:last-child{border-bottom:none}
.card:active{background:rgba(0,0,0,.03)}

.card-bar{position:absolute;left:0;top:10px;bottom:10px;width:3.5px;border-radius:0 2px 2px 0}
.card-emo{font-size:26px;flex-shrink:0;width:36px;text-align:center;line-height:1}
.card-body{flex:1;min-width:0}
.card-name{font-size:17px;font-weight:600;line-height:1.29;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis;color:var(--label)}
.card-gen{font-size:14px;color:var(--label2);line-height:1.38;
  white-space:nowrap;overflow:hidden;text-overflow:ellipsis;margin-top:1px}
.card-pills{display:flex;gap:4px;margin-top:5px;flex-wrap:wrap}
.cpill{font-size:11px;padding:3px 8px;border-radius:5px;font-weight:600;letter-spacing:.2px}
.card-right{display:flex;flex-direction:column;align-items:flex-end;gap:3px;flex-shrink:0}
.card-route{font-size:12px;color:var(--label2);font-weight:600;line-height:1.3;text-align:right;
  background:var(--fill4);padding:2px 7px;border-radius:5px}
.card-chev{color:var(--label3);font-size:15px;font-weight:500}

/* Category Colors â€” vibrant with tinted fills */
.c-cardiac .card-bar{background:var(--red)}       .c-cardiac .cpill.ct{background:var(--red-fill);color:var(--red)}
.c-vasopressor .card-bar{background:var(--orange)} .c-vasopressor .cpill.ct{background:var(--orange-fill);color:#CC7700}
.c-antiarrhythmic .card-bar{background:var(--indigo)} .c-antiarrhythmic .cpill.ct{background:var(--indigo-fill);color:var(--indigo)}
.c-respiratory .card-bar{background:var(--teal)}   .c-respiratory .cpill.ct{background:var(--teal-fill);color:#0094CC}
.c-analgesic .card-bar{background:var(--pink)}     .c-analgesic .cpill.ct{background:var(--pink-fill);color:var(--pink)}
.c-sedation .card-bar{background:var(--purple)}    .c-sedation .cpill.ct{background:var(--purple-fill);color:var(--purple)}
.c-neuro .card-bar{background:var(--orange)}       .c-neuro .cpill.ct{background:var(--orange-fill);color:#CC7700}
.c-metabolic .card-bar{background:var(--green)}    .c-metabolic .cpill.ct{background:var(--green-fill);color:#248A3D}
.c-toxicology .card-bar{background:var(--red)}     .c-toxicology .cpill.ct{background:var(--red-fill);color:var(--red)}
.c-obstetric .card-bar{background:var(--pink)}     .c-obstetric .cpill.ct{background:var(--pink-fill);color:var(--pink)}
.c-gi .card-bar{background:var(--mint)}            .c-gi .cpill.ct{background:var(--mint-fill);color:#008079}
.c-iv-fluid .card-bar{background:var(--cyan)}      .c-iv-fluid .cpill.ct{background:var(--cyan-fill);color:#0077B6}
.c-anticoagulant .card-bar{background:var(--indigo)} .c-anticoagulant .cpill.ct{background:var(--indigo-fill);color:var(--indigo)}
.c-other .card-bar{background:var(--blue)}         .c-other .cpill.ct{background:var(--blue-fill);color:var(--blue)}
.cpill.sc{background:rgba(46,196,164,0.10);color:var(--seafoam-deep)}
.cpill.ha{background:var(--red-fill);color:var(--red);animation:pulse 2.8s ease-in-out infinite}
@keyframes pulse{0%,100%{opacity:1}50%{opacity:.45}}

/* â•â•â•â•â•â•â• MODAL SHEET (Drawer) â•â•â•â•â•â•â• */
.overlay{position:fixed;inset:0;background:rgba(0,0,0,.32);z-index:200;
  opacity:0;pointer-events:none;transition:opacity .3s}
.overlay.open{opacity:1;pointer-events:auto}

.sheet{position:fixed;left:0;right:0;bottom:0;z-index:201;
  background:var(--bg);
  border-radius:14px 14px 0 0;
  transform:translateY(100%);
  transition:transform .4s cubic-bezier(.32,.72,0,1);
  max-height:94vh;max-height:94dvh;
  display:flex;flex-direction:column;
  box-shadow:0 -4px 24px rgba(0,0,0,.1),0 -1px 6px rgba(0,0,0,.06);
  padding-bottom:var(--safe-b)}
.sheet.open{transform:translateY(0)}

.sheet-grab{padding:8px 0 4px;display:flex;justify-content:center;flex-shrink:0;cursor:grab}
.sheet-grab::after{content:'';width:36px;height:5px;border-radius:2.5px;background:rgba(60,60,67,.16)}

/* Sheet Header */
.sh-head{padding:0 20px 16px;flex-shrink:0;position:relative}
.sh-nav{display:flex;align-items:center;gap:6px;position:absolute;top:0;right:16px}
.sh-nav-btn{width:32px;height:32px;border-radius:50%;
  border:none;background:var(--fill3);
  color:var(--label2);cursor:pointer;font-size:14px;
  display:flex;align-items:center;justify-content:center;font-weight:700;
  min-width:44px;min-height:44px}
.sh-nav-btn:active{background:var(--fill2)}
.sh-nav-btn:disabled{opacity:.25;cursor:default}
.sh-pos{font-size:12px;color:var(--label3);min-width:30px;text-align:center;font-weight:500}
.sh-close{width:32px;height:32px;border-radius:50%;
  border:none;background:var(--fill3);
  color:var(--label2);cursor:pointer;font-size:15px;
  display:flex;align-items:center;justify-content:center;
  min-width:44px;min-height:44px}

.sh-top{display:flex;align-items:flex-start;gap:14px;padding-right:110px}
.sh-emo{font-size:40px;flex-shrink:0;line-height:1;
  width:52px;height:52px;display:flex;align-items:center;justify-content:center;
  background:rgba(10,92,143,0.06);border-radius:var(--r-md)}
.sh-info{flex:1;min-width:0}
.sh-name{font-size:22px;font-weight:700;line-height:1.18;letter-spacing:.35px;color:var(--label)}
.sh-gen{font-size:15px;color:var(--label2);margin-top:3px;font-weight:400}
.sh-tags{display:flex;gap:5px;flex-wrap:wrap;margin-top:10px}
.sh-tags .cpill{font-size:12px;padding:4px 10px;border-radius:6px}

/* Sheet Segmented Tabs */
.sh-tabs{display:flex;margin:0 20px;padding:2px;
  background:var(--fill3);border-radius:var(--r-sm);flex-shrink:0}
.sh-tab{flex:1;padding:9px 4px;border:none;border-radius:7px;background:transparent;
  color:var(--label2);cursor:pointer;font-family:inherit;
  font-size:13px;font-weight:600;text-align:center;
  transition:all .15s;min-height:34px}
.sh-tab.on{background:var(--bg2);color:var(--ocean);
  box-shadow:0 1px 3px rgba(0,0,0,.06),0 .5px 1px rgba(0,0,0,.04)}

/* Sheet Body */
.sh-body{flex:1;overflow-y:auto;-webkit-overflow-scrolling:touch;
  overscroll-behavior:contain;padding:18px 20px 24px}
.tpanel{display:none}
.tpanel.on{display:block;animation:fadeUp .22s ease}
@keyframes fadeUp{from{opacity:0;transform:translateY(6px)}to{opacity:1;transform:none}}

/* â”€â”€ Content Blocks â”€â”€ */
.sec{margin-bottom:20px}
.sec-hd{font-size:13px;font-weight:700;color:var(--ocean);text-transform:uppercase;
  letter-spacing:.8px;margin-bottom:10px;display:flex;align-items:center;gap:6px}
.sec-txt{font-size:17px;color:var(--label);line-height:1.7}

/* Pathophysiology Card */
.patho{background:rgba(10,92,143,0.07);border:1px solid rgba(10,92,143,0.18);
  border-radius:var(--r-md);padding:18px 20px;margin-bottom:16px}
.patho .sec-hd{color:var(--ocean);margin-bottom:8px}
.patho .sec-txt{font-size:16px;line-height:1.75;color:var(--label)}

/* Analogy Card */
.analog{background:rgba(46,196,164,0.08);border:1px solid rgba(46,196,164,0.22);
  border-radius:var(--r-md);padding:18px 20px;margin-bottom:16px;position:relative}
.analog::after{content:'ğŸ’¡';position:absolute;top:16px;right:16px;font-size:18px;opacity:.35}
.analog .sec-hd{color:var(--seafoam-deep)}
.analog .an-text{font-size:17px;color:var(--label);line-height:1.75;font-style:italic}

/* Dose Cards */
.dcard{background:var(--bg2);border:1px solid var(--separator);
  border-radius:var(--r-md);padding:16px 18px;margin-bottom:10px;
  box-shadow:0 .5px 2px rgba(0,0,0,.03)}
.dcard-hd{font-size:14px;color:var(--label);font-weight:700;
  letter-spacing:.3px;margin-bottom:12px;
  padding-bottom:10px;border-bottom:1.5px solid var(--separator)}
.drow{display:flex;gap:10px;align-items:center;margin-bottom:8px;flex-wrap:wrap}
.drow-lbl{font-size:13px;font-weight:800;min-width:50px;text-transform:uppercase;letter-spacing:.5px;
  padding:5px 10px;border-radius:6px;text-align:center}
.drow-lbl.lbl-adult{background:rgba(10,92,143,0.12);color:var(--ocean)}
.drow-lbl.lbl-peds{background:rgba(175,82,222,0.12);color:#8B3FC1}
.drow-lbl.lbl-max{background:rgba(255,59,48,0.12);color:var(--red)}
.drow-val{font-size:16px;color:var(--label);font-family:"SF Mono","Menlo","Courier New",monospace;
  font-weight:600;cursor:pointer;padding:6px 10px;border-radius:8px;
  transition:background .15s;word-break:break-word;background:rgba(10,92,143,0.06);
  border:1px solid rgba(10,92,143,0.10)}
.drow-val:active{background:rgba(10,92,143,0.14)}
.drow-val.peds{background:rgba(175,82,222,0.06);border-color:rgba(175,82,222,0.10);color:var(--label)}
.drow-val.peds:active{background:rgba(175,82,222,0.14)}
.drow-val.mx{background:rgba(255,59,48,0.06);border-color:rgba(255,59,48,0.10);color:var(--label)}
.drow-val.mx:active{background:rgba(255,59,48,0.14)}

/* Safety Blocks */
.ci-item{padding:14px 18px;border-radius:var(--r-md);font-size:16px;line-height:1.6;
  background:var(--red-fill);color:var(--label);margin-bottom:8px;
  border-left:4px solid var(--red)}
.adr-item{padding:14px 18px;border-radius:var(--r-md);font-size:16px;line-height:1.6;
  background:var(--orange-fill);color:var(--label);margin-bottom:8px;
  border-left:4px solid var(--orange)}
.alert-box{background:var(--red-fill);border:1.5px solid var(--red-b);border-radius:var(--r-md);
  padding:14px 18px;font-size:15px;color:var(--red);line-height:1.6;margin-bottom:12px;font-weight:600}
.alert-box::before{content:'âš ï¸ '}
.pearl-box{background:var(--yellow-fill);border:1.5px solid var(--yellow-b);
  border-radius:var(--r-md);padding:16px 18px;font-size:17px;color:var(--label);line-height:1.7}
.pearl-box::before{content:'ğŸ’¡ '}

/* Toast */
.toast{position:fixed;bottom:110px;left:50%;transform:translateX(-50%) translateY(16px);
  background:var(--seafoam);color:#fff;padding:10px 22px;border-radius:22px;
  font-size:14px;font-weight:600;z-index:300;opacity:0;transition:all .25s;pointer-events:none;
  box-shadow:0 4px 12px rgba(46,196,164,.35)}
.toast.show{opacity:1;transform:translateX(-50%) translateY(0)}

/* â•â•â•â•â•â•â• TAB BAR â•â•â•â•â•â•â• */
.tab-bar{position:fixed;bottom:0;left:0;right:0;z-index:150;
  background:rgba(255,255,255,0.94);
  backdrop-filter:saturate(180%) blur(20px);-webkit-backdrop-filter:saturate(180%) blur(20px);
  border-top:.33px solid var(--separator);
  padding:6px 2px calc(6px + var(--safe-b));
  display:flex;justify-content:space-around}
.tb-item{display:flex;flex-direction:column;align-items:center;gap:2px;
  padding:2px 4px;border:none;background:transparent;
  color:var(--label3);cursor:pointer;font-family:inherit;
  min-width:44px;min-height:50px;transition:color .1s}
.tb-item:active{opacity:.6}
.tb-item.on{color:var(--ocean)}
.tb-ico{font-size:24px;line-height:1}
.tb-lbl{font-size:10px;font-weight:500;letter-spacing:.1px}

/* â•â•â•â•â•â•â• EMPTY STATE â•â•â•â•â•â•â• */
.empty{text-align:center;padding:60px 20px;color:var(--label3)}
.empty-ico{font-size:48px;margin-bottom:12px}
.empty h3{font-size:20px;color:var(--label2);margin-bottom:6px;font-weight:600}
.empty p{font-size:15px}

/* â•â•â•â•â•â•â• FOOTER â•â•â•â•â•â•â• */
.ftr{text-align:center;padding:32px 20px 24px;margin-top:32px}
.ftr-card{background:var(--bg2);border-radius:var(--r-lg);padding:28px 24px;
  box-shadow:0 1px 4px rgba(0,0,0,.06),0 .5px 1px rgba(0,0,0,.03)}
.ftr-credit{font-size:22px;color:var(--label);font-weight:700;display:block;margin-bottom:4px;letter-spacing:.2px}
.ftr-org{font-size:16px;color:var(--ocean);font-weight:600;display:block;margin-bottom:4px}
.ftr-divider{width:40px;height:3px;background:var(--seafoam);border-radius:2px;margin:14px auto}
.ftr-line{font-size:14px;color:var(--label2);line-height:1.9;font-weight:500}

/* â•â•â•â•â•â•â• RESPONSIVE â•â•â•â•â•â•â• */
@media(min-width:700px){
  .card-group{max-width:680px}
  .list{max-width:712px;margin:0 auto}
  .sheet{max-width:560px;left:50%;right:auto;
    transform:translate(-50%,100%);border-radius:14px 14px 0 0}
  .sheet.open{transform:translate(-50%,0)}
}
@media(min-width:1080px){
  .nav-inner{max-width:700px;margin:0 auto}
}
@media print{
  body{background:#fff;padding-bottom:0}
  .nav,.tab-bar,.overlay,.sheet,.ftr{display:none!important}
  .card-bar{display:none}
}
</style>
</head>
<body>

<!-- NAVIGATION BAR -->
<nav class="nav" id="nav">
  <div class="nav-inner">
    <div class="inline-title">ğŸ’Š Medications</div>
    <div class="lg-title">ğŸ’Š Medications</div>
    <div class="nav-sub">
      <span class="nav-badge" id="navBadge">161 medications</span>
      <span class="nav-credit">Created by Dr. C</span>
    </div>
    <div class="top-acts">
      <button class="top-btn" onclick="toggleScope()" title="Filter by Scope" aria-label="Filter by certification scope">ğŸ¯</button>
    </div>
    <div class="scope-wrap" id="scopeWrap">
      <div class="scope-seg">
        <button class="on" data-s="all" onclick="pickScope(this)">All</button>
        <button data-s="emt" onclick="pickScope(this)">EMT</button>
        <button data-s="aemt" onclick="pickScope(this)">AEMT</button>
        <button data-s="paramedic" onclick="pickScope(this)">Medic</button>
        <button data-s="lpn" onclick="pickScope(this)">LPN</button>
        <button data-s="rn" onclick="pickScope(this)">RN</button>
      </div>
    </div>
    <div class="search-wrap">
      <span class="s-icon">ğŸ”</span>
      <input class="search-bar" id="sBar" type="search" inputmode="search" enterkeyhint="search"
        placeholder="Search medicationsâ€¦" autocomplete="off" oninput="onSearch()">
      <button class="s-clear" id="sX" onclick="clearSearch()" aria-label="Clear search">âœ•</button>
      <span class="s-count" id="sCnt"></span>
    </div>
  </div>
  <div class="chips-outer"><div class="chips-wrap" id="chips"></div></div>
</nav>

<!-- LIST -->
<div class="list">
  <div id="grid"></div>

  <!-- Footer -->
  <div class="ftr">
    <div class="ftr-card">
      <span class="ftr-credit">Created by Dr. C</span>
      <div class="ftr-divider"></div>
      <div class="ftr-line">
        For educational use only â€” Always follow local protocols<br>
        Â© 2025 Paul D. Camp Community College
      </div>
    </div>
  </div>
</div>

<!-- OVERLAY & SHEET -->
<div class="overlay" id="ov" onclick="closeSheet()"></div>
<div class="sheet" id="sheet">
  <div class="sheet-grab" id="shGrab"><div></div></div>
  <div class="sh-head">
    <div class="sh-nav">
      <button class="sh-nav-btn" id="shPrev" onclick="prevSh()" aria-label="Previous medication">â€¹</button>
      <span class="sh-pos" id="shPos">1/82</span>
      <button class="sh-nav-btn" id="shNext" onclick="nextSh()" aria-label="Next medication">â€º</button>
      <button class="sh-close" onclick="closeSheet()" aria-label="Close">âœ•</button>
    </div>
    <div class="sh-top">
      <div class="sh-emo" id="shEmo"></div>
      <div class="sh-info">
        <div class="sh-name" id="shName"></div>
        <div class="sh-gen" id="shGen"></div>
        <div class="sh-tags" id="shTags"></div>
      </div>
    </div>
  </div>
  <div class="sh-tabs">
    <button class="sh-tab on" data-t="dose" onclick="pickTab(this)">ğŸ’‰ Dosing</button>
    <button class="sh-tab" data-t="learn" onclick="pickTab(this)">ğŸ“– Learn</button>
    <button class="sh-tab" data-t="safe" onclick="pickTab(this)">ğŸ›¡ Safety</button>
    <button class="sh-tab" data-t="tips" onclick="pickTab(this)">ğŸ’¡ Tips</button>
  </div>
  <div class="sh-body" id="shBody"></div>
</div>

<!-- TAB BAR -->
<div class="tab-bar" id="tabBar">
  <button class="tb-item on" data-f="all" onclick="tabFilter(this)"><span class="tb-ico">ğŸ’Š</span><span class="tb-lbl">All</span></button>
  <button class="tb-item" data-f="cardiac" onclick="tabFilter(this)"><span class="tb-ico">â¤ï¸</span><span class="tb-lbl">Cardiac</span></button>
  <button class="tb-item" data-f="respiratory" onclick="tabFilter(this)"><span class="tb-ico">ğŸ«</span><span class="tb-lbl">Resp</span></button>
  <button class="tb-item" data-f="sedation" onclick="tabFilter(this)"><span class="tb-ico">ğŸ’‰</span><span class="tb-lbl">RSI</span></button>
  <button class="tb-item" data-f="metabolic" onclick="tabFilter(this)"><span class="tb-ico">âš—ï¸</span><span class="tb-lbl">Metabolic</span></button>
  <button class="tb-item" data-f="toxicology" onclick="tabFilter(this)"><span class="tb-ico">â˜ ï¸</span><span class="tb-lbl">Tox</span></button>
</div>

<!-- TOAST -->
<div class="toast" id="toast">âœ“ Copied</div>

<script>
const CATS=[
  {id:'all',l:'All',i:'ğŸ’Š'},{id:'cardiac',l:'Cardiac',i:'â¤ï¸'},{id:'vasopressor',l:'Pressors',i:'ğŸ“ˆ'},
  {id:'antiarrhythmic',l:'Antiarrhythm',i:'ğŸ’“'},{id:'respiratory',l:'Respiratory',i:'ğŸ«'},
  {id:'analgesic',l:'Analgesics',i:'ğŸ’œ'},{id:'sedation',l:'Sedation/RSI',i:'ğŸ’‰'},
  {id:'neuro',l:'Neuro',i:'ğŸ§ '},{id:'metabolic',l:'Metabolic',i:'âš—ï¸'},
  {id:'toxicology',l:'Toxicology',i:'â˜ ï¸'},{id:'obstetric',l:'OB/GYN',i:'ğŸ¤°'},
  {id:'gi',l:'GI',i:'ğŸŸ¢'},{id:'iv-fluid',l:'IV Fluids',i:'ğŸ’§'},
  {id:'anticoagulant',l:'Anticoag',i:'ğŸ©¸'},{id:'other',l:'Other',i:'ğŸ“¦'}];

const CLR={cardiac:'red',vasopressor:'orange',antiarrhythmic:'indigo',respiratory:'teal',
  analgesic:'pink',sedation:'purple',neuro:'orange',metabolic:'green',toxicology:'red',
  obstetric:'pink',gi:'mint','iv-fluid':'cyan',anticoagulant:'indigo',other:'blue'};

const D=[
// ==================== CARDIAC ====================
{n:"Epinephrine 1:10,000",g:"Adrenalin",c:"cardiac",e:"ğŸ’‰",s:["emt","aemt","paramedic","rn"],r:["IV","IO"],ha:true,
 d:[{i:"Cardiac Arrest",a:"1 mg IV/IO q3-5min",p:"0.01 mg/kg (0.1 mL/kg)",m:"1 mg/dose"},{i:"Bradycardia Infusion",a:"2-10 mcg/min IV drip",p:"0.01 mcg/kg/min",m:"Titrate"}],
 ci:"None in arrest. Relative: tachyarrhythmias.",adr:"Tachycardia, HTN, dysrhythmias, tremor, tissue necrosis.",
 ph:"Epinephrine is a direct-acting catecholamine that stimulates both alpha-1 and beta-1/beta-2 adrenergic receptors. In cardiac arrest, alpha-1 stimulation causes systemic vasoconstriction which raises aortic diastolic pressure â€” the critical driver of coronary perfusion pressure (CPP). Without adequate CPP, blood cannot perfuse the myocardium during CPR compressions. Beta-1 stimulation increases heart rate (chronotropy) and contractile force (inotropy), helping restart organized electrical/mechanical cardiac activity.",
 an:"Think of a garden hose with no water pressure. Epi is like someone turning the spigot to full blast (alpha = squeezes blood vessels tighter) while also getting the sprinkler head to spin faster (beta = heart pumps harder/faster). In arrest, the hose has zero pressure â€” epi cranks it up so blood can actually reach the heart muscle itself during CPR.",
 pearl:"NO contraindications in cardiac arrest. Push with 20 mL NS flush. ET: 2-2.5Ã— dose in 5-10 mL NS.",at:"Verify concentration: 1:10,000 IV vs 1:1,000 IM"},

{n:"Epinephrine 1:1,000",g:"Adrenalin (IM)",c:"cardiac",e:"ğŸ’‰",s:["emt","aemt","paramedic","rn","lpn"],r:["IM","SQ","Neb"],ha:true,
 d:[{i:"Anaphylaxis",a:"0.3-0.5 mg IM (lateral thigh)",p:"0.01 mg/kg IM (max 0.3 mg)",m:"0.5 mg q5-15min"},{i:"Severe Croup/Asthma",a:"0.3-0.5 mg SQ; 5 mg nebulized",p:"0.5 mg/kg neb (max 5 mg)",m:"May repeat Ã—1"}],
 ci:"None in anaphylaxis. Relative: elderly, cardiac hx.",adr:"Tachycardia, palpitations, anxiety, tremor.",
 ph:"In anaphylaxis, massive histamine and leukotriene release from mast cells and basophils causes widespread vasodilation (dropping BP), bronchoconstriction (closing airways), and increased vascular permeability (causing tissue swelling/angioedema). Epinephrine counteracts ALL three pathways simultaneously: alpha-1 vasoconstriction reverses hypotension and reduces mucosal edema; beta-1 increases cardiac output; beta-2 relaxes bronchial smooth muscle and suppresses further mast cell degranulation.",
 an:"Imagine your house flooding from three broken pipes at once â€” one is flooding the basement (low BP), one is filling the walls with water (swelling), and one is collapsing the hallways (airway closing). Epi is the one tool that patches all three leaks at the same time. That's why it's the ONLY first-line drug â€” nothing else hits all three problems.",
 pearl:"IM lateral thigh = fastest absorption. Auto-injector: 0.3 mg adult / 0.15 mg peds. NEVER IV push in non-arrest.",at:"1:1,000 is for IM/SQ ONLY â€” never IV push"},

{n:"Aspirin",g:"ASA",c:"cardiac",e:"ğŸ’Š",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"ACS/STEMI/NSTEMI",a:"324 mg PO chewed",p:"N/A",m:"324 mg once"}],
 ci:"True ASA allergy, active GI bleed, Reye's syndrome in children.",adr:"GI upset, bleeding, tinnitus.",
 ph:"In ACS, a coronary artery plaque ruptures, exposing subendothelial collagen. Platelets immediately adhere and aggregate at the injury site, forming a platelet plug that can partially or fully occlude the artery. Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1) in platelets, blocking the production of thromboxane A2 â€” a potent platelet aggregator and vasoconstrictor. This prevents the clot from growing larger and stops further vessel constriction at the plaque site.",
 an:"Picture a pothole on a highway. Platelets are like rubberneckers pulling over to look â€” they pile up and block the whole road (blood clot). Aspirin is like a traffic cop waving everyone past the pothole so they stop piling up. It doesn't fix the pothole (plaque), but it keeps traffic (blood) flowing.",
 pearl:"CHEW for faster buccal absorption. Non-enteric coated preferred. Give even if patient already takes daily ASA."},

{n:"Nitroglycerin",g:"Nitrostat",c:"cardiac",e:"ğŸ’Š",s:["aemt","paramedic","rn","lpn"],r:["SL","Spray","IV"],ha:true,
 d:[{i:"ACS/Angina",a:"0.4 mg SL or spray q5min Ã—3",p:"N/A",m:"3 doses"},{i:"CHF/Pulmonary Edema",a:"0.4 mg SL; or 10-200 mcg/min IV",p:"N/A",m:"Titrate to BP"}],
 ci:"SBP <100, HR <50 or >100, RV infarct, PDE-5 inhibitor use (24-72 hrs), â†‘ICP.",adr:"Hypotension, headache, dizziness, syncope.",
 ph:"NTG is converted to nitric oxide (NO) in vascular smooth muscle. NO activates guanylate cyclase, increasing cyclic GMP (cGMP), which causes smooth muscle relaxation. At low doses NTG primarily dilates venous capacitance vessels (reducing preload â€” the volume returning to the heart). At higher doses it also dilates coronary arteries and reduces afterload. In angina, reduced preload lowers myocardial oxygen demand while coronary dilation improves oxygen supply. In CHF, venodilation reduces pulmonary congestion.",
 an:"Your heart is like a water pump that's being overworked because too much water is flowing into it (preload) and it's pushing against stiff pipes (afterload). NTG opens the drainage valves downstream (veins dilate), so less water floods back to the pump, giving it a break. It also widens the pump's own supply line (coronary arteries), so the pump motor itself gets better fuel flow.",
 pearl:"Check BP before EACH dose. Ask about erectile dysfunction meds. Suspect RV infarct if inferior STEMI + hypotension â€” NTG can be fatal.",at:"Verify SBP â‰¥100 and no PDE-5 inhibitor use before each dose"},

{n:"Atropine Sulfate",g:"Atropine",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IO","ET"],
 d:[{i:"Symptomatic Bradycardia",a:"0.5 mg IV q3-5min",p:"0.02 mg/kg IV (min 0.1 mg)",m:"3 mg total"},{i:"Organophosphate Poisoning",a:"2-4 mg IV, may double",p:"0.05 mg/kg IV",m:"No max â€” atropinize until dry"}],
 ci:"Glaucoma (relative). NOT for infranodal blocks (Mobitz II, 3rdÂ°).",adr:"Tachycardia, dry mouth, blurred vision, urinary retention.",
 ph:"Atropine is a competitive antagonist at muscarinic (M2) acetylcholine receptors. The vagus nerve (parasympathetic) normally slows heart rate by releasing acetylcholine at the SA and AV nodes. By blocking these muscarinic receptors, atropine removes the vagal 'brake' on the heart, allowing the intrinsic sympathetic tone to increase SA node firing rate and AV conduction speed. It only works on supranodal tissue â€” the AV node below the Bundle of His doesn't have significant vagal innervation, which is why it fails in infranodal blocks.",
 an:"Your heart has a gas pedal (sympathetic) and a brake pedal (vagus nerve). In symptomatic bradycardia, someone is standing on the brake too hard. Atropine doesn't press the gas â€” it yanks the person OFF the brake pedal, letting the heart accelerate on its own. That's why it doesn't work for 3rd-degree block â€” the problem isn't too much braking, it's a broken road between the upper and lower heart.",
 pearl:"Min dose 0.5 mg adult â€” lower causes paradoxical bradycardia. Ineffective for infranodal blocks â€” use pacing."},

{n:"Dopamine",g:"Intropin",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV drip"],ha:true,
 d:[{i:"Bradycardia/Hypotension",a:"5-20 mcg/kg/min IV",p:"2-20 mcg/kg/min",m:"20 mcg/kg/min"}],
 ci:"Pheochromocytoma, VFib, uncorrected tachyarrhythmias.",adr:"Tachycardia, dysrhythmias, HTN, tissue necrosis.",
 ph:"Dopamine is an endogenous catecholamine precursor to norepinephrine with dose-dependent receptor activity. At low doses (2-5 mcg/kg/min), it stimulates dopaminergic (D1) receptors in renal and mesenteric vasculature causing local vasodilation. At moderate doses (5-10), it activates beta-1 receptors increasing cardiac contractility and heart rate. At high doses (10-20), alpha-1 stimulation dominates, causing potent systemic vasoconstriction. This dose-dependent profile makes it versatile but unpredictable.",
 an:"Dopamine is like a volume knob on a stereo with three channels. Turn it low (2-5) and only the kidney channel plays â€” gentle vasodilation. Turn it to medium (5-10) and the heart channel kicks in â€” stronger pumping. Crank it to high (10-20) and the blood vessel channel blasts â€” everything squeezes tight. The catch is you can't play just one channel at high volume.",
 pearl:"Mix: 400mg/250mL=1,600 mcg/mL. Requires pump. Phentolamine for extravasation.",at:"Pump required â€” extravasation causes tissue necrosis"},

{n:"Norepinephrine",g:"Levophed",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV drip"],ha:true,
 d:[{i:"Septic/Cardiogenic Shock",a:"0.1-0.5 mcg/kg/min (2-12 mcg/min)",p:"0.05-0.1 mcg/kg/min",m:"Titrate to MAP â‰¥65"}],
 ci:"Hypovolemia (correct first), mesenteric thrombosis.",adr:"Severe HTN, tissue necrosis, reflex bradycardia.",
 ph:"Norepinephrine is a potent alpha-1 agonist with moderate beta-1 activity and minimal beta-2 effect. In septic shock, massive vasodilation from inflammatory cytokines (TNF-Î±, IL-1, IL-6) and excess nitric oxide production causes pathologic low SVR â€” blood vessels lose their tone and BP plummets despite normal or high cardiac output. Norepinephrine restores vascular tone by stimulating alpha-1 receptors on vascular smooth muscle, increasing SVR and MAP. Its beta-1 activity provides modest inotropic support without excessive tachycardia.",
 an:"In sepsis, all the blood vessels in the body go limp like a deflated balloon â€” even though the heart is pumping hard, blood pools in the saggy vessels and can't maintain pressure. Norepinephrine re-inflates the balloon (squeezes vessels back to shape) so pressure returns to normal and organs get blood flow again. That's why volume must be given first â€” you need fluid in the balloon before squeezing helps.",
 pearl:"First-line pressor for septic shock. Central line preferred but can use proximal large-bore peripheral short-term.",at:"Central line preferred â€” devastating extravasation necrosis"},

{n:"Vasopressin",g:"Pitressin",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV","IO"],
 d:[{i:"Cardiac Arrest (VFib/pVT)",a:"40 units IV Ã—1",p:"Not recommended",m:"Single dose"},{i:"Septic Shock",a:"0.01-0.04 units/min drip",p:"0.0002-0.002 units/kg/min",m:"0.04 units/min"}],
 ci:"Responsive patients with CAD (relative).",adr:"Cardiac ischemia, abdominal cramping.",
 ph:"Vasopressin (ADH) acts on V1 receptors in vascular smooth muscle to cause vasoconstriction through a non-catecholamine pathway â€” it works via phospholipase C and intracellular calcium release, completely independent of the adrenergic system. In prolonged cardiac arrest or catecholamine-resistant shock, the adrenergic receptors become downregulated (desensitized) from endogenous catecholamine surge. Vasopressin bypasses this problem entirely by using a different receptor system. V2 receptors in the kidney promote water reabsorption.",
 an:"If epinephrine is like calling the fire department through phone line A, vasopressin is like calling through phone line B. In prolonged arrest, phone line A gets jammed (adrenergic receptors desensitize). Vasopressin gets through on a completely different line that isn't jammed, achieving the same result â€” blood vessel constriction â€” through a separate pathway.",
 pearl:"Single 40-unit dose replaces 1st or 2nd epi dose in arrest. Non-catecholamine pressor."},

{n:"Dobutamine",g:"Dobutrex",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV drip"],
 d:[{i:"Cardiogenic Shock / CHF",a:"2-20 mcg/kg/min IV",p:"2-20 mcg/kg/min",m:"20 mcg/kg/min"}],
 ci:"IHSS, severe aortic stenosis. Use cautiously in AFib.",adr:"Tachycardia, dysrhythmias, hypotension, headache.",
 ph:"Dobutamine is a synthetic catecholamine that primarily stimulates beta-1 adrenergic receptors in the myocardium, increasing intracellular cAMP and calcium availability in cardiac myocytes. This enhances contractile force (positive inotropy) and modestly increases heart rate. Unlike dopamine, dobutamine has minimal alpha-1 activity, so it improves cardiac output without significantly increasing SVR. Its mild beta-2 effect may actually reduce afterload slightly, making it ideal for a failing heart that needs help pumping without fighting against increased resistance.",
 an:"If the heart is a tired horse pulling a heavy cart uphill, dobutamine is like giving the horse an energy boost AND slightly flattening the hill. It makes the horse stronger (inotropy) without adding more weight to the cart (no vasoconstriction). That's why it's perfect for cardiogenic shock â€” the heart needs help pumping, not more resistance to push against.",
 pearl:"Use for pump failure, NOT hypovolemia. May cause hypotension at low doses (Î²2 vasodilation)."},

{n:"Phenylephrine",g:"Neo-Synephrine",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Hypotension (non-cardiac)",a:"100-500 mcg IV bolus; or 40-180 mcg/min drip",p:"5-20 mcg/kg IV bolus",m:"Titrate to effect"}],
 ci:"Severe HTN, ventricular tachycardia, pheochromocytoma.",adr:"Reflex bradycardia, severe HTN, tissue necrosis.",
 ph:"Phenylephrine is a pure alpha-1 adrenergic agonist with virtually no beta activity. It directly stimulates alpha-1 receptors on vascular smooth muscle, activating the Gq protein â†’ phospholipase C â†’ IP3 pathway, releasing intracellular calcium to cause vasoconstriction. The resulting increase in SVR raises MAP. Because it does NOT stimulate beta-1 receptors, the baroreceptor reflex detects the sudden BP increase and triggers vagal-mediated reflex bradycardia to compensate.",
 an:"Phenylephrine is like squeezing a garden hose nozzle tighter â€” it increases the pressure purely by narrowing the opening (vasoconstriction), not by turning up the faucet (heart rate). In fact, the body senses the sudden pressure rise and actually slows the faucet down (reflex bradycardia). Useful when you need pressure but the patient is already tachycardic.",
 pearl:"Pure Î±1 agonist â€” raises BP via vasoconstriction only. Causes reflex bradycardia."},

// ==================== ANTIARRHYTHMICS ====================
{n:"Amiodarone",g:"Cordarone",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn"],r:["IV","IO"],ha:true,
 d:[{i:"VFib/Pulseless VTach",a:"300 mg IV/IO push",p:"5 mg/kg IV/IO",m:"300mg 1st, 150mg 2nd"},{i:"Stable Wide-Complex Tach",a:"150 mg IV over 10 min",p:"5 mg/kg over 20-60 min",m:"2.2 g/24 hrs"}],
 ci:"Cardiogenic shock, severe sinus dysfunction, 2nd/3rdÂ° AV block.",adr:"Hypotension, bradycardia, QT prolongation, phlebitis.",
 ph:"Amiodarone is a Class III antiarrhythmic that blocks potassium channels (prolonging repolarization and refractory period), but uniquely also blocks sodium channels (Class I effect), calcium channels (Class IV effect), and has non-competitive beta-blocking properties (Class II). By extending the refractory period, it prevents re-entrant circuits â€” the most common mechanism behind VFib and VTach. The sodium channel blockade slows conduction through abnormal tissue, and calcium channel blockade suppresses triggered automaticity. This multi-channel blockade is why amiodarone works on so many arrhythmia types.",
 an:"Imagine an electrical fire in a building with flames spreading through walls, wiring, and insulation simultaneously. Most antiarrhythmics are like using a fire extinguisher on just one material. Amiodarone is like flooding the whole building with flame retardant â€” it blocks sodium, potassium, calcium, AND beta pathways all at once. That's why it's the most effective drug for refractory VFib â€” it attacks the chaotic electrical circuits from every angle.",
 pearl:"PUSH fast in arrest, DRIP slow in stable patients. Half-life 40-55 days.",at:"Arrest = fast push; Stable VT = slow 10-min infusion"},

{n:"Lidocaine",g:"Xylocaine",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn","lpn"],r:["IV","IO","ET"],
 d:[{i:"VFib/pVT (alt to amio)",a:"1-1.5 mg/kg IV push",p:"1 mg/kg IV",m:"3 mg/kg total"},{i:"Maintenance",a:"1-4 mg/min drip",p:"20-50 mcg/kg/min",m:"4 mg/min"}],
 ci:"High-degree AV block, WPW, amide anesthetic allergy.",adr:"CNS depression, seizures, slurred speech, bradycardia.",
 ph:"Lidocaine is a Class IB antiarrhythmic that selectively blocks fast sodium channels in cardiac tissue, particularly in ischemic myocardium where cells are partially depolarized. During ischemia, injured cells have resting membrane potentials around -60 to -70 mV instead of the normal -90 mV. Lidocaine binds preferentially to these depolarized sodium channels (use-dependent blockade), suppressing abnormal automaticity and terminating re-entrant circuits in ischemic tissue while having minimal effect on healthy myocardium.",
 an:"In a VFib heart, some cells are damaged and firing randomly like broken car alarms going off in a parking lot. Lidocaine is like a mechanic who only silences the broken alarms (ischemic cells) while leaving the working ones alone. It selectively targets the misbehaving cells because their electrical state makes them more vulnerable to the drug. Healthy cells are barely affected.",
 pearl:"Reduce dose 50% in >70 yrs, liver disease, CHF, shock."},

{n:"Adenosine",g:"Adenocard",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"SVT (narrow-complex regular)",a:"6 mg â†’ 12 mg â†’ 12 mg rapid IV push",p:"0.1 mg/kg (max 6mg) â†’ 0.2 mg/kg (max 12mg)",m:"12 mg/dose q1-2min"}],
 ci:"2nd/3rdÂ° AV block, sick sinus, asthma/COPD (relative).",adr:"Brief asystole (expected!), chest tightness, flushing, dyspnea.",
 ph:"Adenosine activates A1 purinergic receptors on AV nodal cells, opening potassium channels (IKAdo) and inhibiting calcium channels. The potassium efflux hyperpolarizes the cell membrane (making it more negative), dramatically slowing conduction through the AV node. Most SVTs (like AVNRT and AVRT) involve a re-entrant circuit that requires the AV node as one limb. By transiently blocking AV conduction, adenosine 'breaks the circuit' and terminates the tachycardia. Its half-life is under 10 seconds because red blood cells and endothelial cells rapidly metabolize it.",
 an:"SVT is like a toy train stuck racing around a circular track at full speed. The track has one narrow bridge (the AV node). Adenosine temporarily blows up the bridge (blocks AV conduction for a few seconds), the train derails, and when the bridge rebuilds itself 10 seconds later, the train has stopped. The normal signal can then restart properly. That's also why it must be pushed FAST â€” the bridge repairs itself in seconds.",
 pearl:"RAPID push at proximal port + 20 mL NS flush + arm elevation. Half-life <10 sec.",at:"Rapid push + immediate 20 mL flush â€” half-life <10 seconds"},

{n:"Diltiazem",g:"Cardizem",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"AFib/AFlutter with RVR",a:"0.25 mg/kg IV over 2 min (~15-20 mg)",p:"Not recommended prehospital",m:"0.35 mg/kg 2nd dose"},{i:"Maintenance",a:"5-15 mg/hr IV drip",p:"N/A",m:"15 mg/hr"}],
 ci:"WPW with AFib, wide-complex tach, severe hypotension, 2nd/3rdÂ° AV block, concurrent IV beta-blocker.",adr:"Hypotension, bradycardia, AV block.",
 ph:"Diltiazem is a non-dihydropyridine calcium channel blocker that blocks L-type calcium channels in cardiac tissue, particularly at the AV node. AV nodal cells depend on slow calcium currents (not fast sodium) for depolarization. By blocking calcium influx, diltiazem slows AV nodal conduction velocity and increases the refractory period of the AV node. In AFib, the atria fire chaotically at 350-600 bpm, but the AV node normally filters these impulses. Diltiazem makes the AV node filter more aggressively, letting fewer impulses through to the ventricles, thus slowing ventricular rate.",
 an:"In AFib, the atria are like a crowd of people all trying to rush through a doorway at once (AV node). Diltiazem makes the doorway narrower and the bouncer stricter, so fewer people get through per minute. The crowd upstairs (atria) is still chaotic, but the room downstairs (ventricles) calms down because fewer impulses make it through the gate.",
 pearl:"Excellent for AFib/RVR rate control. NEVER with IV beta-blockers. Have calcium chloride ready."},

{n:"Procainamide",g:"Pronestyl",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Stable Monomorphic VT",a:"20-50 mg/min until suppressed",p:"15 mg/kg over 30-60 min",m:"17 mg/kg total"}],
 ci:"Complete heart block, torsades, lupus.",adr:"Hypotension, QT prolongation, torsades, lupus-like (chronic).",
 ph:"Procainamide is a Class IA antiarrhythmic that blocks fast sodium channels, slowing the rate of depolarization (phase 0) in both atrial and ventricular tissue. It also blocks potassium channels, prolonging the action potential duration and effective refractory period. This dual blockade suppresses ectopic pacemakers, slows conduction through re-entrant pathways, and prolongs the time cardiac tissue needs before it can fire again. Its metabolite NAPA has additional Class III (potassium blocking) properties.",
 an:"If the heart's electrical wiring has a short circuit causing VT, procainamide works like an electrician who both slows the current flow through the wires (sodium blockade) AND makes each wire take longer to recharge before it can carry current again (potassium blockade). The short circuit can't sustain itself because the wires won't conduct fast enough.",
 pearl:"Stop if: arrhythmia suppressed, hypotension, QRS widens >50%, or max dose."},

{n:"Verapamil",g:"Calan/Isoptin",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"SVT (alt to adenosine)",a:"2.5-5 mg IV over 2 min",p:"0.1-0.3 mg/kg (max 5 mg)",m:"May repeat 5-10 mg in 15-30 min; max 20 mg"}],
 ci:"Wide-complex tach, WPW, severe CHF, concurrent IV beta-blocker, <1 yr old.",adr:"Hypotension, bradycardia, AV block, CHF worsening.",
 ph:"Verapamil blocks L-type calcium channels in AV nodal tissue and vascular smooth muscle. Like diltiazem, it slows AV conduction by reducing calcium-dependent depolarization in nodal cells. However, verapamil also has significant negative inotropic effects (reduces cardiac contractility) and causes peripheral vasodilation. The combined effect on the AV node makes it effective for SVT, but its cardiodepressant properties make it dangerous in patients with heart failure or hypotension.",
 an:"Think of diltiazem and verapamil as two bouncers at the AV node door. Verapamil is the bigger bouncer â€” blocks more people (more potent calcium blockade) but also accidentally leans on the walls and weakens the whole building (negative inotropy). That's why it's riskier in patients with an already weak heart â€” diltiazem is usually the safer choice.",
 pearl:"NEVER with IV beta-blockers. Pre-treat hypotension with calcium chloride 500 mg IV."},

{n:"Magnesium Sulfate",g:"MgSOâ‚„",c:"antiarrhythmic",e:"ğŸ’“",s:["paramedic","rn","lpn"],r:["IV","IM"],ha:true,
 d:[{i:"Torsades de Pointes",a:"1-2 g IV over 5-20 min",p:"25-50 mg/kg (max 2 g)",m:"2 g"},{i:"Eclamptic Seizures",a:"4-6 g IV over 15-20 min",p:"N/A",m:"Then 1-2 g/hr"},{i:"Severe Refractory Asthma",a:"2 g IV over 20 min",p:"25-75 mg/kg (max 2 g)",m:"Single dose"}],
 ci:"Heart block, renal failure (caution).",adr:"Hypotension, flushing, resp depression, loss of DTRs.",
 ph:"Magnesium is a natural calcium channel antagonist and membrane stabilizer. In Torsades de Pointes, magnesium reduces early afterdepolarizations (EADs) by decreasing calcium influx during phases 2-3 of the cardiac action potential. It also stabilizes potassium channels, shortening the prolonged QT interval that causes Torsades. In eclampsia, magnesium acts as a central nervous system depressant by blocking NMDA glutamate receptors and stabilizing neuronal membranes. In asthma, it relaxes bronchial smooth muscle by inhibiting calcium-dependent muscle contraction.",
 an:"Magnesium is nature's chill pill for excitable cells. In Torsades, heart cells are getting overstimulated by too much calcium flooding in during repolarization. Magnesium blocks the calcium doorway and says 'calm down.' In eclampsia, brain cells are too excited â€” magnesium sedates them. In asthma, airway muscles are clenching too tight â€” magnesium makes them relax. Same mechanism everywhere: blocking calcium = calming excitable cells.",
 pearl:"Monitor DTRs â€” loss of knee jerk = early toxicity. Antidote: Calcium Gluconate 1-2 g IV.",at:"Monitor DTRs â€” antidote is calcium gluconate"},

// ==================== RESPIRATORY ====================
{n:"Albuterol",g:"Proventil/Ventolin",c:"respiratory",e:"ğŸ«",s:["emt","aemt","paramedic","rn","lpn"],r:["Neb","MDI"],
 d:[{i:"Bronchospasm/Asthma/COPD",a:"2.5 mg neb or 4-8 puffs MDI",p:"0.15 mg/kg neb (min 2.5 mg)",m:"May repeat Ã—3 or continuous"}],
 ci:"Hypersensitivity. Caution: arrhythmias, hypokalemia.",adr:"Tachycardia, tremor, anxiety, hypokalemia.",
 ph:"Albuterol is a selective beta-2 adrenergic agonist. Beta-2 receptors on bronchial smooth muscle are coupled to Gs proteins that activate adenylate cyclase, increasing intracellular cAMP. Elevated cAMP activates protein kinase A, which phosphorylates myosin light chain kinase (MLCK), inactivating it and preventing smooth muscle contraction. The result is rapid bronchial smooth muscle relaxation and bronchodilation. It also stabilizes mast cells, inhibiting further histamine release, and stimulates mucociliary clearance.",
 an:"Imagine your airways are like a fist clenching shut (bronchospasm). Inside each muscle cell, there's a tiny wrench tightening the fist (MLCK). Albuterol floods the cell with a chemical signal (cAMP) that breaks the wrench, so the fist unclenches and the airway opens up. It takes about 5 minutes for enough wrenches to break â€” that's the onset of action.",
 pearl:"Can give continuously in severe asthma. Combine with ipratropium (DuoNeb)."},

{n:"Ipratropium Bromide",g:"Atrovent",c:"respiratory",e:"ğŸ«",s:["aemt","paramedic","rn","lpn"],r:["Neb","MDI"],
 d:[{i:"Bronchospasm (adjunct)",a:"0.5 mg neb (DuoNeb)",p:"0.25-0.5 mg neb",m:"3 doses q20min"}],
 ci:"Allergy to atropine, soy, peanuts (MDI).",adr:"Dry mouth, cough, headache, blurred vision.",
 ph:"Ipratropium is an anticholinergic (muscarinic antagonist) that blocks M3 receptors on bronchial smooth muscle. The parasympathetic vagus nerve normally releases acetylcholine which binds M3 receptors, activating phospholipase C, increasing intracellular calcium, and causing bronchoconstriction. By blocking this pathway, ipratropium reduces vagal-mediated bronchomotor tone. It also decreases mucus gland secretion. Unlike albuterol (which opens airways via beta-2 stimulation), ipratropium works by removing the parasympathetic bronchoconstriction signal â€” a different mechanism providing additive benefit.",
 an:"Your airways have two controls: a 'squeeze' signal from the vagus nerve (parasympathetic) and a 'relax' signal from beta-2 receptors. Albuterol turns UP the relax signal; ipratropium turns OFF the squeeze signal. Using both together is like pressing the gas AND releasing the brake at the same time â€” you get more bronchodilation than either alone. That's why DuoNeb exists.",
 pearl:"Always WITH albuterol, not alone. DuoNeb = 2.5mg albuterol + 0.5mg ipratropium."},

{n:"Levalbuterol",g:"Xopenex",c:"respiratory",e:"ğŸ«",s:["aemt","paramedic","rn","lpn"],r:["Neb"],
 d:[{i:"Bronchospasm",a:"0.63-1.25 mg neb",p:"0.31-0.63 mg neb",m:"Every 6-8 hrs"}],
 ci:"Hypersensitivity.",adr:"Tachycardia, tremor (less than albuterol).",
 ph:"Albuterol is a racemic mixture of R- and S-isomers. Only the R-isomer (levalbuterol) is pharmacologically active at beta-2 receptors. The S-isomer was thought to be inert but may actually promote airway inflammation and paradoxically increase bronchial hyperreactivity in some patients. Levalbuterol provides pure R-isomer, theoretically delivering more targeted bronchodilation with less cardiac stimulation since the S-isomer may contribute to tachycardia through separate mechanisms.",
 an:"Regular albuterol is like buying a bag of mixed nuts when you only want the cashews (R-isomer). Half the bag is peanuts (S-isomer) that don't help and might even upset your stomach. Levalbuterol is like buying a bag of pure cashews â€” you get the good stuff without the unwanted extras. In practice, the difference is modest but may matter for patients who get very tachycardic on regular albuterol.",
 pearl:"R-isomer of albuterol â€” fewer cardiac side effects. Useful in patients with tachycardia."},

{n:"Racemic Epinephrine",g:"S2/Vaponefrin",c:"respiratory",e:"ğŸ«",s:["paramedic","rn"],r:["Neb"],
 d:[{i:"Croup/Stridor/Upper Airway Edema",a:"0.5 mL of 2.25% in 3 mL NS neb",p:"Same dose all ages",m:"May repeat Ã—1 in 20 min"}],
 ci:"Epiglottitis (relative â€” don't agitate child).",adr:"Tachycardia, rebound stridor (observe 2-4 hrs).",
 ph:"Nebulized epinephrine acts topically on alpha-1 receptors in the upper airway subglottic mucosal vasculature. Alpha-1 stimulation causes local arteriolar vasoconstriction, reducing blood flow to the edematous subglottic tissue and decreasing mucosal swelling. In croup, the subglottic region becomes inflamed and swollen from parainfluenza virus infection, narrowing the already-small pediatric airway. The vasoconstrictive effect shrinks the swollen tissue, widening the airway. The effect is temporary (1-2 hrs) because once the drug wears off, blood flow returns and swelling recurs (rebound).",
 an:"Think of a sponge stuffed inside a drinking straw (the child's airway with croup). The sponge is swollen with water (blood/fluid from inflammation), blocking airflow. Racemic epi is like squeezing the sponge â€” it wrings out the excess water temporarily by constricting blood vessels in the sponge. But if you let go (drug wears off), the sponge soaks up water again (rebound). That's why you must observe or transport â€” the squeeze is temporary.",
 pearl:"Same dose regardless of age/weight. Rebound swelling possible â€” must observe or transport."},

{n:"Terbutaline",g:"Brethine",c:"respiratory",e:"ğŸ«",s:["paramedic","rn","lpn"],r:["SQ","IV"],
 d:[{i:"Severe Bronchospasm",a:"0.25 mg SQ",p:"0.01 mg/kg SQ (max 0.25 mg)",m:"May repeat Ã—1 in 15-30 min"},{i:"Preterm Labor (Tocolysis)",a:"0.25 mg SQ",p:"N/A",m:"May repeat Ã—1"}],
 ci:"Tachycardia >150, severe cardiac disease.",adr:"Tachycardia, tremor, palpitations, hypokalemia.",
 ph:"Terbutaline is a beta-2 selective agonist similar to albuterol but administered systemically (SQ). It activates beta-2 receptors in bronchial smooth muscle (causing bronchodilation) and uterine smooth muscle (causing uterine relaxation/tocolysis). The beta-2 â†’ cAMP â†’ PKA pathway relaxes smooth muscle regardless of location. Systemic administration means it reaches ALL beta-2 receptors including cardiac beta-2 (minor) and skeletal muscle beta-2 (causing tremor), which is why side effects are more pronounced than inhaled albuterol.",
 an:"Terbutaline is like a skeleton key that opens all the 'relax' locks (beta-2 receptors) in the body. When inhaled albuterol can't get past severely constricted airways, terbutaline injected under the skin takes the back door through the bloodstream to reach lung smooth muscle from the inside. It also relaxes uterine muscle â€” same key, different lock â€” which is why it doubles as a labor-stopping drug.",
 pearl:"Î²2 agonist â€” SQ route when nebulizer not possible. Also used for tocolysis in preterm labor."},

{n:"Albuterol/Ipratropium",g:"DuoNeb/Combivent",c:"respiratory",e:"ğŸ«",s:["aemt","paramedic","rn","lpn"],r:["Neb","MDI"],
 d:[{i:"Severe Bronchospasm",a:"3 mL unit-dose neb (2.5 mg/0.5 mg)",p:"Same",m:"Every 20 min Ã— 3"}],
 ci:"Atropine/peanut/soy allergy.",adr:"Tachycardia, dry mouth, tremor.",
 ph:"Combination therapy exploits two complementary bronchodilation pathways simultaneously. Albuterol activates beta-2 receptors (increasing cAMP â†’ smooth muscle relaxation) while ipratropium blocks muscarinic M3 receptors (removing parasympathetic bronchoconstriction). These synergistic mechanisms produce greater bronchodilation than either agent alone. The combination also reaches different airway generations â€” large central airways respond more to anticholinergics while smaller peripheral airways respond more to beta-2 agonists.",
 an:"Fighting bronchospasm with just albuterol is like pushing a stalled car with one person. Adding ipratropium is like having a second person push from a different angle. Together they move the car (open the airway) more effectively than twice the effort from one direction alone.",
 pearl:"Premixed combo â€” saves time in acute exacerbation. Synergistic bronchodilation."},

{n:"Aminophylline",g:"Theophylline IV",c:"respiratory",e:"ğŸ«",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Refractory Bronchospasm",a:"5-6 mg/kg IV over 20-30 min",p:"Same",m:"Then 0.5-0.7 mg/kg/hr"}],
 ci:"Uncontrolled arrhythmias, seizure disorder, active peptic ulcer.",adr:"Tachycardia, seizures, N/V, arrhythmias.",
 ph:"Aminophylline (theophylline + ethylenediamine) is a methylxanthine that inhibits phosphodiesterase (PDE), the enzyme that breaks down cAMP. By preventing cAMP degradation, theophylline indirectly increases cAMP levels in bronchial smooth muscle, promoting relaxation. It also blocks adenosine receptors (which normally cause bronchoconstriction) and may have mild anti-inflammatory effects by inhibiting mast cell mediator release. Its narrow therapeutic index (10-20 mcg/mL) means the difference between therapeutic and toxic levels is small.",
 an:"If albuterol fills a bucket with relaxation chemical (cAMP), aminophylline plugs the drain at the bottom so the bucket stays full longer. More cAMP in the cell = more bronchodilation. The problem is the bucket has a very specific water level it needs â€” too little doesn't work, too much overflows into toxicity (seizures, arrhythmias). That's the narrow therapeutic window.",
 pearl:"Narrow therapeutic index â€” toxicity risk high. Third-line after albuterol/ipratropium and steroids."},

// ==================== ANALGESICS ====================
{n:"Fentanyl",g:"Sublimaze",c:"analgesic",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM","IN"],ha:true,
 d:[{i:"Acute Pain",a:"1-2 mcg/kg IV slow (typical 25-100 mcg)",p:"1 mcg/kg IV/IN (max 50 mcg)",m:"200 mcg per protocol"},{i:"Intranasal (MAD)",a:"1-2 mcg/kg IN",p:"1.5 mcg/kg IN",m:"100 mcg/naris"}],
 ci:"Resp depression, altered LOC, hypotension, MAOIs 14 days.",adr:"Resp depression, hypotension, bradycardia, chest wall rigidity, nausea.",
 ph:"Fentanyl is a synthetic opioid that binds primarily to mu (Î¼) opioid receptors in the CNS â€” specifically in the dorsal horn of the spinal cord, periaqueductal gray matter, and limbic system. Mu receptor activation opens potassium channels (hyperpolarizing neurons) and closes voltage-gated calcium channels (reducing neurotransmitter release), inhibiting ascending pain signal transmission. Its high lipophilicity allows rapid CNS penetration (2-3 min IV onset) and short redistribution half-life. Fentanyl causes less histamine release than morphine because it doesn't trigger mast cell degranulation â€” making it more hemodynamically stable.",
 an:"Pain signals travel up the spinal cord like cars on a highway. Fentanyl puts up roadblocks at tollbooths (mu receptors) throughout the highway, stopping the pain 'cars' from reaching the brain. Because fentanyl is very fat-soluble, it slides through the brain's security gate (blood-brain barrier) much faster than morphine â€” that's the rapid onset. And because it doesn't kick over trash cans along the way (no histamine release), it causes less mess (less hypotension).",
 pearl:"80-100Ã— more potent than morphine. Onset 2-3 min IV. Preferred in hemodynamically unstable.",at:"Have naloxone immediately available"},

{n:"Morphine Sulfate",g:"MS Contin",c:"analgesic",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM"],ha:true,
 d:[{i:"Acute Pain/ACS/Pulmonary Edema",a:"2-4 mg IV slow over 1-5 min",p:"0.1-0.2 mg/kg (max 5 mg)",m:"10 mg initial"}],
 ci:"Resp depression, hypotension, head injury, volume depletion.",adr:"Resp depression, hypotension, N/V, histamine release.",
 ph:"Morphine binds mu and kappa opioid receptors, producing analgesia through CNS pain pathway inhibition similar to fentanyl. However, morphine also triggers direct mast cell degranulation (non-IgE mediated), releasing histamine which causes vasodilation, hypotension, and potentially bronchospasm. In pulmonary edema, this vasodilatory effect was historically considered beneficial (reducing preload), but current evidence shows morphine may increase mortality in ACS by masking symptoms without improving outcomes. It's less lipophilic than fentanyl, so it crosses the BBB slower (onset 5-10 min IV) but has a longer duration.",
 an:"Morphine is like fentanyl's older, less refined cousin. Both stop pain signals at the same roadblocks (mu receptors), but morphine also accidentally knocks over fire hydrants along the way (triggers histamine release), flooding the streets (vasodilation = low BP). This flooding was once thought helpful in pulmonary edema â€” like draining a swamp â€” but we now know it often causes more harm than good, which is why AHA has de-emphasized it.",
 pearl:"AHA de-emphasized in ACS â€” NTG and heparin preferred. Histamine release â†’ hypotension.",at:"De-emphasized in ACS per AHA â€” consider fentanyl"},

{n:"Ketorolac",g:"Toradol",c:"analgesic",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Moderate Pain (NSAID)",a:"15-30 mg IV or 30-60 mg IM",p:"0.5 mg/kg (max 15 mg)",m:"30 mg IV / 60 mg IM once"}],
 ci:"Active GI bleed, renal impairment, coagulopathy, NSAID allergy, 3rd tri pregnancy.",adr:"GI upset, bleeding risk, renal impairment.",
 ph:"Ketorolac is a parenteral NSAID that inhibits cyclooxygenase-1 and -2 (COX-1/COX-2). COX enzymes convert arachidonic acid to prostaglandins, which are key mediators of inflammation, pain sensitization, and fever. Prostaglandin E2 (PGE2) sensitizes peripheral nociceptors (pain receptors) to bradykinin and other pain mediators â€” essentially turning up the volume on pain signals. By blocking PGE2 production, ketorolac turns the volume back down at the peripheral nerve endings. COX-1 inhibition also reduces thromboxane A2, impairing platelet aggregation (bleeding risk) and reducing protective gastric mucus (GI risk).",
 an:"At the site of injury, the body releases chemicals that make nerve endings extra sensitive â€” like turning the volume knob on a speaker to maximum so every vibration is deafening (pain). Ketorolac turns the volume knob back down by blocking prostaglandin production. The injury is still there, but the nerves aren't screaming as loud. The downside is that the same volume knob also controls stomach protection and blood clotting â€” turning it down affects those too.",
 pearl:"Excellent opioid-sparing adjunct. Great for renal colic, MSK pain. Max 5 days."},

{n:"Acetaminophen",g:"Tylenol/Ofirmev",c:"analgesic",e:"ğŸ’Š",s:["emt","aemt","paramedic","rn","lpn"],r:["PO","IV","PR"],
 d:[{i:"Pain/Fever",a:"650-1000 mg PO; 1000 mg IV over 15 min",p:"15 mg/kg q4-6hr",m:"4 g/day (2 g if liver dz)"}],
 ci:"Severe hepatic impairment.",adr:"Hepatotoxicity (overdose >150 mg/kg).",
 ph:"Acetaminophen's exact mechanism remains partially unclear. It appears to work centrally (not peripherally like NSAIDs) by inhibiting COX enzymes in the brain, particularly COX-3, reducing central prostaglandin synthesis. It may also activate descending serotonergic pain inhibition pathways and interact with the endocannabinoid system (its metabolite AM404 inhibits anandamide reuptake). In overdose, the liver's normal glutathione conjugation pathway becomes overwhelmed, and a toxic metabolite (NAPQI) accumulates, causing hepatocellular necrosis.",
 an:"If NSAIDs turn down the pain volume at the speakers (peripheral nerves), acetaminophen turns it down at the control booth in the brain (central processing). Nobody fully understands all the knobs it turns, but the result is effective pain and fever relief. The catch: the control booth is in the liver's building, and too much acetaminophen sets the building on fire (NAPQI toxicity). NAC is the fire extinguisher.",
 pearl:"Safe multimodal adjunct. IV onset 5 min. NAC is antidote for OD. Check for APAP in combo products."},

{n:"Nitrous Oxide",g:"Nitronox",c:"analgesic",e:"ğŸ˜¶â€ğŸŒ«ï¸",s:["paramedic","rn"],r:["Inhaled"],
 d:[{i:"Pain/Anxiety",a:"Self-administered 50:50 Nâ‚‚O:Oâ‚‚ inhaled",p:"Same if cooperative",m:"Self-limiting â€” drops mask when sedated"}],
 ci:"Altered LOC, pneumothorax, bowel obstruction, COPD (relative), decompression sickness.",adr:"N/V, dizziness, euphoria, diffusion hypoxia.",
 ph:"Nâ‚‚O produces analgesia and anxiolysis through multiple CNS mechanisms: it stimulates endogenous opioid peptide release (endorphins and enkephalins), antagonizes NMDA glutamate receptors (reducing excitatory pain transmission), and activates GABA-A receptors (enhancing inhibitory neurotransmission). The 50:50 mix with oxygen ensures adequate oxygenation while providing effective analgesia. Its rapid onset and offset occur because of its low blood-gas solubility â€” it moves quickly in and out of the bloodstream across alveolar membranes.",
 an:"Nitrous oxide is like a triple cocktail for the brain's pain system. It releases the body's own painkillers (endorphins), muffles the pain alarm system (NMDA blockade), AND turns up the brain's natural calm-down signals (GABA). Because it evaporates from the blood as fast as it enters, the effect starts and stops almost instantly â€” like a light switch for pain relief. The patient holding their own mask IS the safety switch.",
 pearl:"Patient must hold own mask â€” built-in safety. Excellent for MSK pain, burns, procedural pain."},

{n:"Ketamine",g:"Ketalar",c:"analgesic",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM","IN"],ha:true,
 d:[{i:"Pain (sub-dissociative)",a:"0.1-0.3 mg/kg IV over 10 min",p:"Same",m:"Titrate"},{i:"Procedural Sedation",a:"1-2 mg/kg IV",p:"1-2 mg/kg IV",m:"May repeat 0.5 mg/kg"},{i:"Excited Delirium",a:"4 mg/kg IM",p:"3-4 mg/kg IM",m:"500 mg IM"}],
 ci:"Age <3mo (relative), severe HTN, eclampsia, active psychosis.",adr:"Emergence reaction, laryngospasm, â†‘secretions, nystagmus, HTN.",
 ph:"Ketamine is a dissociative anesthetic that works primarily by non-competitively antagonizing NMDA glutamate receptors in the CNS. NMDA receptors are critical for excitatory neurotransmission and pain wind-up (central sensitization). By blocking NMDA, ketamine disconnects the thalamocortical and limbic systems from the cerebral cortex â€” the patient is 'dissociated' from their environment and pain. Uniquely, ketamine stimulates the sympathetic nervous system by inhibiting catecholamine reuptake, which increases heart rate, BP, and cardiac output â€” opposite of most anesthetics. It also preserves pharyngeal/laryngeal protective reflexes and maintains respiratory drive.",
 an:"Most sedatives are like dimming the lights in the brain until it's dark (unconscious). Ketamine is different â€” it's like putting the patient inside a soundproof room. The brain is still 'on' (reflexes, breathing continue), but it's completely disconnected from incoming pain and environmental signals. The room has its own generator (sympathetic stimulation) that keeps the heart and lungs running. That's why ketamine is the only sedative that doesn't typically tank blood pressure.",
 pearl:"Unique: analgesia + sedation + amnesia while maintaining airway reflexes and BP.",at:"Maintain airway positioning â€” laryngospasm risk"},

{n:"Lidocaine 2% (Topical/Local)",g:"Xylocaine Local",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["Topical","SQ","IO"],
 d:[{i:"IO Pain Prior to Infusion",a:"20-40 mg (1-2 mL of 2%) IO slow push",p:"0.5 mg/kg IO",m:"40 mg"},{i:"Local Wound Anesthesia",a:"1-5 mg/kg SQ infiltrated",p:"Same",m:"4.5 mg/kg without epi; 7 mg/kg with epi"}],
 ci:"Amide anesthetic allergy.",adr:"Local: tissue swelling. Systemic: CNS toxicity if exceed max dose.",
 ph:"Topical/local lidocaine blocks voltage-gated sodium channels in peripheral nerve axons from the intracellular side. By preventing sodium influx, it stops action potential propagation along sensory (pain) nerve fibers. Smaller, unmyelinated C-fibers (dull pain, temperature) and thinly myelinated AÎ´-fibers (sharp pain) are blocked first because they have higher surface-area-to-volume ratios, allowing faster drug penetration. This differential blockade is why pain sensation is lost before touch and motor function.",
 an:"Nerve signals travel like a chain of dominoes falling. Lidocaine is like gluing some dominoes upright so they can't fall over â€” the pain signal hits the glued section and stops dead. Thin pain nerves are like small dominoes (easier to glue), so pain disappears first. Thick motor nerves are like heavy dominoes (harder to glue), so movement is preserved longer. That's differential blockade.",
 pearl:"IO lidocaine significantly reduces flush pain â€” give slow push, wait 60 sec, then flush."},

{n:"Benzocaine",g:"Hurricaine/Cetacaine",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["Topical"],
 d:[{i:"Topical Airway Anesthesia",a:"Spray to oropharynx (1-2 sec spray)",p:"Same but limit exposure",m:"Brief application"}],
 ci:"Methemoglobinemia history, G6PD deficiency, infants.",adr:"Methemoglobinemia (potentially fatal), allergic dermatitis.",
 ph:"Benzocaine is an ester-type local anesthetic that blocks sodium channels on mucosal surface nerve endings. The unique danger is its ability to oxidize the iron in hemoglobin from the ferrous (FeÂ²âº) to the ferric (FeÂ³âº) state, creating methemoglobin. Methemoglobin cannot bind or transport oxygen. Normal methemoglobin reductase (using NADH) maintains methemoglobin levels below 1%. Benzocaine overwhelms this enzyme system in susceptible individuals, causing symptomatic methemoglobinemia â€” cyanosis unresponsive to supplemental oxygen because the problem isn't in the lungs but in the hemoglobin itself.",
 an:"Normal hemoglobin is like a delivery truck with working arms that can pick up oxygen packages at the lung warehouse and deliver them to tissues. Benzocaine can 'break the arms' of hemoglobin (oxidize the iron), creating methemoglobin â€” trucks that drive around but can't pick up or deliver any oxygen. Giving more oxygen at the warehouse doesn't help because the trucks are broken. Methylene blue is the mechanic that fixes the arms.",
 pearl:"METHEMOGLOBINEMIA RISK â€” cyanosis unresponsive to Oâ‚‚. Treat with methylene blue 1-2 mg/kg IV."},

{n:"Tetracaine/Lidocaine/Epinephrine",g:"LET Gel",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["Topical"],
 d:[{i:"Laceration Anesthesia",a:"1-3 mL applied to wound for 20-30 min",p:"Same",m:"3 mL"}],
 ci:"Mucous membranes, digits/ears/nose/penis (epi component), large wounds.",adr:"Rare local irritation.",
 ph:"LET gel combines two local anesthetics (tetracaine and lidocaine) with epinephrine for synergistic wound anesthesia. Tetracaine and lidocaine both block sodium channels but through different pharmacokinetics â€” tetracaine (ester) has slower onset but longer duration while lidocaine (amide) has faster onset. The epinephrine component causes local vasoconstriction which reduces bleeding at the wound site, slows systemic absorption of the anesthetics (extending duration and reducing toxicity), and prolongs tissue contact time.",
 an:"LET gel is like a three-person repair crew at a wound: Lidocaine is the fast worker who starts numbing immediately, Tetracaine is the marathon worker who keeps numbing for hours, and Epinephrine is the assistant who squeezes the blood vessels shut to reduce bleeding AND keeps the first two workers on-site longer by preventing them from being washed away in the bloodstream.",
 pearl:"Non-invasive wound anesthesia â€” excellent for pediatric lacerations. Apply 20-30 min."},

{n:"Ibuprofen",g:"Advil/Motrin",c:"analgesic",e:"ğŸ’œ",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Pain/Fever/Inflammation",a:"400-800 mg PO q6-8hr",p:"10 mg/kg q6-8hr",m:"3200 mg/day (adult)"}],
 ci:"Active GI bleed, renal failure, NSAID allergy, 3rd trimester pregnancy, recent CABG.",adr:"GI upset, bleeding, renal impairment, cardiovascular events.",
 ph:"Ibuprofen non-selectively inhibits COX-1 and COX-2. COX-2 is induced at sites of inflammation and produces prostaglandins that cause pain, swelling, and fever. COX-1 is constitutively expressed and produces prostaglandins that maintain gastric mucosal integrity, regulate renal blood flow, and support platelet function (thromboxane A2). This explains the classic NSAID triad of side effects: GI ulceration (lost mucosal protection), renal impairment (reduced renal prostaglandin-mediated vasodilation), and bleeding (impaired platelet aggregation).",
 an:"COX enzymes are like a factory that makes both helpful products (stomach lining protector, kidney blood flow regulator) AND harmful products (pain and inflammation signals). Ibuprofen shuts down the entire factory â€” stopping pain AND the helpful stuff. That's the trade-off with all NSAIDs: you can't selectively shut down just the pain production line without also affecting the stomach and kidney production lines.",
 pearl:"OTC NSAID. EMT scope in many systems. Alternate with acetaminophen for pediatric fever."},

{n:"Meperidine",g:"Demerol",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Acute Pain / Rigors",a:"25-100 mg IV/IM q3-4hr",p:"1-1.5 mg/kg (max 100 mg)",m:"600 mg/day"}],
 ci:"MAOI use within 14 days, renal failure, seizure disorder.",adr:"Seizures (normeperidine metabolite), resp depression, serotonin syndrome with MAOIs.",
 ph:"Meperidine is a synthetic opioid mu-agonist with a unique toxic metabolite: normeperidine. The liver demethylates meperidine to normeperidine, which has a long half-life (15-30 hrs) and accumulates with repeated dosing or renal impairment. Normeperidine is a CNS excitant that lowers the seizure threshold. Additionally, meperidine has weak serotonin reuptake inhibitor properties â€” combined with MAOIs (which prevent serotonin breakdown), this can trigger fatal serotonin syndrome: hyperthermia, rigidity, myoclonus, and cardiovascular collapse.",
 an:"Most opioids leave behind harmless waste products. Meperidine leaves behind a toxic byproduct (normeperidine) that's like leaving lit matches in a trash can â€” eventually the trash can catches fire (seizures). The more meperidine you give and the worse the kidneys are at emptying the trash, the more matches pile up. That's why it's falling out of favor â€” safer alternatives exist that don't leave toxic garbage behind.",
 pearl:"Falling out of favor due to seizure risk. Useful for rigors/shivering (25 mg IV)."},

{n:"Nalbuphine",g:"Nubain",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["IV","IM","SQ"],
 d:[{i:"Moderate Pain",a:"10 mg IV/IM/SQ",p:"0.1-0.2 mg/kg",m:"20 mg/dose"}],
 ci:"Hypersensitivity. Caution in opioid-dependent patients.",adr:"Sedation, N/V, dizziness, sweating.",
 ph:"Nalbuphine is a mixed opioid agonist-antagonist. It acts as an agonist at kappa (Îº) receptors (producing analgesia and sedation) while simultaneously antagonizing mu (Î¼) receptors. This mixed profile creates a 'ceiling effect' for respiratory depression â€” beyond a certain dose, additional drug doesn't further suppress breathing. The mu-antagonism means it can precipitate withdrawal in patients physically dependent on pure mu-agonist opioids (morphine, fentanyl, heroin) by displacing those drugs from their receptors.",
 an:"Think of opioid receptors as two types of light switches: mu-switches (strong pain relief but can turn off breathing) and kappa-switches (moderate pain relief, safer). Nalbuphine flips the kappa switches ON while also taping the mu-switches to prevent them from being turned too far (ceiling effect on breathing). The downside: if a patient is dependent on drugs that use mu-switches, nalbuphine rips those drugs off the switches, triggering withdrawal.",
 pearl:"Mixed agonist-antagonist opioid. Ceiling effect for resp depression â€” safer profile."},

{n:"Butorphanol",g:"Stadol",c:"analgesic",e:"ğŸ’œ",s:["paramedic","rn","lpn"],r:["IV","IM","IN"],
 d:[{i:"Moderate-Severe Pain",a:"1-2 mg IV/IM; or 1 mg IN",p:"Not recommended",m:"4 mg/dose"}],
 ci:"Opioid dependence, hypersensitivity.",adr:"Sedation, N/V, dizziness, diaphoresis.",
 ph:"Similar to nalbuphine, butorphanol is a mixed kappa-agonist/mu-antagonist with a ceiling effect for respiratory depression. Its kappa-agonism in the spinal cord dorsal horn produces visceral analgesia, making it particularly effective for labor pain, migraines, and renal colic. The intranasal formulation achieves rapid systemic absorption through the highly vascular nasal mucosa, with onset in 1-2 minutes â€” comparable to IV administration.",
 an:"Butorphanol works on the same 'safer switch' system (kappa receptors) as nalbuphine. The nasal spray version is like having a fast-pass â€” the nose's rich blood supply delivers the drug to the brain almost as fast as an IV, without needing to start a line. It's especially useful for migraines because patients who are nauseated can't take pills.",
 pearl:"Mixed agonist-antagonist. IN route useful in field. Ceiling effect for resp depression."},

// ==================== SEDATION / RSI ====================
{n:"Midazolam",g:"Versed",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM","IN"],ha:true,
 d:[{i:"Seizure",a:"5 mg IM or 2.5-5 mg IV or 5 mg IN",p:"0.1-0.2 mg/kg (max 5 mg)",m:"10 mg total"},{i:"Sedation",a:"1-2.5 mg IV titrated slowly",p:"0.05-0.1 mg/kg",m:"5 mg"}],
 ci:"Narrow-angle glaucoma, shock, severe resp depression.",adr:"Resp depression, hypotension, paradoxical agitation.",
 ph:"Midazolam is a benzodiazepine that binds to a specific site on the GABA-A receptor complex (the benzodiazepine binding site on the alpha subunit). It does NOT directly open the chloride channel â€” instead, it increases the FREQUENCY of chloride channel opening when GABA is present (allosteric modulation). Increased chloride influx hyperpolarizes neurons, raising the threshold for firing. In seizures, this rapidly suppresses the excessive, synchronized neuronal firing. Its water-soluble formulation at acidic pH becomes lipophilic at physiologic pH, enabling IN/IM absorption while maintaining IV compatibility.",
 an:"GABA is like the brain's brake fluid, and GABA-A receptors are the brake pads. Midazolam doesn't add more brake fluid â€” it makes the existing brake pads grip 'stickier,' so every drop of brake fluid works harder. In a seizure, the brain's accelerator is floored. Midazolam supercharges the brakes to regain control. The IN route works because the drug changes its chemical form at body pH â€” like a chameleon adapting to get absorbed through the nasal tissue.",
 pearl:"IN route gold standard for prehospital seizures â€” MAD device, split dose between nares.",at:"Monitor resp continuously â€” BVM and suction ready"},

{n:"Diazepam",g:"Valium",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM","PR"],
 d:[{i:"Seizure/Status Epilepticus",a:"5-10 mg IV slow q10-15min",p:"0.2-0.5 mg/kg IV/PR",m:"20 mg total"},{i:"Sedation/Muscle Relaxant",a:"2-10 mg IV/IM",p:"0.1-0.3 mg/kg",m:"Per protocol"}],
 ci:"Narrow-angle glaucoma, shock, severe resp depression, pregnancy.",adr:"Resp depression, hypotension, thrombophlebitis.",
 ph:"Diazepam has the same GABA-A allosteric modulation mechanism as midazolam but with important pharmacokinetic differences. It is highly lipophilic (faster CNS penetration but erratic IM absorption due to precipitation in muscle tissue), has a longer duration of action (half-life 20-100 hrs with active metabolites including desmethyldiazepam/nordiazepam), and its propylene glycol vehicle causes thrombophlebitis with IV administration and pain with IM injection. The rectal formulation (Diastat) provides reliable absorption because the rectal venous plexus delivers drug directly to systemic circulation, bypassing first-pass hepatic metabolism.",
 an:"Diazepam and midazolam both supercharge the brain's brakes (GABA), but diazepam is like a slow-release brake enhancement that keeps working for a long time (hours to days). Its IM absorption is unpredictable â€” like trying to dissolve oil in water (it precipitates). But rectally, it absorbs beautifully because the lower rectum drains directly into the bloodstream, skipping the liver. That's why Diastat gel works so well for at-home seizure rescue in kids.",
 pearl:"Rectal route excellent for pediatric seizures (Diastat). IM absorption erratic."},

{n:"Lorazepam",g:"Ativan",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Seizure/Status Epilepticus",a:"2-4 mg IV slow over 2 min",p:"0.05-0.1 mg/kg (max 4 mg)",m:"May repeat Ã—1"},{i:"Anxiety/Sedation",a:"0.5-2 mg IV/IM",p:"0.05 mg/kg",m:"4 mg"}],
 ci:"Severe resp depression, acute narrow-angle glaucoma.",adr:"Resp depression, sedation, hypotension.",
 ph:"Lorazepam shares the GABA-A mechanism of all benzodiazepines but has a uniquely favorable profile for status epilepticus: moderate lipophilicity allows reliable brain penetration without rapid redistribution (unlike diazepam, which quickly redistributes to fat stores causing seizure recurrence). Its intermediate half-life (10-20 hrs) provides sustained anticonvulsant effect without excessively prolonged sedation. No active metabolites means more predictable pharmacokinetics. However, it requires refrigeration because the drug is unstable at room temperature.",
 an:"Imagine three benzos trying to put out a brain fire (seizure): Diazepam rushes in fast but then runs away to hide in the fat stores, letting the fire restart. Midazolam works well but wears off quickly. Lorazepam arrives at moderate speed, stays put at the fire, and keeps hosing it down steadily. That's why many status epilepticus guidelines prefer it â€” it stays at the scene. The catch: it needs to be kept cold (refrigerated) or it goes bad.",
 pearl:"Preferred benzo for status epilepticus. Longer anticonvulsant effect than diazepam. Must refrigerate."},

{n:"Etomidate",g:"Amidate",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],
 d:[{i:"RSI Induction",a:"0.3 mg/kg IV over 30-60 sec",p:"0.3 mg/kg IV",m:"Single induction dose"}],
 ci:"Adrenal insufficiency.",adr:"Myoclonus, transient adrenal suppression, pain on injection.",
 ph:"Etomidate is an imidazole derivative that enhances GABA-A receptor activity, producing rapid-onset sedation and amnesia. Unlike benzodiazepines, it acts at a different binding site on the GABA-A complex and directly increases the DURATION of chloride channel opening (not frequency). Its hemodynamic stability is remarkable â€” it does not release histamine, minimally affects myocardial contractility, and has no significant effect on SVR. The concern is inhibition of 11-beta-hydroxylase, the enzyme that converts 11-deoxycortisol to cortisol, causing transient adrenal suppression (4-12 hrs after a single dose). In septic patients who are already adrenally stressed, this suppression may be clinically significant.",
 an:"If ketamine is a soundproof room and benzos supercharge the brakes, etomidate is like a precise dimmer switch â€” it smoothly turns consciousness down without touching any other switches in the room (blood pressure, heart rate, breathing drive). That's why it's the go-to for RSI in hypotensive patients. The one problem: it temporarily unplugs the body's stress hormone generator (cortisol) for a few hours, which matters if the patient is already in septic shock.",
 pearl:"Hemodynamically neutral â€” ideal for hypotensive patients needing RSI. Onset 15-45 sec."},

{n:"Propofol",g:"Diprivan",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"RSI Induction/Post-Intubation Sedation",a:"1-2.5 mg/kg IV; 25-75 mcg/kg/min drip",p:"2.5-3.5 mg/kg; 125-300 mcg/kg/min",m:"Titrate to sedation"}],
 ci:"Egg/soy allergy, hemodynamic instability, elevated triglycerides.",adr:"Hypotension (dose-dependent), apnea, bradycardia, pain on injection.",
 ph:"Propofol potentiates GABA-A at low concentrations and directly activates GABA-A channels at higher concentrations (bypassing GABA entirely). It also inhibits NMDA glutamate receptors and modulates glycine receptors. Its profound hypotension results from direct vasodilation (reduced SVR), negative inotropy, and resetting of the baroreceptor reflex. Formulated as a lipid emulsion (soybean oil, egg lecithin, glycerol), which is why egg/soy allergy is a contraindication. Propofol infusion syndrome (rare, prolonged use >48 hrs at high doses) involves mitochondrial impairment causing metabolic acidosis, rhabdomyolysis, and cardiac failure.",
 an:"Propofol is like flipping the master breaker switch in the brain â€” everything goes off instantly (15-30 sec). But unlike etomidate's precise dimmer switch, propofol also hits the blood pressure breaker on the way down. It's the fastest, smoothest sedation available, but the blood pressure 'power outage' can be dangerous in already-hypotensive patients. The lipid formulation (white milky appearance) is why it's called 'milk of amnesia.'",
 pearl:"Extremely rapid onset (15-30 sec) and recovery. Causes significant hypotension."},

{n:"Succinylcholine",g:"Anectine",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV","IM"],ha:true,
 d:[{i:"RSI Paralytic",a:"1-1.5 mg/kg IV push",p:"2 mg/kg IV",m:"Single dose"},{i:"IM (no IV)",a:"3-4 mg/kg IM",p:"4 mg/kg IM",m:"150 mg IM"}],
 ci:"Hyperkalemia, burns/crush >24hr, malignant hyperthermia hx, penetrating eye injury, denervation injury.",adr:"Malignant hyperthermia, hyperkalemia, bradycardia (peds), fasciculations.",
 ph:"Succinylcholine is a depolarizing neuromuscular blocker â€” structurally it's two acetylcholine molecules joined together. It binds nicotinic acetylcholine receptors at the neuromuscular junction (NMJ), causing initial depolarization and muscle contraction (fasciculations), then the channel remains open, causing sustained depolarization and preventing repolarization (Phase I block). The muscle cannot contract again because it's stuck in a depolarized state. Normally, acetylcholinesterase rapidly breaks down ACh, but succinylcholine is resistant to this enzyme â€” instead, plasma cholinesterase (pseudocholinesterase) in the blood slowly metabolizes it over 6-10 minutes. During fasciculation, intracellular potassium leaks out. In patients with burns, crush injuries, or denervation (>24 hrs), upregulated extrajunctional receptors cause massive potassium release â†’ fatal hyperkalemia.",
 an:"At the NMJ, acetylcholine is like a key that turns the ignition (muscle contracts) then immediately falls out (enzyme destroys it). Succinylcholine is like jamming a key in the ignition and BREAKING it off â€” the ignition fires once (fasciculations) then stays jammed so no more signals get through (paralysis). After 6-10 min, a different mechanic (plasma cholinesterase) extracts the broken key. In burn/crush patients, the locks multiply all over the muscle, so when the key jams, massive amounts of potassium leak out â€” like a dam breaking.",
 pearl:"Fastest onset (45-60 sec), shortest duration (6-10 min). Pretreat peds with atropine.",at:"MUST have BVM + backup airway BEFORE giving"},

{n:"Rocuronium",g:"Zemuron",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"RSI Paralytic",a:"1-1.2 mg/kg IV push",p:"1 mg/kg IV",m:"Single dose"}],
 ci:"Known hypersensitivity.",adr:"Prolonged paralysis (40-60 min), bronchospasm (rare).",
 ph:"Rocuronium is a non-depolarizing neuromuscular blocker that competitively antagonizes acetylcholine at nicotinic receptors on the motor end plate. Unlike succinylcholine, it blocks the receptor WITHOUT causing initial depolarization â€” no fasciculations, no potassium release. It competes with ACh for receptor binding: when enough receptors are occupied (~75-80%), neuromuscular transmission fails and paralysis occurs. Recovery happens as the drug redistributes and is slowly eliminated by the liver. Sugammadex (modified cyclodextrin) can immediately reverse rocuronium by encapsulating the molecules like a molecular cage.",
 an:"If succinylcholine jams a key in the lock, rocuronium is like putting bubble gum in the keyhole â€” the real key (ACh) simply can't get in, so the ignition never turns (no fasciculations, no potassium release). The gum stays stuck for 40-60 minutes until the body slowly clears it. Sugammadex is like a tiny Pac-Man that eats each piece of gum one by one, instantly clearing the keyholes and restoring muscle function â€” a true reversal agent.",
 pearl:"Non-depolarizing. Safe in hyperkalemia/burns/crush. Sugammadex reverses.",at:"Duration 40-60 min â€” MUST secure airway"},

{n:"Vecuronium",g:"Norcuron",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"RSI / Maintenance Paralysis",a:"0.1 mg/kg IV (RSI); 0.01 mg/kg maintenance",p:"Same",m:"Per protocol"}],
 ci:"Hypersensitivity.",adr:"Prolonged paralysis, bronchospasm (rare).",
 ph:"Vecuronium is an aminosteroid non-depolarizing neuromuscular blocker with the same competitive nicotinic receptor antagonism as rocuronium. It has no vagolytic properties (unlike pancuronium), so it doesn't cause tachycardia. Metabolism is primarily hepatic with some renal elimination. It requires reconstitution from powder, adding preparation time. Its intermediate duration (25-40 min) and lack of cardiovascular side effects make it useful for maintenance paralysis after initial RSI.",
 an:"Vecuronium is rocuronium's mellower sibling â€” same gum-in-the-keyhole mechanism but slightly slower onset, shorter duration, and zero heart rate effects. The tradeoff is you have to mix it from powder first (like making instant coffee), which costs precious time during an emergency RSI when seconds matter. That's why rocuronium (pre-mixed, ready to go) has largely replaced it for first-line RSI.",
 pearl:"Non-depolarizing. Onset 2-3 min, duration 25-40 min. Requires reconstitution."},

{n:"Sugammadex",g:"Bridion",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Rocuronium/Vecuronium Reversal",a:"16 mg/kg IV for immediate reversal; 4 mg/kg for moderate block",p:"Same",m:"16 mg/kg"}],
 ci:"Known hypersensitivity.",adr:"Bradycardia, N/V, hypersensitivity, interference with hormonal contraceptives.",
 ph:"Sugammadex is a modified gamma-cyclodextrin â€” a ring-shaped sugar molecule with a lipophilic core that encapsulates steroidal neuromuscular blockers (rocuronium, vecuronium) in a 1:1 molecular complex. This encapsulation removes free rocuronium from the NMJ by creating a concentration gradient â€” rocuronium moves from the NMJ back into plasma where sugammadex captures it. The complex is then renally excreted intact. This is fundamentally different from traditional reversal (neostigmine), which indirectly increases ACh to outcompete the blocker. Sugammadex can reverse even profound (deep) blockade within 1-3 minutes.",
 an:"Traditional reversal (neostigmine) is like trying to shout louder than the noise (adding more ACh to outcompete the blocker at the receptor). Sugammadex is like grabbing the noisemaker and stuffing it in a soundproof box â€” each cyclodextrin molecule wraps around one rocuronium molecule and neutralizes it completely. It's not fighting at the receptor; it's removing the drug entirely. That's why it works even in deep paralysis when neostigmine can't.",
 pearl:"Game-changer for failed airway after rocuronium. Complete reversal in 1-3 min. Expensive."},

// ==================== NEURO / SEIZURE ====================
{n:"Levetiracetam",g:"Keppra",c:"neuro",e:"ğŸ§ ",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Status Epilepticus (2nd line)",a:"20-60 mg/kg IV over 15 min (max 4500 mg)",p:"20-60 mg/kg (max 4500 mg)",m:"4500 mg"}],
 ci:"Known hypersensitivity.",adr:"Drowsiness, dizziness, behavioral changes.",
 ph:"Levetiracetam's mechanism is unique â€” it binds to synaptic vesicle protein 2A (SV2A) in presynaptic nerve terminals. SV2A is involved in the fusion of synaptic vesicles with the cell membrane during neurotransmitter release. By modulating SV2A, levetiracetam reduces the release of excitatory neurotransmitters, dampening excessive neuronal firing without broadly suppressing normal brain activity. It also inhibits N-type calcium channels and reduces intraneuronal calcium release. This novel mechanism explains why it has fewer drug interactions than traditional anticonvulsants â€” it doesn't affect cytochrome P450 enzymes.",
 an:"Most seizure drugs are like traffic cops standing at intersections (ion channels) trying to slow everything down. Levetiracetam takes a completely different approach â€” it goes to the warehouse (presynaptic terminal) and reduces the number of packages (neurotransmitters) being loaded onto delivery trucks. Fewer packages shipped = less excitatory signaling = seizure stops. Since it works at the warehouse level, it doesn't interfere with the traffic cops (no drug interactions).",
 pearl:"Increasingly used as 2nd-line for status epilepticus. Fewer drug interactions than phenytoin."},

{n:"Phenytoin / Fosphenytoin",g:"Dilantin / Cerebyx",c:"neuro",e:"ğŸ§ ",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Status Epilepticus (2nd line)",a:"Fosphenytoin: 20 mg PE/kg IV at 150 mg/min",p:"20 mg PE/kg at 1-3 mg PE/kg/min",m:"30 mg PE/kg total"}],
 ci:"Sinus bradycardia, SA/AV block, Adams-Stokes syndrome.",adr:"Hypotension, bradycardia, cardiac arrest if too fast, purple glove syndrome.",
 ph:"Phenytoin blocks voltage-gated sodium channels in neurons in a use-dependent manner â€” it preferentially binds to channels that are firing rapidly (as in seizures) by stabilizing the inactivated state of the channel. This prevents the repetitive, high-frequency neuronal firing characteristic of seizure activity while having minimal effect on normal low-frequency firing. Fosphenytoin is a water-soluble prodrug converted to phenytoin by plasma phosphatases (1.5 mg fosphenytoin = 1 mg phenytoin equivalent, hence 'PE' dosing). The cardiac toxicity from rapid infusion comes from the propylene glycol diluent (phenytoin) or direct sodium channel effects on cardiac tissue.",
 an:"During a seizure, neurons are firing like a machine gun â€” rapid, repetitive bursts. Phenytoin is like putting a speed limiter on the firing mechanism: after each shot, it prevents the gun from reloading quickly enough to fire again at machine-gun speed, but doesn't prevent normal single shots. Fast-firing seizure neurons are affected most while normal neurons barely notice. Fosphenytoin is the same bullet in a safer casing (water-soluble) that's gentler on the veins.",
 pearl:"Fosphenytoin preferred â€” less phlebitis, can give IM. NEVER mix with dextrose."},

{n:"Haloperidol",g:"Haldol",c:"neuro",e:"ğŸ§ ",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Acute Psychosis / Agitation",a:"2-5 mg IM or IV slowly",p:"Not typically used prehospital",m:"10 mg"},{i:"Antiemetic (2nd line)",a:"1-2 mg IV/IM",p:"N/A",m:"5 mg"}],
 ci:"CNS depression, Parkinson's disease, QT prolongation.",adr:"Dystonia, QT prolongation, NMS, akathisia.",
 ph:"Haloperidol is a typical (first-generation) antipsychotic that primarily blocks dopamine D2 receptors in the mesolimbic and mesocortical pathways. In psychosis, excess dopaminergic activity in the mesolimbic pathway produces hallucinations and delusions. D2 blockade reduces this hyperdopaminergic state. However, D2 blockade in the nigrostriatal pathway (motor control) causes extrapyramidal symptoms (dystonia, akathisia) and in the tuberoinfundibular pathway causes hyperprolactinemia. QT prolongation results from potassium channel (hERG) blockade, which can lead to torsades. Neuroleptic malignant syndrome (NMS) is a rare but life-threatening reaction involving extreme D2 blockade in the hypothalamus and basal ganglia.",
 an:"Dopamine is the brain's 'reward and reality' chemical. In psychosis, certain brain pathways are flooded with too much dopamine â€” like a radio tuned between stations, picking up signals that aren't there (hallucinations). Haloperidol turns down the dopamine volume throughout the brain. The problem is it can't turn down JUST the psychosis pathway â€” it also turns down the motor control pathway (causing stiffness/dystonia) and the hormone pathway (prolactin issues). It's a blunt tool.",
 pearl:"Butyrophenone antipsychotic. Causes less resp depression than benzos. Watch for dystonic reaction."},

// ==================== METABOLIC ====================
{n:"Dextrose 50% (D50)",g:"Dextrose",c:"metabolic",e:"âš—ï¸",s:["aemt","paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hypoglycemia (BGL <60)",a:"25 g (50 mL of D50) IV push",p:"D25: 2-4 mL/kg; D10: 5 mL/kg (neonates)",m:"25 g"}],
 ci:"None in confirmed hypoglycemia.",adr:"Hyperglycemia, tissue necrosis if infiltrates.",
 ph:"Glucose is the primary energy substrate for the brain. Neurons cannot store glycogen in significant amounts and cannot use fatty acids for fuel, making them entirely dependent on continuous blood glucose supply. When blood glucose drops below ~50 mg/dL, neurons experience energy failure â€” ATP production via glycolysis and the citric acid cycle stalls, ion pumps fail, and neurons depolarize uncontrollably (causing seizures) or cease functioning (causing altered LOC). IV dextrose rapidly restores blood glucose, providing immediate substrate for cellular ATP production and reversing neuroglycopenic symptoms within minutes.",
 an:"The brain is like a luxury sports car that runs ONLY on premium fuel (glucose) â€” it can't switch to diesel (fats) or regular gas (other substrates) like the rest of the body can. When the gas tank runs dry (hypoglycemia), the engine starts misfiring (confusion, seizures) then stalls completely (coma). D50 is like a direct injection of premium fuel into the tank â€” the engine roars back to life almost immediately. That's why glucose is the most dramatic 'save' in EMS.",
 pearl:"CHECK BGL BEFORE GIVING. Hypertonic â€” infiltration = tissue necrosis. Consider thiamine first in alcoholics."},

{n:"Glucagon",g:"GlucaGen",c:"metabolic",e:"âš—ï¸",s:["emt","aemt","paramedic","rn","lpn"],r:["IM","IN","IV"],
 d:[{i:"Hypoglycemia (no IV)",a:"1 mg IM",p:"0.5 mg (<20 kg); 1 mg (>20 kg)",m:"Repeat Ã—1 in 15 min"},{i:"Beta-Blocker/CCB Overdose",a:"3-5 mg IV bolus",p:"0.05-0.15 mg/kg",m:"10 mg, then drip"}],
 ci:"Pheochromocytoma, insulinoma.",adr:"Nausea, vomiting, hyperglycemia, tachycardia.",
 ph:"Glucagon is a peptide hormone normally produced by pancreatic alpha cells. It binds to glucagon receptors on hepatocytes, activating adenylate cyclase â†’ cAMP â†’ protein kinase A, which stimulates glycogenolysis (glycogen â†’ glucose) and gluconeogenesis (amino acids/lactate â†’ glucose). For beta-blocker/CCB overdose, glucagon activates the same cAMP pathway in cardiac myocytes, BYPASSING the blocked beta-receptors entirely. It increases intracellular cAMP â†’ increases calcium availability â†’ restores cardiac contractility and heart rate independent of adrenergic receptor function.",
 an:"For hypoglycemia: the liver keeps a pantry full of stored sugar (glycogen). Glucagon is like calling the liver and saying 'open the pantry and dump everything into the bloodstream NOW.' If the pantry is empty (malnourished/alcoholic patients), the call goes unanswered â€” that's why it fails in those patients. For beta-blocker OD: the front door to heart cells (beta receptors) is locked by the poison. Glucagon uses a SIDE DOOR (its own receptor) that leads to the same room (cAMP pathway), getting the heart pumping again by going around the blockade.",
 pearl:"Requires glycogen stores â€” ineffective if malnourished. Also first-line for beta-blocker/CCB OD."},

{n:"Thiamine (Vitamin B1)",g:"Thiamine HCl",c:"metabolic",e:"âš—ï¸",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Wernicke's Prevention",a:"100 mg IV/IM",p:"Not typically indicated",m:"100 mg"}],
 ci:"Known hypersensitivity (rare).",adr:"Rare anaphylaxis (IV), pain at injection site.",
 ph:"Thiamine (vitamin B1) is an essential cofactor for three critical enzymes in glucose metabolism: pyruvate dehydrogenase (links glycolysis to the citric acid cycle), alpha-ketoglutarate dehydrogenase (citric acid cycle), and transketolase (pentose phosphate pathway). Without thiamine, the brain cannot efficiently convert glucose to ATP. In chronic alcoholism/malnutrition, thiamine stores are depleted. Giving glucose (D50) to a thiamine-depleted patient accelerates glucose metabolism through pathways that REQUIRE thiamine, potentially precipitating acute Wernicke's encephalopathy (ophthalmoplegia, ataxia, confusion) by exhausting the last remaining thiamine reserves.",
 an:"Think of glucose metabolism as an assembly line in a factory. Thiamine is the crucial bolt that holds three different machines together. Without the bolt, the machines (enzymes) can't process raw materials (glucose) into the finished product (ATP energy). If you flood the factory with raw materials (give D50) but the bolts are missing (thiamine depleted), the machines jam catastrophically (Wernicke's encephalopathy). That's why you install the bolts FIRST (give thiamine) before sending in the raw materials.",
 pearl:"Give BEFORE dextrose in alcoholic/malnourished patients. Negligible risk â€” huge upside."},

{n:"Sodium Bicarbonate",g:"NaHCOâ‚ƒ",c:"metabolic",e:"âš—ï¸",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"TCA Overdose",a:"1-2 mEq/kg IV push",p:"1 mEq/kg",m:"Repeat to QRS <100ms"},{i:"Hyperkalemia",a:"1 mEq/kg IV",p:"1 mEq/kg",m:"Based on labs"},{i:"Prolonged Arrest",a:"1 mEq/kg IV",p:"1 mEq/kg",m:"Per ABG"}],
 ci:"Alkalosis, hypochloremia, hypokalemia.",adr:"Alkalosis, hypernatremia, hypokalemia, tissue necrosis.",
 ph:"In TCA overdose, the drug blocks fast sodium channels in the heart, widening the QRS complex and causing lethal arrhythmias. Sodium bicarbonate works via TWO mechanisms: (1) the sodium load provides additional sodium ions that compete with the TCA for sodium channel binding, partially overcoming the blockade; (2) the bicarbonate alkalinizes the blood, increasing protein binding of the TCA (trapping it in plasma, away from cardiac tissue) and reducing the fraction of ionized drug available to block channels. In hyperkalemia, alkalosis drives hydrogen ions out of cells in exchange for potassium ions moving in, temporarily lowering serum potassium.",
 an:"In TCA overdose, the drug is like gum clogging the heart's electrical wires (sodium channels). Bicarb works two ways: it floods the wires with extra electricity (sodium) to push through the blockage, AND it makes the blood more alkaline which makes the gum stickier to proteins in the blood instead of the wires â€” pulling the gum OFF the heart and trapping it in the bloodstream. For hyperkalemia, bicarb is like opening the cell doors and saying 'potassium, come inside' â€” trading extracellular K+ for intracellular H+.",
 pearl:"NOT routine in arrest. TCA: give until QRS narrows. Inactivates vasopressors â€” flush between meds!"},

{n:"Calcium Chloride 10%",g:"CaClâ‚‚",c:"metabolic",e:"âš—ï¸",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"Hyperkalemia/CCB OD/HF Burns",a:"500-1000 mg IV slow over 2-5 min",p:"20 mg/kg slow push",m:"1000 mg/dose q10min"}],
 ci:"Digitalis toxicity (relative), hypercalcemia.",adr:"Bradycardia if too fast, tissue necrosis, cardiac arrest.",
 ph:"In hyperkalemia, elevated extracellular potassium reduces the resting membrane potential difference in cardiac myocytes, making them more excitable and prone to arrhythmias. Calcium raises the threshold potential (the voltage needed to trigger an action potential), restoring the normal gap between resting and threshold potentials. This stabilizes the cardiac membrane WITHOUT lowering potassium levels. In CCB overdose, calcium provides additional substrate to overcome competitive calcium channel blockade â€” flooding the system with calcium increases the probability of channel occupancy despite the blocker.",
 an:"In hyperkalemia, the heart's electrical system is like a hair-trigger mousetrap â€” any small stimulus sets it off (arrhythmia). Calcium is like adding weight to the trigger mechanism so it takes a bigger stimulus to set it off. It doesn't remove the excess potassium (that's insulin/bicarb's job) â€” it just makes the heart less jumpy while you work on the actual problem. For CCB overdose, the blocker is like a bouncer keeping calcium out of heart cells. Giving extra calcium is like sending so many people to the door that some get past the bouncer through sheer numbers.",
 pearl:"3Ã— more elemental calcium than gluconate. Stabilizes cardiac membrane in hyperkalemia.",at:"SLOW push over 2-5 min â€” rapid push can cause arrest"},

{n:"Calcium Gluconate",g:"Cal-Gluconate",c:"metabolic",e:"âš—ï¸",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hyperkalemia/Mag Toxicity Antidote",a:"1-2 g IV over 5-10 min",p:"60-100 mg/kg (max 3 g)",m:"May repeat"}],
 ci:"Digitalis toxicity, hypercalcemia.",adr:"Hypotension, bradycardia, flushing.",
 ph:"Same membrane-stabilizing mechanism as calcium chloride, but calcium gluconate contains only one-third the elemental calcium per gram (4.65 mEq/g vs 13.6 mEq/g for CaClâ‚‚). The gluconate salt must be hepatically metabolized to release free calcium ions. Its major advantage is peripheral IV safety â€” calcium gluconate is less irritating to veins and causes far less tissue necrosis if it infiltrates, because the calcium is bound to gluconate and not immediately ionized. As the magnesium toxicity antidote, calcium directly antagonizes magnesium at the NMJ and cardiac tissue, reversing respiratory depression and hypotension.",
 an:"Calcium gluconate and calcium chloride are like two delivery trucks carrying the same product (calcium), but gluconate wraps each unit in protective packaging (gluconate salt). You get less product per truck (â…“ the calcium) and the liver has to unwrap each package before it's usable, BUT if the truck crashes and spills (IV infiltration), the wrapped packages don't damage the road (less tissue necrosis). That's why it's safer for peripheral IVs.",
 pearl:"Safer via peripheral IV than CaClâ‚‚. Antidote for magnesium sulfate toxicity."},

{n:"Insulin (Regular)",g:"Humulin R",c:"metabolic",e:"âš—ï¸",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hyperkalemia (with D50)",a:"10 units IV with 25 g D50",p:"Protocol dependent",m:"10 units"}],
 ci:"Hypoglycemia.",adr:"Hypoglycemia, hypokalemia.",
 ph:"Insulin binds to insulin receptors on cell membranes, activating the Naâº/Kâº-ATPase pump via downstream signaling (PI3K pathway). This pump actively transports potassium INTO cells while pumping sodium OUT, lowering serum potassium by 0.5-1.2 mEq/L within 15-30 minutes. Insulin also stimulates translocation of GLUT4 glucose transporters to the cell surface, pulling glucose into cells (which is why D50 must be co-administered â€” to prevent iatrogenic hypoglycemia). This is a REDISTRIBUTION strategy â€” total body potassium doesn't change; it's just shifted intracellularly as a bridge until definitive removal (dialysis, kayexalate) occurs.",
 an:"The body's cells have revolving doors (Na/K-ATPase pumps) that push potassium inside and sodium outside. In hyperkalemia, there's too much potassium loitering in the bloodstream (dangerous for the heart). Insulin is like a manager who walks through the building yelling 'everyone inside NOW!' â€” it activates the revolving doors to spin faster, pulling potassium into cells. The D50 given alongside is like free pizza inside the building (glucose) to prevent a blood sugar crash since insulin also pulls glucose inside.",
 pearl:"ALWAYS give with dextrose to prevent hypoglycemia. Monitor BGL q15-30 min."},

// ==================== TOXICOLOGY ====================
{n:"Naloxone",g:"Narcan",c:"toxicology",e:"ğŸ’‰",s:["emt","aemt","paramedic","rn","lpn"],r:["IV","IM","IN","ET"],ha:true,
 d:[{i:"Opioid Overdose",a:"0.4-2 mg IV/IM/IN q2-3min",p:"0.1 mg/kg (max 2 mg)",m:"10 mg total"},{i:"Intranasal",a:"4 mg IN (2 mg/naris)",p:"Same",m:"May repeat q2-3min"}],
 ci:"Known hypersensitivity.",adr:"Acute withdrawal (N/V, agitation, tachycardia, diaphoresis, pulmonary edema).",
 ph:"Naloxone is a pure competitive opioid antagonist with highest affinity for mu (Î¼) receptors. It rapidly displaces opioid agonists (heroin, fentanyl, morphine) from mu receptors without activating them, immediately reversing respiratory depression, miosis, and CNS depression. Its affinity for mu receptors is HIGHER than most opioid agonists, which is why it can displace them. However, its duration of action (30-90 min) is often shorter than the opioid it's reversing â€” especially long-acting opioids or large fentanyl doses â€” necessitating repeat dosing or continuous monitoring.",
 an:"Opioids are like keys stuck in the brain's 'stop breathing' lock (mu receptors). Naloxone is like a master locksmith who shows up, yanks out the stuck key (displaces the opioid), and puts in a blank key that fits the lock but doesn't turn it (binds without activating). The catch: the blank key (naloxone) falls out after 30-90 minutes, and if the stuck key (opioid) is still floating around in the bloodstream, it can slide right back in. That's why patients can re-narcotize â€” the locksmith left but the opioid didn't.",
 pearl:"TITRATE to respiratory effort, NOT consciousness. Goal: RR >12. Duration 30-90 min.",at:"Titrate to breathing, NOT consciousness"},

{n:"Activated Charcoal",g:"ActiDose",c:"toxicology",e:"â˜ ï¸",s:["paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Toxic Ingestion (<1 hr)",a:"1 g/kg PO (typical 25-50 g)",p:"1 g/kg (max 50 g)",m:"50 g single dose"}],
 ci:"Unprotected airway, caustics, petroleum, altered LOC, GI obstruction.",adr:"Vomiting, aspiration, constipation.",
 ph:"Activated charcoal is wood or coconut shell carbon heated to extreme temperatures, creating a vast network of microscopic pores with enormous surface area (~1000 mÂ²/gram). Toxins adsorb (bind) to this surface via van der Waals forces and hydrophobic interactions, trapping them in the GI tract and preventing systemic absorption. It works best on large, non-polar organic molecules. It does NOT bind: metals (iron, lithium), alcohols (methanol, ethylene glycol), cyanide, caustics, or hydrocarbons â€” these are too small, too polar, or too corrosive for effective adsorption.",
 an:"Activated charcoal is like a super-absorbent sponge thrown into a puddle of spilled poison in the stomach. Each grain of charcoal has millions of tiny pockets that grab and trap poison molecules before they can soak through the stomach lining into the blood. But the sponge can only grab certain types of molecules â€” small slippery ones (alcohols, metals) slip right through the pockets. And the sponge must be thrown in while the puddle is still there (within 1 hour) â€” after the poison is absorbed, the sponge has nothing to grab.",
 pearl:"Most effective <1 hr post-ingestion. Does NOT bind: iron, lithium, alcohols, cyanide, caustics."},

{n:"Flumazenil",g:"Romazicon",c:"toxicology",e:"â˜ ï¸",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"Benzodiazepine Reversal",a:"0.2 mg IV over 30 sec, may repeat 0.2 mg q1min",p:"0.01 mg/kg (max 0.2 mg/dose)",m:"3 mg total"}],
 ci:"Chronic benzo use (seizure risk!), TCA co-ingestion, seizure disorder, elevated ICP.",adr:"Seizures, agitation, nausea, withdrawal.",
 ph:"Flumazenil is a competitive antagonist at the benzodiazepine binding site on the GABA-A receptor. It displaces benzodiazepines from this allosteric site without having any intrinsic activity â€” essentially removing the 'brake enhancer' without affecting the brake itself (GABA). In chronic benzodiazepine users, the brain has downregulated GABA-A receptors to compensate for chronic enhancement. Abruptly removing all benzodiazepine enhancement with flumazenil in these patients unmasks the receptor deficiency, potentially causing life-threatening seizures â€” the brain has forgotten how to brake on its own.",
 an:"In chronic benzo users, the brain has gotten used to having super-powered brakes (enhanced GABA) and has actually REMOVED some brake pads to compensate (receptor downregulation). Flumazenil rips away the power boost while the brain still has fewer brake pads than normal. The result: total brake failure = seizures. That's why it's rarely used prehospital â€” you almost never know for certain that a patient isn't a chronic benzo user. The risk of triggering seizures outweighs the benefit in most field situations.",
 pearl:"RARELY used prehospital â€” risk of seizures. Only for iatrogenic oversedation.",at:"Risk of seizures â€” avoid in chronic benzo users"},

{n:"Hydroxocobalamin",g:"Cyanokit",c:"toxicology",e:"â˜ ï¸",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Cyanide Poisoning/Smoke Inhalation",a:"5 g IV over 15 min",p:"70 mg/kg (max 5 g)",m:"May repeat Ã—1"}],
 ci:"None in suspected cyanide poisoning.",adr:"Red discoloration of skin/urine (expected), HTN, headache.",
 ph:"Cyanide kills by binding to cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain, halting aerobic ATP production. Cells switch to anaerobic metabolism, producing lactic acid (severe metabolic acidosis). Hydroxocobalamin (vitamin B12a precursor) has a cobalt center that has higher affinity for cyanide than cytochrome oxidase. It directly chelates cyanide, forming cyanocobalamin (vitamin B12), which is non-toxic and renally excreted. This removes cyanide from the equation without creating methemoglobin (unlike the older cyanide kit with sodium nitrite).",
 an:"Cyanide is like a wrench jammed into every cell's power generator (mitochondria), shutting off ATP production. Hydroxocobalamin is like a powerful magnet (cobalt center) that attracts the wrench out of the generator and locks it up in a harmless shell (cyanocobalamin = vitamin B12). The generator restarts, cells make energy again. The patient turns red because the drug itself is dark red â€” that's normal, not a side effect to worry about.",
 pearl:"Binds cyanide directly â†’ cyanocobalamin (B12). Give empirically in smoke inhalation + AMS + acidosis."},

{n:"Methylene Blue",g:"Provayblue",c:"toxicology",e:"â˜ ï¸",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Methemoglobinemia",a:"1-2 mg/kg IV over 5 min",p:"Same",m:"May repeat Ã—1 (max 7 mg/kg)"}],
 ci:"G6PD deficiency (causes hemolytic anemia), renal failure.",adr:"Blue-green urine/skin (expected), HTN, N/V.",
 ph:"Methemoglobin contains oxidized iron (FeÂ³âº) that cannot bind oxygen. The body normally reduces methemoglobin back to hemoglobin using NADH-methemoglobin reductase, keeping levels below 1%. When this system is overwhelmed (by benzocaine, dapsone, nitrites), methylene blue provides an alternative reduction pathway: it is reduced by NADPH-methemoglobin reductase (using NADPH generated by the G6PD enzyme in the pentose phosphate pathway) to leucomethylene blue, which then non-enzymatically reduces FeÂ³âº back to FeÂ²âº. This is why it fails in G6PD deficiency â€” no NADPH = no leucomethylene blue = no reduction.",
 an:"Normal hemoglobin has working 'hands' (FeÂ²âº) that grab oxygen. Methemoglobin has 'hands' frozen into fists (FeÂ³âº) that can't grab anything. The body has a built-in hand-thawer (NADH pathway), but it's been overwhelmed. Methylene blue provides a BACKUP thawer (NADPH pathway) that unfreezes the fists so hemoglobin can grab oxygen again. In G6PD deficiency, the backup thawer has no power supply (no NADPH), so methylene blue is useless â€” these patients need their entire blood replaced (exchange transfusion).",
 pearl:"Onset 10-30 min. Ineffective in G6PD deficiency. SpOâ‚‚ readings unreliable with methemoglobinemia."},

{n:"Dantrolene",g:"Dantrium/Ryanodex",c:"toxicology",e:"â˜ ï¸",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Malignant Hyperthermia",a:"2.5 mg/kg IV rapid push",p:"Same",m:"Repeat until temp drops; max 10 mg/kg"}],
 ci:"None in malignant hyperthermia crisis.",adr:"Muscle weakness, hepatotoxicity, phlebitis.",
 ph:"Malignant hyperthermia (MH) is a pharmacogenetic disorder where susceptible individuals exposed to volatile anesthetics or succinylcholine experience uncontrolled calcium release from the sarcoplasmic reticulum (SR) via mutant ryanodine receptors (RyR1). The massive calcium surge causes sustained muscle contraction, hypermetabolism, COâ‚‚ production, heat generation, rhabdomyolysis, and metabolic acidosis. Dantrolene directly binds to RyR1 channels and blocks pathologic calcium release from the SR, breaking the cycle. It is the ONLY treatment for MH â€” nothing else addresses the root cause.",
 an:"Malignant hyperthermia is like every muscle cell in the body simultaneously doing an uncontrollable full-body cramp. The calcium 'floodgates' (ryanodine receptors) on the muscle cell's internal calcium storage tank are stuck wide open, flooding the cell with calcium that forces constant contraction. Dantrolene is the only wrench that can close those specific floodgates. Every second matters â€” the longer the gates are open, the more heat, acid, and muscle destruction occurs.",
 pearl:"Only treatment for MH. Ryanodex faster to reconstitute. Also for NMS and severe serotonin syndrome.",at:"Reconstitution is time-consuming â€” start mixing immediately"},

// ==================== OB/GYN ====================
{n:"Oxytocin",g:"Pitocin",c:"obstetric",e:"ğŸ¤°",s:["paramedic","rn","lpn"],r:["IV drip","IM"],
 d:[{i:"Postpartum Hemorrhage",a:"10-20 units IM or 10-40 units in 1L NS drip",p:"N/A",m:"40 units in 1L"}],
 ci:"Do NOT give before delivery. Hypertonic uterine patterns.",adr:"Uterine hyperstimulation, water intoxication, hypotension if bolused.",
 ph:"Oxytocin binds to oxytocin receptors (G-protein coupled) on uterine myometrial smooth muscle cells, activating phospholipase C â†’ IP3 â†’ intracellular calcium release from the SR, causing uterine contraction. After placental delivery, the myometrium must contract to compress the spiral arteries at the former placental site â€” these arteries were dilated to supply placental blood flow and will hemorrhage if not mechanically compressed by uterine contraction. Oxytocin receptors are dramatically upregulated during pregnancy, making the postpartum uterus highly responsive.",
 an:"After the placenta detaches, it leaves behind a dinner-plate-sized wound on the uterine wall with hundreds of open blood vessels (spiral arteries). The only way to stop the bleeding is for the uterine muscle to clamp down like a fist, squeezing those arteries shut â€” nature's tourniquet. Oxytocin is like telling the uterus 'SQUEEZE NOW' â€” it triggers the muscle contraction that compresses those bleeding vessels. That's why uterine massage (mechanical squeezing) is first-line even before oxytocin.",
 pearl:"Given AFTER placenta delivery. Do NOT bolus IV â€” causes hypotension. Uterine massage first."},

// ==================== GI ====================
{n:"Ondansetron",g:"Zofran",c:"gi",e:"ğŸŸ¢",s:["aemt","paramedic","rn","lpn"],r:["IV","IM","PO/ODT"],
 d:[{i:"Nausea/Vomiting",a:"4 mg IV slow over 2-5 min or 4 mg ODT",p:"0.1 mg/kg (max 4 mg)",m:"16 mg/day"}],
 ci:"Congenital long QT syndrome. Caution with QT-prolonging drugs.",adr:"Headache, QT prolongation, constipation.",
 ph:"Ondansetron selectively blocks serotonin 5-HT3 receptors in the chemoreceptor trigger zone (CTZ) in the area postrema of the medulla and on vagal afferents in the GI tract. Nausea and vomiting are triggered when serotonin (released from enterochromaffin cells in the gut wall in response to irritation, distension, or chemotherapy) activates 5-HT3 receptors on vagal nerve endings, sending signals to the CTZ and vomiting center. By blocking these receptors both centrally and peripherally, ondansetron interrupts the vomiting reflex arc at multiple points.",
 an:"The gut has 'alarm cells' (enterochromaffin cells) that release serotonin when something is wrong (toxins, irritation, stretching). Serotonin activates 'alarm wires' (vagal nerves with 5-HT3 receptors) running to the brain's vomiting center. Ondansetron cuts the alarm wires at both ends â€” in the gut AND in the brain's control room â€” so the vomiting signal never completes the circuit. The alarm cells still fire, but nobody hears them.",
 pearl:"ODT dissolves on tongue without water â€” great for active vomiting. Give BEFORE opioids."},

{n:"Famotidine",g:"Pepcid",c:"gi",e:"ğŸŸ¢",s:["paramedic","rn","lpn"],r:["IV","PO"],
 d:[{i:"Anaphylaxis Adjunct (H2 blocker)",a:"20 mg IV over 2 min",p:"0.25 mg/kg IV (max 20 mg)",m:"20 mg"}],
 ci:"Hypersensitivity.",adr:"Headache, dizziness, constipation.",
 ph:"Famotidine blocks histamine H2 receptors on gastric parietal cells, reducing acid secretion. In anaphylaxis, it serves a different role: histamine acts on BOTH H1 receptors (causing hives, bronchospasm, vasodilation) AND H2 receptors (causing tachycardia, vasodilation, increased vascular permeability). Diphenhydramine only blocks H1. Adding famotidine provides H2 blockade for more complete histamine antagonism. About 15% of histamine-mediated vasodilation occurs through H2 receptors.",
 an:"In anaphylaxis, histamine is attacking through two doors: the H1 door (causing hives, wheezing, swelling) and the H2 door (causing additional vasodilation and tachycardia). Diphenhydramine blocks the H1 door, and famotidine blocks the H2 door. Together they lock histamine out of both entrances. Using just one leaves the other door wide open â€” that's why combination H1+H2 blockade is recommended.",
 pearl:"H2 blocker â€” adjunct in anaphylaxis. Replaced ranitidine (withdrawn due to NDMA contamination)."},

// ==================== IV FLUIDS ====================
{n:"Normal Saline 0.9% (NS)",g:"0.9% NaCl",c:"iv-fluid",e:"ğŸ’§",s:["emt","aemt","paramedic","rn","lpn"],r:["IV","IO"],
 d:[{i:"Volume Resuscitation",a:"1-2 L bolus",p:"20 mL/kg bolus",m:"Reassess after each bolus"},{i:"KVO",a:"10-30 mL/hr",p:"Maintenance rate",m:"N/A"}],
 ci:"CHF exacerbation (limit volume), pulmonary edema.",adr:"Fluid overload, hyperchloremic acidosis (large volumes).",
 ph:"Normal saline is an isotonic crystalloid (osmolality 308 mOsm/L, similar to plasma's 285-295). Being isotonic, it initially expands intravascular volume without causing osmotic fluid shifts into or out of cells. However, only ~25% of infused NS remains in the intravascular space after 1 hour â€” the rest distributes into the interstitial space following Starling forces. Large-volume NS resuscitation (>2L) causes hyperchloremic metabolic acidosis because NS contains 154 mEq/L chloride (plasma normal is 96-106), and excess chloride displaces bicarbonate, reducing blood buffering capacity. The high chloride load may also reduce renal blood flow.",
 an:"Pouring NS into the bloodstream is like pouring water into a leaky fish tank. Only about Â¼ of what you pour stays in the tank (blood vessels) â€” the rest leaks through the walls into the surrounding area (interstitial space). That's why you often need 3-4 times the blood lost to restore volume with crystalloid. The 'leaking' isn't wasted â€” it restores interstitial fluid too â€” but it means you need more volume than you might expect. Too much creates a 'chloride flood' that makes the blood acidotic.",
 pearl:"First-line crystalloid. Reassess lungs q500 mL. Trauma: permissive hypotension (SBP 80-90)."},

{n:"Lactated Ringer's (LR)",g:"Ringer's Lactate",c:"iv-fluid",e:"ğŸ’§",s:["aemt","paramedic","rn","lpn"],r:["IV","IO"],
 d:[{i:"Volume Resuscitation",a:"1-2 L bolus",p:"20 mL/kg bolus",m:"Reassess q bolus"},{i:"Burn Resuscitation",a:"Parkland: 4 mL/kg/%TBSA over 24hr",p:"Same formula",m:"Half in first 8 hrs"}],
 ci:"Severe hepatic failure, hyperkalemia.",adr:"Fluid overload, hyperkalemia (contains 4 mEq/L K+).",
 ph:"LR is a balanced crystalloid whose electrolyte composition more closely matches plasma: sodium 130, potassium 4, calcium 3, chloride 109, and lactate 28 mEq/L. The lactate acts as a buffer â€” the liver converts it to bicarbonate via the Cori cycle, helping offset acidosis rather than causing it (unlike NS). The lower chloride content (109 vs 154 in NS) avoids hyperchloremic acidosis. In burns, the Parkland formula addresses massive capillary leak â€” burned tissue releases inflammatory mediators that increase vascular permeability throughout the body, causing systemic edema and hypovolemia requiring aggressive fluid replacement.",
 an:"If NS is tap water for the bloodstream, LR is more like a sports drink â€” it has electrolytes mixed in proportions closer to what your blood actually contains. The lactate in LR isn't lactic acid (bad) â€” the liver converts it to bicarbonate (good) which actually helps fight acidosis instead of causing it. In burns, the body becomes like a leaky garden hose with holes everywhere â€” fluid pours out of blood vessels into tissues. LR replaces what's lost with a fluid that matches what's leaking out.",
 pearl:"More physiologic than NS â€” less acidosis. Preferred for burns. Don't mix with blood products."},

{n:"Hypertonic Saline 3%",g:"3% NaCl",c:"iv-fluid",e:"ğŸ’§",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"Symptomatic Hyponatremia",a:"100 mL IV over 10 min",p:"2-5 mL/kg over 10-20 min",m:"Repeat Ã—2 max"},{i:"Increased ICP (Herniation)",a:"250 mL IV over 15-30 min",p:"3-5 mL/kg over 10-20 min",m:"Per protocol"}],
 ci:"Hypernatremia.",adr:"Osmotic demyelination syndrome (if corrected too fast), phlebitis.",
 ph:"Hypertonic saline creates an osmotic gradient â€” its high sodium concentration (513 mEq/L) makes intravascular fluid hypertonic relative to both the intracellular and interstitial spaces. Water moves by osmosis from areas of low solute concentration (brain cells, interstitial tissue) into the high-solute intravascular space. In cerebral herniation, this draws water out of swollen brain tissue, reducing intracranial pressure. In hyponatremia, it raises serum sodium to restore normal osmolality. Overly rapid correction can cause osmotic demyelination syndrome (ODS) â€” brain cells that adapted to chronic hyponatremia shrink too quickly, damaging myelin sheaths.",
 an:"Brain cells in herniation are waterlogged sponges pressing against the skull. Hypertonic saline is like pouring salt around the sponges â€” osmosis pulls water OUT of them and into the saltier bloodstream, shrinking the sponges and relieving pressure. For hyponatremia, the brain cells have swollen because surrounding fluid is too dilute. Adding concentrated salt to the blood re-establishes the proper salt balance. The danger: if you wring the sponges out too fast (correct too quickly), they crack and crumble (demyelination).",
 pearl:"For herniation: alternative to mannitol. Monitor Na+ â€” don't correct >10 mEq/L per 24 hrs.",at:"Correct slowly â€” osmotic demyelination if too fast"},

// ==================== ANTICOAGULANTS ====================
{n:"Heparin (Unfractionated)",g:"Heparin Sodium",c:"anticoagulant",e:"ğŸ©¸",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"ACS / PE",a:"60-80 units/kg bolus (max 5000 units) then 12-18 units/kg/hr",p:"Protocol dependent",m:"Per aPTT"}],
 ci:"Active uncontrolled bleeding, HIT, severe thrombocytopenia.",adr:"Bleeding, HIT (type II), thrombocytopenia.",
 ph:"Unfractionated heparin binds to antithrombin III (AT-III), a natural anticoagulant, causing a conformational change that accelerates AT-III's ability to inhibit thrombin (Factor IIa) and Factor Xa by 1000-fold. This dramatically amplifies the body's natural anticoagulation cascade. The heparin-AT-III complex forms a ternary complex with thrombin, deactivating it. Heparin-induced thrombocytopenia (HIT) type II is an immune-mediated response where antibodies form against heparin-PF4 complexes on platelet surfaces, paradoxically causing both thrombocytopenia AND thrombosis.",
 an:"The coagulation cascade is like a domino chain leading to a blood clot. Antithrombin III is a natural security guard who catches falling dominoes (clotting factors), but he's slow. Heparin is like giving the security guard a high-speed suit â€” suddenly he can catch dominoes 1000Ã— faster, preventing the chain from reaching the end (clot formation). HIT is the bizarre twist where the suit triggers an allergic reaction that actually CAUSES clots instead of preventing them â€” the opposite of what you'd expect.",
 pearl:"Protamine is reversal agent. Monitor aPTT. HIT = discontinue immediately.",at:"Monitor for bleeding â€” protamine reverses"},

{n:"Tenecteplase",g:"TNKase",c:"anticoagulant",e:"ğŸ©¸",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"STEMI (Fibrinolytic)",a:"Weight-based: <60kg=30mg, 60-69=35mg, 70-79=40mg, 80-89=45mg, â‰¥90=50mg IV push",p:"N/A",m:"50 mg single dose"}],
 ci:"Active internal bleed, CVA <3mo, intracranial neoplasm, severe HTN, aortic dissection.",adr:"Major hemorrhage, intracranial hemorrhage, reperfusion arrhythmias.",
 ph:"Tenecteplase is a genetically modified tissue plasminogen activator (tPA) that converts plasminogen to plasmin. Plasmin is a serine protease that cleaves fibrin cross-links within formed blood clots (fibrinolysis), dissolving the thrombus. Tenecteplase has enhanced fibrin specificity (preferentially activates plasminogen BOUND to the clot rather than circulating plasminogen), longer half-life (20-24 min vs 4-5 min for alteplase), and greater resistance to PAI-1 inhibition â€” allowing single-bolus dosing. In STEMI, the goal is to dissolve the coronary thrombus and restore blood flow to ischemic myocardium when PCI is not available within 120 minutes.",
 an:"A heart attack clot is like a dam blocking a river (coronary artery). Tenecteplase releases a swarm of molecular chainsaws (plasmin) that specifically target the dam's framework (fibrin) and cut it apart, restoring flow. Unlike older drugs that release chainsaws everywhere (causing bleeding), tenecteplase's chainsaws are smart â€” they preferentially go to the dam (fibrin-specific). One injection releases the whole swarm. The risk: some chainsaws might cut through a dam you NEED (a healed brain artery, a surgical wound), causing catastrophic hemorrhage.",
 pearl:"Single IV bolus â€” easier than alteplase. Given when PCI unavailable within 120 min.",at:"Strict contraindication screening â€” major hemorrhage risk"},

{n:"Tranexamic Acid (TXA)",g:"Cyklokapron",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hemorrhagic Shock (trauma)",a:"1 g IV over 10 min",p:"15-20 mg/kg over 10 min",m:"Then 1 g/8 hrs (hospital)"}],
 ci:">3 hrs from injury, active DIC.",adr:"N/V, dizziness, seizures (high dose), thromboembolic events.",
 ph:"TXA is a synthetic lysine analog that competitively blocks plasminogen's lysine binding sites â€” the sites that allow plasminogen to attach to fibrin. Without binding to fibrin, plasminogen cannot be activated to plasmin, and existing clots are protected from fibrinolysis (breakdown). In trauma, the body's fibrinolytic system often becomes pathologically overactive (hyperfibrinolysis/acute traumatic coagulopathy), breaking down clots as fast as they form. TXA stabilizes clots by preventing this destructive cycle. The CRASH-2 trial demonstrated significant mortality reduction when given within 3 hours of injury.",
 an:"When you're bleeding badly, your body forms blood clots to plug the holes. But in severe trauma, the body panics and also activates its clot-dissolving system too aggressively â€” it's like patching a leaky boat while someone else is ripping the patches off (hyperfibrinolysis). TXA grabs the patch-ripper's hands (blocks plasminogen from attaching to fibrin) so the patches stay in place. The 3-hour window matters because after that, the coagulation system has shifted and TXA may actually be harmful.",
 pearl:"MUST give within 3 hrs of injury. CRASH-2: significant mortality reduction. Mix 1g in 100 mL NS."},

// ==================== OTHER ====================
{n:"Diphenhydramine",g:"Benadryl",c:"other",e:"ğŸ“¦",s:["aemt","paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Allergic Reaction (adjunct)",a:"25-50 mg IV/IM",p:"1-2 mg/kg (max 50 mg)",m:"50 mg"},{i:"Dystonic Reaction",a:"50 mg IV/IM",p:"1-2 mg/kg",m:"50 mg"}],
 ci:"Neonates, nursing (relative). Caution: glaucoma, urinary retention.",adr:"Sedation, dry mouth, blurred vision, urinary retention.",
 ph:"Diphenhydramine is a first-generation H1 antihistamine that competitively blocks histamine H1 receptors on smooth muscle, endothelium, and sensory nerves. H1 blockade reduces urticaria (hives), pruritus, and rhinorrhea in allergic reactions. Its ability to cross the blood-brain barrier accounts for its sedative and antiemetic properties. For dystonic reactions (caused by D2 blockade from antipsychotics), diphenhydramine's anticholinergic properties restore the dopamine-acetylcholine balance in the basal ganglia â€” antipsychotics cause relative acetylcholine excess which diphenhydramine counteracts.",
 an:"In allergic reactions, histamine is the troublemaker molecule binding to H1 'complaint windows' on cells, causing hives, swelling, and itching. Diphenhydramine stands in front of these windows, blocking histamine from filing complaints. For dystonic reactions, the brain's movement center needs a balance between dopamine ('go') and acetylcholine ('control'). Antipsychotics suppress dopamine, leaving too much acetylcholine (causing rigid, twisted muscles). Diphenhydramine blocks some acetylcholine, restoring balance and releasing the muscle spasm.",
 pearl:"ALWAYS after epinephrine in anaphylaxis â€” second-line. Excellent for dystonic reactions."},

{n:"Dexamethasone",g:"Decadron",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Croup",a:"0.6 mg/kg (max 16 mg)",p:"0.6 mg/kg (max 16 mg)",m:"16 mg"},{i:"Allergic Reaction/Asthma",a:"10 mg IV/IM",p:"0.6 mg/kg",m:"16 mg"}],
 ci:"Systemic fungal infections.",adr:"Hyperglycemia, GI upset, immunosuppression.",
 ph:"Dexamethasone is a potent synthetic glucocorticoid that crosses cell membranes and binds to intracellular glucocorticoid receptors (GR). The activated GR-steroid complex translocates to the nucleus and either upregulates anti-inflammatory genes (lipocortin-1 which inhibits phospholipase A2) or downregulates pro-inflammatory genes (IL-1, TNF-Î±, COX-2, adhesion molecules). By inhibiting phospholipase A2, it blocks the entire arachidonic acid cascade upstream of both COX and lipoxygenase pathways â€” reducing prostaglandins, leukotrienes, and thromboxanes simultaneously. Onset requires gene transcription, explaining the 1-2 hour delay to clinical effect.",
 an:"Inflammation is like a wildfire with multiple fires burning at once. NSAIDs are like hosing down one fire (COX pathway only). Dexamethasone goes to the fire department headquarters (cell nucleus) and issues an order to SHUT DOWN THE ENTIRE ARSONIST ORGANIZATION (all inflammatory pathways). It takes 1-2 hours for the order to be carried out (gene transcription), but once active, it's the most powerful anti-inflammatory available. In croup, a single dose can extinguish the airway inflammation fire for 24-72 hours.",
 pearl:"Preferred steroid in croup â€” often curative single dose. Onset 1-2 hrs. PO option for peds."},

{n:"Furosemide",g:"Lasix",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Pulmonary Edema/CHF",a:"0.5-1 mg/kg IV (typical 20-80 mg)",p:"1 mg/kg",m:"Usually 80 mg initial"}],
 ci:"Anuria, hypovolemia, severe electrolyte depletion.",adr:"Hypotension, dehydration, hypokalemia, ototoxicity.",
 ph:"Furosemide is a loop diuretic that inhibits the Naâº/Kâº/2Clâ» co-transporter (NKCC2) in the thick ascending limb of the loop of Henle. By blocking this transporter, furosemide prevents sodium, potassium, and chloride reabsorption â€” up to 25% of filtered sodium can be lost. The resulting massive sodium excretion obligates water loss (osmotic diuresis), rapidly reducing intravascular volume and pulmonary congestion. It also has a rapid-onset vasodilatory effect (within 5 min IV) that reduces preload BEFORE significant diuresis occurs, providing early symptomatic relief in pulmonary edema.",
 an:"The kidneys normally recycle 99% of the water they filter. The loop of Henle is like a conveyor belt that picks up salt and water and puts them back in the bloodstream. Furosemide jams the conveyor belt's main sorting machine, so salt (and obligated water) falls off the belt into the urine instead of being recycled. For pulmonary edema specifically â€” the lungs are drowning in fluid that backed up from a failing heart. Furosemide opens the drain (kidneys) to pull fluid out of the system. CPAP + NTG are now preferred first, though.",
 pearl:"CPAP + NTG now preferred over furosemide in acute CHF. Onset 5 min IV."},

{n:"Mannitol",g:"Osmitrol",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Increased ICP / Cerebral Herniation",a:"0.5-1 g/kg IV over 5-10 min",p:"0.5-1 g/kg",m:"Single dose prehospital"}],
 ci:"Severe dehydration, active intracranial bleed, severe renal failure, pulmonary edema.",adr:"Hypotension, dehydration, electrolyte imbalance, rebound ICP elevation.",
 ph:"Mannitol is an osmotic diuretic â€” a large sugar alcohol molecule that is freely filtered at the glomerulus but NOT reabsorbed by the renal tubules. In the bloodstream, it creates a transient osmotic gradient that draws water from the interstitial and intracellular spaces into the intravascular compartment. In the brain, this dehydrates brain parenchyma, reducing cerebral edema and ICP. In the kidneys, the unabsorbed mannitol in the tubules obligates water excretion (osmotic diuresis), ultimately reducing total body water. The ICP reduction typically occurs within 15-30 minutes.",
 an:"If hypertonic saline is salt pulling water out of brain cells, mannitol is a molecular sponge traveling through the bloodstream that soaks up water from surrounding tissues (including the brain) as it passes by. The swollen sponge then gets filtered by the kidneys and wrung out into the urine, taking the extra water with it. The net effect: brain shrinks slightly, ICP drops. Use an in-line filter because mannitol can crystallize at cool temperatures â€” like sugar crystallizing in a syrup bottle.",
 pearl:"Osmotic diuretic â€” draws water from brain tissue. Use in-line filter. Keep warm."},

{n:"Methylprednisolone",g:"Solu-Medrol",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Asthma/Anaphylaxis Adjunct",a:"125 mg IV/IM",p:"2 mg/kg (max 125 mg)",m:"Single dose"}],
 ci:"Systemic fungal infections.",adr:"Hyperglycemia, GI upset, immunosuppression.",
 ph:"Same glucocorticoid receptor mechanism as dexamethasone â€” binds intracellular GR, translocates to nucleus, modulates gene transcription to suppress inflammatory cascades. Methylprednisolone has less mineralocorticoid activity than hydrocortisone (meaning less sodium/water retention) but more potent glucocorticoid (anti-inflammatory) effect. It takes 4-6 hours for peak clinical effect because the mechanism requires new protein synthesis. In asthma, it reduces airway inflammation and edema, restores beta-2 receptor sensitivity (allowing albuterol to work better), and suppresses mucus production.",
 an:"Methylprednisolone works at the same 'fire department headquarters' as dexamethasone â€” it changes the orders being sent out to reduce inflammation. One important bonus: after hours of albuterol nebulization, beta-2 receptors start to become 'deaf' to the signal (desensitized). Steroids 'wake the receptors back up' (restore sensitivity), making subsequent albuterol doses work again. That's why early steroid administration in asthma improves the patient's response to bronchodilators.",
 pearl:"4-6 hr onset â€” give early. Adjunct to bronchodilators. Not a substitute for epi in anaphylaxis."},

{n:"Hydrocortisone",g:"Solu-Cortef",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Adrenal Crisis",a:"100 mg IV/IM",p:"1-2 mg/kg IV",m:"100 mg, then 50 mg q6-8hr"}],
 ci:"Systemic fungal infections.",adr:"Hyperglycemia, fluid retention, immunosuppression.",
 ph:"Hydrocortisone uniquely provides BOTH glucocorticoid AND mineralocorticoid activity â€” making it essential in adrenal crisis where the adrenal glands fail to produce cortisol AND aldosterone. Cortisol is required for vascular smooth muscle responsiveness to catecholamines â€” without it, blood vessels cannot constrict in response to epinephrine/norepinephrine, causing refractory hypotension. Aldosterone regulates sodium and potassium balance via the renal collecting duct. Adrenal crisis presents with severe hypotension, hyperkalemia, hyponatremia, and hypoglycemia â€” hydrocortisone addresses ALL of these by replacing both missing hormones.",
 an:"The adrenal glands are like a car's voltage regulator â€” they keep the electrical system (vascular tone, electrolytes, blood sugar) running smoothly in the background. In adrenal crisis, the regulator fails completely: blood pressure crashes (vessels won't respond to signals), sodium drops, potassium rises, and blood sugar plummets. Hydrocortisone is a replacement voltage regulator that restores BOTH the cortisol circuit (vascular tone + glucose) AND the aldosterone circuit (sodium/potassium balance). Dexamethasone won't work here â€” it only replaces the cortisol circuit.",
 pearl:"Most mineralocorticoid activity of all steroids â€” preferred for adrenal crisis."},

{n:"Oxygen",g:"Oâ‚‚",c:"respiratory",e:"ğŸ«",s:["emt","aemt","paramedic","rn","lpn"],r:["Inhaled"],
 d:[{i:"Hypoxia / Respiratory Distress",a:"NRB: 10-15 LPM; NC: 1-6 LPM; BVM: 15 LPM",p:"Same with appropriate sizing",m:"Titrate SpOâ‚‚ â‰¥94% (88-92% COPD)"}],
 ci:"Relative: paraquat poisoning. COPD: use cautiously.",adr:"Oâ‚‚ toxicity (prolonged high FiOâ‚‚), absorption atelectasis, retinopathy of prematurity.",
 ph:"Oxygen follows a pressure gradient from alveoli to blood to tissues. In the alveolus, Oâ‚‚ diffuses across the alveolar-capillary membrane (0.5 Î¼m thick) into pulmonary capillary blood, where it binds hemoglobin (98.5% of Oâ‚‚ transport) and dissolves in plasma (1.5%). Supplemental Oâ‚‚ increases alveolar pOâ‚‚, steepening the diffusion gradient and improving hemoglobin saturation. In COPD patients with chronic COâ‚‚ retention, the central chemoreceptor response to COâ‚‚ is blunted â€” they rely on the hypoxic drive (peripheral chemoreceptors in carotid bodies) to breathe. Excessive Oâ‚‚ can suppress this backup drive, causing hypoventilation and COâ‚‚ narcosis.",
 an:"Oxygen delivery is like a postal system: hemoglobin molecules are mail trucks carrying Oâ‚‚ packages from the lung post office to tissue mailboxes. Supplemental Oâ‚‚ packs more packages into the post office, so more trucks leave fully loaded. In COPD patients, their breathing alarm clock has been broken for so long (chronic high COâ‚‚) that they set up a BACKUP alarm (low Oâ‚‚ trigger). Flooding them with too much Oâ‚‚ disables their backup alarm, and they stop waking up to breathe. Target 88-92% to keep just enough alarm signal to maintain breathing.",
 pearl:"It's a DRUG â€” document and titrate. In STEMI, only give if SpOâ‚‚ <90%."},

{n:"Oral Glucose",g:"Glutose/Insta-Glucose",c:"metabolic",e:"âš—ï¸",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Hypoglycemia (conscious patient)",a:"15-30 g PO (1 tube oral glucose gel)",p:"Same",m:"May repeat Ã—1"}],
 ci:"Unconscious patient, inability to swallow, N/V.",adr:"N/V, aspiration risk if altered LOC.",
 ph:"Oral glucose gel is a concentrated simple carbohydrate (dextrose) that is absorbed across the oral and GI mucosal membranes. Some absorption begins buccally (between cheek and gum), but the majority occurs via the GI tract. The glucose is absorbed into the portal circulation, processed by the liver, and released into systemic circulation, raising blood glucose within 10-15 minutes. Unlike IV dextrose which is immediately available, oral glucose requires a conscious patient with intact swallow and gag reflexes to prevent aspiration of the viscous gel.",
 an:"If IV dextrose is a direct fuel injection into the engine (bloodstream), oral glucose is pouring gas into the tank (stomach) the normal way â€” it works, but takes the scenic route through the GI tract. The patient must be awake enough to swallow safely because the gel is thick and sticky â€” if it goes into the lungs instead of the stomach, you've traded one problem (low sugar) for a worse one (aspiration). Place it between the cheek and gum to maximize buccal absorption.",
 pearl:"EMT scope. Patient MUST be conscious with intact gag. Recheck BGL in 15 min."},

{n:"Epinephrine Autoinjector",g:"EpiPen/Auvi-Q",c:"cardiac",e:"ğŸ’‰",s:["emt","aemt","paramedic","rn","lpn"],r:["IM"],
 d:[{i:"Anaphylaxis (EMT scope)",a:"0.3 mg IM auto-injector",p:"0.15 mg IM auto-injector (<30 kg)",m:"May repeat Ã—1"}],
 ci:"None in anaphylaxis.",adr:"Tachycardia, anxiety, palpitations.",
 ph:"Same pharmacology as epinephrine 1:1,000 â€” alpha-1 vasoconstriction, beta-1 cardiac stimulation, beta-2 bronchodilation, and mast cell stabilization. The auto-injector delivers a pre-measured dose via a spring-loaded needle designed to penetrate through clothing to reach the vastus lateralis muscle. The lateral thigh provides reliable IM absorption due to consistent muscle mass and blood flow. The auto-injector format enables administration by patients, bystanders, and BLS providers without drawing up medication.",
 an:"The EpiPen is the fire extinguisher on the wall â€” designed so ANYONE can grab it and use it in an emergency without training on how to measure doses or fill syringes. It delivers the same epinephrine through the same mechanism (hits all three anaphylaxis problems: blood pressure, breathing, swelling), just packaged for simplicity. Press, hold, count to 10. The lateral thigh is the target because the muscle is large, consistent, and accessible even through jeans.",
 pearl:"EMT scope. Press firmly into lateral thigh, hold 10 sec. Carry used injector to hospital."},

{n:"Glycopyrrolate",g:"Robinul",c:"other",e:"ğŸ“¦",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"With neostigmine for reversal",a:"0.2 mg IV per 1 mg neostigmine",p:"0.004-0.01 mg/kg",m:"0.2 mg/dose"},{i:"Excessive Secretions",a:"0.1-0.2 mg IV/IM q4hr",p:"0.004 mg/kg",m:"0.2 mg/dose"}],
 ci:"Narrow-angle glaucoma, GI obstruction, myasthenia gravis.",adr:"Tachycardia, dry mouth, urinary retention, blurred vision.",
 ph:"Glycopyrrolate is a quaternary ammonium anticholinergic that blocks muscarinic receptors peripherally â€” blocking the effects of acetylcholine on smooth muscle, secretory glands, and the heart. Being quaternary (permanently charged), it does NOT cross the blood-brain barrier (unlike atropine, which is tertiary and crosses readily). This means it blocks peripheral muscarinic effects (drying secretions, increasing heart rate) without causing central effects (confusion, sedation, agitation). When given with neostigmine (which increases ACh at ALL cholinergic sites), glycopyrrolate prevents the dangerous bradycardia and excessive secretions caused by muscarinic overstimulation.",
 an:"Neostigmine reverses paralysis by flooding the system with acetylcholine, but ACh also hits the heart (bradycardia) and secretory glands (drooling, bronchorrhea). Glycopyrrolate is like a bodyguard stationed ONLY at the heart and glands â€” it blocks the unwanted ACh effects there while letting the beneficial effects at the NMJ (paralysis reversal) proceed unopposed. Unlike atropine, this bodyguard can't get past the brain's security gate (BBB), so it doesn't cause confusion or hallucinations.",
 pearl:"Does NOT cross BBB â€” less CNS effects than atropine. Used with neostigmine and to dry secretions."},

{n:"Sucrose 24% (Oral)",g:"Sweet-Ease",c:"other",e:"ğŸ“¦",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Neonatal/Infant Pain Management",a:"0.5-2 mL PO (on pacifier or tongue)",p:"0.5-2 mL",m:"May repeat q2min PRN"}],
 ci:"Premature infants <32 weeks (use cautiously).",adr:"None significant at standard doses.",
 ph:"Oral sucrose activates endogenous opioid pathways in neonates. Sweet taste receptors on the tongue trigger release of endogenous beta-endorphins in the brainstem, producing measurable analgesia. The analgesic effect is enhanced by non-nutritive sucking (pacifier) which activates additional serotonergic pathways. Combined, these produce a brief (5-8 minute) analgesic window sufficient for minor painful procedures (heel sticks, IV starts, vaccinations). The mechanism is developmentally specific â€” it works best in neonates and young infants whose endogenous opioid system is highly responsive to sweet taste stimulation.",
 an:"Babies have a built-in pain relief system triggered by sweetness â€” when sugar hits their tongue, their brain releases its own natural painkillers (endorphins). It's like nature's way of rewarding breastfeeding (sweet breastmilk) with a calming, pain-relieving bonus. Sucking on a pacifier amplifies the effect by activating additional calming pathways. Together, the sweetness + sucking creates a brief 'analgesic cocoon' lasting about 5-8 minutes â€” just long enough for a heel stick or IV start.",
 pearl:"Activates endogenous opioid pathways. Give 2 min before procedure. Duration ~5-8 min."},


// ==================== CARDIAC (ADDITIONAL) ====================
{n:"Labetalol",g:"Trandate",c:"cardiac",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"Hypertensive Emergency",a:"10-20 mg slow IVP q10min; or 0.5-2 mg/min drip",p:"0.2-1 mg/kg/dose",m:"300 mg total"}],
 ci:"Asthma/reactive airway, 2nd/3rd degree heart block, cardiogenic shock, severe bradycardia.",adr:"Bradycardia, hypotension, bronchospasm, dizziness, fatigue.",
 ph:"Labetalol is a combined alpha-1 and non-selective beta-adrenergic antagonist (alpha:beta ratio ~1:7 IV). Alpha-1 blockade causes peripheral vasodilation, reducing systemic vascular resistance (SVR) and afterload. Beta-1 blockade slows heart rate and reduces myocardial contractility, decreasing cardiac output and myocardial oxygen demand. Beta-2 blockade can cause bronchospasm in susceptible patients. The dual mechanism allows BP reduction without the reflex tachycardia seen with pure vasodilators.",
 an:"Think of a firehose at full blast â€” the nozzle is wide open (alpha = vessels constricted) and the pump is cranked up (beta = heart racing). Labetalol partially closes both the pump speed AND narrows the nozzle, bringing the pressure down from two directions at once without the sudden rebound you'd get from just turning one knob.",
 pearl:"Keep patient supine during administration. Onset 2-5 min IV, peak 5-15 min. Monitor for orthostatic hypotension.",at:"Slow IV push over 2 min. Monitor HR closely."},

{n:"Metoprolol",g:"Lopressor",c:"cardiac",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","PO"],
 d:[{i:"SVT/Rate Control",a:"5 mg slow IVP q5min Ã—3",p:"N/A",m:"15 mg total"},{i:"Hypertension/ACS",a:"25-50 mg PO; 5 mg IV",p:"N/A",m:"15 mg IV"}],
 ci:"HR <60, SBP <100, 2nd/3rd degree block, decompensated CHF, severe asthma.",adr:"Bradycardia, hypotension, fatigue, bronchospasm, AV block.",
 ph:"Metoprolol is a cardioselective beta-1 antagonist that primarily blocks beta-1 receptors in the myocardium. This reduces heart rate (negative chronotropy), contractile force (negative inotropy), and conduction velocity through the AV node (negative dromotropy). In ACS, beta blockade decreases myocardial oxygen demand by reducing the rate-pressure product (HR Ã— SBP), limiting infarct size. Cardioselectivity is dose-dependent and may be lost at higher doses.",
 an:"Your heart is like a car engine revving too fast. Metoprolol is like gently easing off the gas pedal â€” it specifically slows the engine (heart) without slamming the brakes on the rest of the car's systems. At low doses it mainly targets the heart; crank the dose too high and it starts affecting the lungs too.",
 pearl:"Cardioselective â€” safer in COPD than non-selective beta-blockers but still use caution. Give slow IVP over 1-2 min."},

{n:"Esmolol",g:"Brevibloc",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"SVT/Rate Control",a:"500 mcg/kg bolus then 50-200 mcg/kg/min drip",p:"100-500 mcg/kg bolus",m:"200 mcg/kg/min drip"}],
 ci:"Sinus bradycardia, heart block >1st degree, cardiogenic shock, decompensated CHF.",adr:"Hypotension, bradycardia, injection site irritation.",
 ph:"Esmolol is an ultra-short-acting cardioselective beta-1 antagonist with a half-life of approximately 9 minutes. It is rapidly hydrolyzed by red blood cell esterases, making it highly titratable. Like metoprolol, it reduces heart rate, AV conduction, and contractility by blocking cardiac beta-1 receptors. Its extremely short duration makes it ideal when precise hemodynamic control is needed or when beta-blocker tolerance is uncertain.",
 an:"If metoprolol is easing off the gas pedal, esmolol is like tapping the brake â€” the effect is almost instant and wears off in minutes. If the patient reacts badly, just stop the drip and it clears within 10 minutes. It's the 'test drive' beta-blocker.",
 pearl:"Ultra-short acting â€” 9 min half-life. Ideal for unstable patients where you need quick on/off control. Titrate drip to target HR.",at:"Bolus over 1 min. Dedicated IV line preferred."},

{n:"Enalaprilat",g:"Vasotec IV",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hypertensive Emergency/CHF",a:"0.625-1.25 mg IVP over 5 min q6h",p:"5-10 mcg/kg/dose",m:"5 mg/dose"}],
 ci:"Angioedema hx, bilateral renal artery stenosis, pregnancy, hyperkalemia.",adr:"Hypotension, hyperkalemia, renal impairment, cough, angioedema.",
 ph:"Enalaprilat is the active metabolite of enalapril and the only IV ACE inhibitor. ACE (angiotensin-converting enzyme) converts angiotensin I to angiotensin II, a powerful vasoconstrictor. By inhibiting ACE, enalaprilat reduces angiotensin II levels, causing vasodilation and decreased aldosterone secretion (reducing sodium/water retention). It also prevents bradykinin degradation, contributing to vasodilation but also explaining the cough and angioedema risk.",
 an:"Imagine your blood vessels are being squeezed tight by a chemical foreman (angiotensin II) who keeps yelling 'constrict!' Enalaprilat fires the foreman â€” vessels relax, the kidneys stop hoarding salt and water, and blood pressure drops. The downside? With the foreman gone, another chemical (bradykinin) builds up and can irritate the throat.",
 pearl:"Onset 15-30 min IV. Unpredictable response â€” start low. Avoid in suspected bilateral renal artery stenosis. Check K+ levels."},

{n:"Nicardipine",g:"Cardene",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Hypertensive Emergency",a:"5 mg/hr IV drip; titrate by 2.5 mg/hr q5-15min",p:"1-3 mcg/kg/min",m:"15 mg/hr"}],
 ci:"Advanced aortic stenosis, hypotension.",adr:"Hypotension, tachycardia, headache, flushing, peripheral edema.",
 ph:"Nicardipine is a dihydropyridine calcium channel blocker that selectively blocks L-type calcium channels in vascular smooth muscle. By preventing calcium influx, it inhibits smooth muscle contraction, causing potent arteriolar vasodilation with minimal cardiac depression. This selectivity for blood vessels over myocardium distinguishes it from non-dihydropyridines (diltiazem/verapamil). It also dilates cerebral and coronary arteries, making it useful in stroke and ACS-associated hypertension.",
 an:"Calcium is the key that unlocks muscle contraction in blood vessel walls. Nicardipine is like changing the locks on the vessel doors â€” calcium can't get in, so the muscles can't squeeze, and the vessels relax wide open. Unlike some other calcium blockers, nicardipine mainly changes the locks on blood vessel doors, not heart muscle doors.",
 pearl:"Excellent for stroke-related HTN â€” does not increase ICP. Titratable drip. Onset 1-2 min IV. Must use dedicated line â€” incompatible with many drugs.",at:"Central line preferred. Titrate to target MAP."},

{n:"Hydralazine",g:"Apresoline",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Hypertensive Emergency",a:"5-20 mg IV/IM q20-30min",p:"0.1-0.2 mg/kg IV",m:"40 mg/dose"}],
 ci:"CAD, mitral valve disease, dissecting aortic aneurysm.",adr:"Reflex tachycardia, headache, flushing, lupus-like syndrome (chronic).",
 ph:"Hydralazine is a direct arteriolar vasodilator that relaxes vascular smooth muscle through incompletely understood mechanisms â€” likely involving interference with calcium transport, nitric oxide release, and opening of potassium channels. It reduces systemic vascular resistance (SVR) and afterload without significant venous dilation. The resulting drop in BP triggers baroreceptor-mediated reflex tachycardia and increased renin release, which is why it's often paired with a beta-blocker.",
 an:"Think of blood vessels as garden hoses being squeezed tight. Hydralazine directly loosens the grip on the arteries (but not the veins). The problem? When arteries suddenly relax, the heart panics and starts beating faster to compensate â€” like a sprinkler system that speeds up when pressure drops. That's why you often pair it with a beta-blocker to calm the heart down.",
 pearl:"Common in pregnancy-related HTN (eclampsia). Onset IV: 5-20 min. Unpredictable response. Often combined with beta-blocker to prevent reflex tachy."},

{n:"Sodium Nitroprusside",g:"Nipride",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Hypertensive Emergency",a:"0.3-10 mcg/kg/min IV drip",p:"Same as adult",m:"10 mcg/kg/min"}],
 ci:"Compensatory HTN (coarctation, AV shunts), hepatic failure, severe renal impairment, B12 deficiency.",adr:"Cyanide toxicity, thiocyanate toxicity, hypotension, methemoglobinemia.",
 ph:"Nitroprusside spontaneously releases nitric oxide (NO) in the bloodstream, activating guanylate cyclase in vascular smooth muscle to produce cGMP, causing both arterial AND venous dilation. This balanced vasodilation reduces both preload and afterload simultaneously. However, the molecule also contains five cyanide groups â€” as the drug is metabolized, free cyanide is released and must be converted to thiocyanate by the liver (requiring thiosulfate). Prolonged use or high doses can overwhelm this detoxification pathway.",
 an:"Nitroprusside is like dynamite for blood pressure â€” it blows open BOTH arteries and veins instantly and powerfully. But like dynamite, it has a toxic byproduct: cyanide. Short controlled blasts are safe, but if you keep it running too long, the cyanide builds up like toxic fumes in a mine shaft.",
 pearl:"Light-sensitive â€” cover IV bag/tubing with foil. Monitor for cyanide toxicity: metabolic acidosis, altered mental status. Keep thiosulfate at bedside.",at:"Continuous A-line monitoring required. Max 72 hrs use."},

{n:"Nifedipine",g:"Procardia",c:"cardiac",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO","SL"],
 d:[{i:"Hypertensive Urgency",a:"10-20 mg PO",p:"0.25-0.5 mg/kg/dose",m:"30 mg/dose"}],
 ci:"Acute MI, cardiogenic shock, advanced aortic stenosis.",adr:"Reflex tachycardia, hypotension, headache, flushing, peripheral edema.",
 ph:"Nifedipine is a dihydropyridine calcium channel blocker that blocks L-type calcium channels in vascular smooth muscle, causing potent arteriolar vasodilation. Unlike the IV form nicardipine, oral nifedipine (especially immediate-release) can cause rapid unpredictable BP drops, triggering dangerous reflex tachycardia and coronary steal phenomenon. Extended-release formulations provide more controlled vasodilation.",
 an:"Similar to nicardipine but in pill form â€” it changes the locks on blood vessel doors so calcium can't get in and muscles can't squeeze. The problem with the short-acting version is it works TOO fast, like opening a dam all at once instead of slowly raising the gates.",
 pearl:"âš  Immediate-release 'bite and swallow' is discouraged â€” unpredictable drops. Extended-release preferred. Not recommended for acute MI."},

{n:"Digoxin",g:"Lanoxin",c:"cardiac",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","PO"],ha:true,
 d:[{i:"Heart Rate Control (A-fib/Flutter)",a:"0.25-0.5 mg IV loading; then 0.125-0.25 mg IV q6h",p:"10-15 mcg/kg loading",m:"1.5 mg/24h loading"},{i:"Heart Failure",a:"0.125-0.25 mg PO daily",p:"5-10 mcg/kg/day",m:"0.25 mg/day"}],
 ci:"Hypokalemia, hypomagnesemia, hypercalcemia, ventricular tachycardia, WPW syndrome, IHSS.",adr:"Nausea/vomiting, visual changes (yellow halos), dysrhythmias, AV block.",
 ph:"Digoxin is a cardiac glycoside that inhibits the sodium-potassium ATPase pump (Na+/K+-ATPase) on myocardial cell membranes. This increases intracellular sodium, which in turn increases intracellular calcium via the Na+/Ca2+ exchanger, enhancing contractile force (positive inotrope). Digoxin also increases vagal tone to the AV node (slowing conduction), making it useful for rate control in atrial fibrillation. The narrow therapeutic window (0.8-2.0 ng/mL) and dependence on electrolyte balance make toxicity common.",
 an:"The heart cell has a revolving door that swaps sodium and potassium. Digoxin jams this door, causing calcium to back up inside the cell â€” and calcium is what makes the heart squeeze harder. It also turns up the vagus nerve 'chill out' signal to the heart's electrical switchboard (AV node), slowing rapid rhythms. But jam the door too much and the whole electrical system goes haywire.",
 pearl:"Check K+/Mg2+ before giving â€” low levels potentiate toxicity. Classic toxicity signs: nausea, yellow vision, new dysrhythmias. Antidote: Digoxin Immune Fab.",at:"Extremely narrow therapeutic index. Verify electrolytes."},

{n:"Inamrinone",g:"Inocor",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Refractory CHF",a:"0.75 mg/kg bolus over 2-3 min; then 5-15 mcg/kg/min drip",p:"Same as adult",m:"10 mg/kg/24h"}],
 ci:"Severe aortic/pulmonic stenosis, acute MI, hypovolemia.",adr:"Hypotension, thrombocytopenia, dysrhythmias, hepatotoxicity.",
 ph:"Inamrinone is a phosphodiesterase III (PDE-III) inhibitor â€” it prevents breakdown of cyclic AMP (cAMP) in cardiac and vascular smooth muscle. Elevated cAMP in myocytes increases calcium availability for contraction (positive inotropy), while elevated cAMP in vascular smooth muscle causes relaxation (vasodilation). This combined inotropic and vasodilatory effect is called 'inodilation.' Unlike catecholamines, PDE-III inhibitors work downstream of beta receptors, so they remain effective when beta receptors are downregulated in chronic heart failure.",
 an:"In heart failure, the heart's gas pedal (beta receptors) wears out from being pressed too hard for too long. Inamrinone bypasses the worn-out pedal entirely and directly fills the engine with more fuel (cAMP). The engine runs stronger AND the exhaust pipes widen (vasodilation), reducing back-pressure on the struggling heart.",
 pearl:"Formerly called 'amrinone' â€” renamed to avoid confusion with amiodarone. Do NOT mix with dextrose solutions. Monitor platelets for thrombocytopenia.",at:"Must use NS only â€” precipitates in dextrose."},

{n:"Milrinone",g:"Primacor",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Refractory CHF/Cardiogenic Shock",a:"50 mcg/kg bolus over 10 min; then 0.375-0.75 mcg/kg/min drip",p:"Same as adult",m:"1.13 mg/kg/day"}],
 ci:"Severe aortic/pulmonic stenosis, hypovolemia.",adr:"Hypotension, ventricular dysrhythmias, thrombocytopenia.",
 ph:"Milrinone, like inamrinone, is a PDE-III inhibitor that increases intracellular cAMP. However, milrinone is approximately 15Ã— more potent and has a shorter half-life (~2.3 hrs vs ~3.6 hrs). It produces potent positive inotropy and lusitropy (improved relaxation) in the heart while causing significant peripheral and pulmonary vasodilation. This reduces both preload and afterload while improving cardiac output â€” ideal for decompensated heart failure.",
 an:"Same concept as inamrinone â€” bypasses the worn-out gas pedal to directly boost engine power. But milrinone is the premium version: stronger, faster-acting, and more predictable. Think of it as inamrinone's more refined younger sibling.",
 pearl:"Preferred over inamrinone due to shorter half-life and fewer side effects. Compatible with D5W and NS. Watch for hypotension â€” may need volume loading first.",at:"Loading dose must be given slowly over 10 min."},

// ==================== SEDATION/RSI (ADDITIONAL) ====================
{n:"Pancuronium",g:"Pavulon",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Neuromuscular Blockade (Maintenance)",a:"0.06-0.1 mg/kg IV",p:"Same as adult",m:"0.1 mg/kg"}],
 ci:"Myasthenia gravis, hypersensitivity.",adr:"Tachycardia, hypertension, prolonged paralysis, salivation.",
 ph:"Pancuronium is a non-depolarizing (competitive) neuromuscular blocking agent that competes with acetylcholine for nicotinic receptors at the motor end plate. Unlike depolarizing agents (succinylcholine), it does not cause fasciculations. Pancuronium also has vagolytic properties â€” it blocks muscarinic receptors, which causes tachycardia and hypertension. It has a long duration of action (60-90 minutes), making it less titratable than rocuronium or vecuronium.",
 an:"At the nerve-muscle junction, acetylcholine is the key that turns on muscle contraction. Pancuronium shoves a blank key into every lock â€” muscles can't fire because the real key can't get in. Unlike succinylcholine (which jams AND turns the key once), pancuronium just blocks without any initial contraction.",
 pearl:"Long-acting â€” 60-90 min. Causes tachycardia (vagolytic). Must always ensure adequate sedation before and during paralysis.",at:"MUST have sedation/analgesia before administration. Verify airway secured."},

{n:"Neostigmine",g:"Prostigmin",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV","IM"],
 d:[{i:"Reversal of Non-Depolarizing NMBAs",a:"0.04-0.07 mg/kg IV (with glycopyrrolate)",p:"0.04 mg/kg IV",m:"5 mg"}],
 ci:"Bowel/bladder obstruction, peritonitis.",adr:"Bradycardia, bronchospasm, nausea, salivation, abdominal cramps.",
 ph:"Neostigmine is a reversible acetylcholinesterase inhibitor. It prevents the enzyme acetylcholinesterase from breaking down acetylcholine at the neuromuscular junction. The resulting ACh buildup competes with and eventually overwhelms the non-depolarizing blocker at nicotinic receptors, restoring neuromuscular transmission. However, increased ACh also stimulates muscarinic receptors (causing bradycardia, bronchospasm, secretions), so glycopyrrolate is always co-administered.",
 an:"After pancuronium shoved blank keys into every muscle lock, neostigmine floods the area with SO many real keys (acetylcholine) that they push the blank keys out through sheer numbers. Problem is, those extra keys also activate other locks in the body (heart slows down, lungs tighten), so you give glycopyrrolate to block those unwanted effects.",
 pearl:"ALWAYS co-administer glycopyrrolate (0.01 mg/kg) to prevent muscarinic side effects. Does NOT reverse succinylcholine. Onset 3-5 min."},

// ==================== NEURO (ADDITIONAL) ====================
{n:"Phenobarbital",g:"Luminal",c:"neuro",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM"],ha:true,
 d:[{i:"Status Epilepticus (refractory)",a:"15-20 mg/kg IV at 25-50 mg/min",p:"15-20 mg/kg IV at 1 mg/kg/min",m:"30 mg/kg"},{i:"Neonatal Seizures",a:"N/A",p:"20 mg/kg IV over 15-20 min",m:"40 mg/kg"}],
 ci:"Porphyria, severe hepatic dysfunction, severe respiratory depression.",adr:"Respiratory depression, hypotension, sedation, paradoxical excitation, extravasation necrosis.",
 ph:"Phenobarbital is a long-acting barbiturate that enhances GABAa receptor activity by increasing the duration of chloride channel opening (compared to benzodiazepines which increase frequency). At higher concentrations, barbiturates can directly activate GABA channels without GABA being present â€” this is why barbiturates carry a higher risk of respiratory depression than benzodiazepines. The prolonged chloride influx hyperpolarizes neurons, dramatically reducing excitability and terminating seizure activity.",
 an:"If benzodiazepines are like making a door open more often to let calming signals through, phenobarbital is like propping the door open longer each time â€” AND at high doses, it can kick the door open entirely without even needing the doorbell (GABA) to ring. That's why it's more powerful but also more dangerous than benzos.",
 pearl:"Respiratory arrest risk â€” have airway equipment ready. Very long half-life (80-120 hrs). Drug of choice for neonatal seizures. IV push rate must be slow.",at:"Rate >50 mg/min can cause cardiovascular collapse."},

{n:"Droperidol",g:"Inapsine",c:"neuro",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM"],
 d:[{i:"Acute Agitation/Psychosis",a:"2.5-5 mg IV/IM",p:"0.05-0.1 mg/kg",m:"10 mg"},{i:"Antiemetic",a:"0.625-1.25 mg IV",p:"N/A",m:"2.5 mg"}],
 ci:"Known/suspected QT prolongation, hypokalemia, hypomagnesemia.",adr:"QT prolongation, torsades de pointes, hypotension, dystonic reactions, sedation.",
 ph:"Droperidol is a butyrophenone antipsychotic that blocks dopamine D2 receptors in the mesolimbic and mesocortical pathways, producing rapid tranquilization. It also has anti-serotonergic properties at the chemoreceptor trigger zone (CTZ), explaining its potent antiemetic effect. The QT prolongation risk relates to potassium channel (hERG) blockade in cardiac myocytes, which can predispose to torsades de pointes, especially in patients with electrolyte abnormalities.",
 an:"Droperidol is like a bouncer at a nightclub â€” it blocks dopamine (the 'excitement' chemical) from getting through the door, calming everything down fast. It also blocks the nausea signals in the brain's vomiting center. But it has one risky side effect: it can mess with the heart's electrical timing, like a DJ suddenly skipping beats in the music.",
 pearl:"FDA black box warning for QT prolongation â€” obtain 12-lead ECG when possible. Very effective for acute agitation. Onset IM: 3-10 min. Monitor cardiac rhythm.",at:"12-lead ECG recommended before administration."},

{n:"Chlorpromazine",g:"Thorazine",c:"neuro",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Acute Psychosis/Agitation",a:"25-50 mg IM",p:"0.5-1 mg/kg IM",m:"100 mg/dose"},{i:"Intractable Hiccups",a:"25-50 mg IV/IM",p:"N/A",m:"50 mg"}],
 ci:"CNS depression, bone marrow suppression, severe hypotension.",adr:"Hypotension (orthostatic), sedation, dystonia, NMS, QT prolongation, anticholinergic effects.",
 ph:"Chlorpromazine is a low-potency typical (first-generation) antipsychotic that blocks dopamine D2 receptors across multiple brain pathways. It also has significant antihistaminic (H1), anticholinergic (muscarinic), and alpha-1 adrenergic blocking properties. The D2 blockade in the mesolimbic pathway reduces psychotic symptoms, while blockade in the CTZ provides antiemetic effects. Its alpha-1 blockade causes significant orthostatic hypotension, and dopamine blockade in the nigrostriatal pathway can cause extrapyramidal symptoms.",
 an:"Chlorpromazine is like a shotgun approach to calming the brain â€” it blocks dopamine, histamine, and adrenaline all at once. This makes it very effective at sedation, but the wide spread means lots of side effects: blood pressure drops (adrenaline blocked), you get sleepy (histamine blocked), and muscles can get stiff (dopamine blocked in the wrong area).",
 pearl:"First-ever antipsychotic discovered. Causes significant orthostatic hypotension â€” keep patient supine. Watch for extrapyramidal symptoms. Can cause NMS."},

{n:"Hydroxyzine",g:"Vistaril/Atarax",c:"neuro",e:"ğŸ’Š",s:["aemt","paramedic","rn","lpn"],r:["IM","PO"],
 d:[{i:"Anxiety/Agitation",a:"50-100 mg IM/PO",p:"0.5-1 mg/kg",m:"100 mg"},{i:"Pruritus/Allergic Reaction",a:"25-50 mg IM/PO",p:"0.5-1 mg/kg",m:"100 mg"}],
 ci:"Early pregnancy, prolonged QT.",adr:"Sedation, dry mouth, dizziness, QT prolongation at high doses.",
 ph:"Hydroxyzine is a first-generation antihistamine (H1 blocker) with additional anxiolytic, antiemetic, and mild analgesic-potentiating properties. It crosses the blood-brain barrier and blocks central H1 receptors, producing sedation and anxiolysis. It also has anticholinergic and anti-serotonergic activity. Unlike benzodiazepines, it does not carry risk of respiratory depression, physical dependence, or abuse potential, making it a useful anxiolytic alternative.",
 an:"Hydroxyzine is the Swiss Army knife of calm â€” it blocks histamine (reducing itch and nausea), calms anxiety through brain H1 receptors, and enhances pain medicine effectiveness, all without the addiction risk of benzos. It's like a gentle dimmer switch for multiple 'alarm systems' in the body.",
 pearl:"IM ONLY for injection â€” IV causes thrombosis and tissue necrosis. Good alternative anxiolytic without respiratory depression risk. Potentiates opioid effects."},

// ==================== METABOLIC (ADDITIONAL) ====================
{n:"Dextrose 10% (D10)",g:"Dextrose 10%",c:"metabolic",e:"ğŸ’‰",s:["aemt","paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Hypoglycemia (Adult)",a:"100-250 mL IV (10-25 g dextrose)",p:"N/A",m:"25 g"},{i:"Hypoglycemia (Neonate/Pediatric)",a:"N/A",p:"5 mL/kg IV (0.5 g/kg)",m:"25 g"}],
 ci:"None in hypoglycemia.",adr:"Hyperglycemia, phlebitis, tissue necrosis if infiltration.",
 ph:"Dextrose 10% provides glucose directly into the bloodstream for cells that are critically fuel-depleted. Unlike D50 (which is hyperosmolar at ~2,525 mOsm/L), D10 has lower osmolarity (~505 mOsm/L), making it significantly less damaging to peripheral veins and surrounding tissue. This is especially important in neonates and pediatrics where D50 can cause severe phlebitis, extravasation injury, and rebound hyperglycemia/hypoglycemia. Many EMS systems are transitioning from D50 to D10 as their primary dextrose formulation.",
 an:"If D50 is like pouring pure syrup into a water pipe (thick, sticky, can damage the pipe), D10 is like adding sugar water â€” gentler on the veins, easier to control, and much safer for tiny pipes (pediatric/neonatal veins). You need more volume, but the trade-off in safety is worth it.",
 pearl:"Preferred over D50 in many EMS systems â€” safer for peripheral veins. Can titrate to effect. Neonates: NEVER use D50 or D25. Mix D50 1:1 with NS to make D25 if D10 unavailable."},

{n:"Sodium Polystyrene Sulfonate",g:"Kayexalate",c:"metabolic",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO","PR"],
 d:[{i:"Hyperkalemia",a:"15-30 g PO in sorbitol; or 30-50 g PR in retention enema",p:"1 g/kg PO/PR",m:"60 g/day"}],
 ci:"Bowel obstruction, neonates with reduced gut motility.",adr:"Constipation, hypokalemia, hypocalcemia, intestinal necrosis (rare), sodium loading.",
 ph:"Sodium polystyrene sulfonate (SPS) is a cation exchange resin that exchanges sodium ions for potassium ions in the gastrointestinal tract, primarily in the colon. Each gram binds approximately 1 mEq of potassium. The potassium-loaded resin is then excreted in stool. Onset is slow (2-6 hours PO, 30-60 min PR), making it unsuitable for acute emergency treatment of life-threatening hyperkalemia where calcium chloride and insulin/glucose are preferred first-line agents.",
 an:"Think of Kayexalate as tiny sponges traveling through the gut that absorb potassium and replace it with sodium. They soak up excess K+ as they pass through the intestines and carry it out with the stool. But the sponges work slowly â€” not fast enough for a true emergency â€” and they leave sodium behind, which can be a problem in heart failure.",
 pearl:"Slow onset â€” NOT a first-line emergent therapy for lethal hyperkalemia. Use calcium chloride/gluconate, insulin/D50, bicarb, and albuterol first. SPS is adjunctive."},

// ==================== TOXICOLOGY (ADDITIONAL) ====================
{n:"Pralidoxime (2-PAM)",g:"Protopam",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV","IM"],ha:true,
 d:[{i:"Organophosphate Poisoning",a:"1-2 g IV over 15-30 min; may repeat in 1 hr",p:"25-50 mg/kg IV",m:"2 g/dose"}],
 ci:"Poisoning by carbamate insecticides (relative). Myasthenia gravis.",adr:"Tachycardia, hypertension, dizziness, blurred vision, muscle rigidity.",
 ph:"Organophosphates irreversibly inhibit acetylcholinesterase (AChE), causing acetylcholine to accumulate at muscarinic and nicotinic receptors, producing the classic SLUDGE/DUMBELS toxidrome. Pralidoxime works by reactivating AChE before the enzyme-OP bond 'ages' (becomes permanent, typically 24-48 hours). 2-PAM attacks the phosphorus atom on the OP compound, cleaving it from AChE and restoring normal enzyme function. It primarily works at nicotinic receptors (NMJ) â€” atropine must be given concurrently for muscarinic effects.",
 an:"Organophosphate poison glues a wrench into the acetylcholine recycling machine (AChE), jamming it. Atropine blocks the overflow of acetylcholine at one set of switches (muscarinic), but 2-PAM actually reaches in and pulls the wrench OUT of the machine â€” IF you get there before the glue dries permanently (aging). That's why timing is critical.",
 pearl:"Give WITH atropine â€” 2-PAM alone is insufficient. Must give before 'aging' (~24-48 hrs). DuoDote auto-injector contains both atropine + 2-PAM for nerve agent exposure.",at:"Administer SLOWLY â€” rapid IVP can cause hypertensive crisis and cardiac arrest."},

{n:"N-Acetylcysteine (NAC)",g:"Mucomyst / Acetadote",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","PO"],
 d:[{i:"Acetaminophen Overdose",a:"150 mg/kg IV over 1 hr, then 50 mg/kg over 4 hrs, then 100 mg/kg over 16 hrs (21-hr protocol)",p:"Same as adult weight-based",m:"Per protocol"}],
 ci:"None absolute for life-threatening overdose.",adr:"Anaphylactoid reactions (flushing, urticaria, bronchospasm â€” dose-related), nausea/vomiting.",
 ph:"Acetaminophen is normally metabolized by hepatic glucuronidation and sulfation. In overdose, these pathways saturate and excess APAP is shunted through cytochrome P450 (CYP2E1) to produce the toxic metabolite NAPQI (N-acetyl-p-benzoquinone imine). Normally, glutathione neutralizes NAPQI, but glutathione stores deplete in overdose. NAC serves as a glutathione precursor â€” it provides cysteine for glutathione synthesis, directly binds NAPQI, and enhances non-toxic sulfation pathways. It is most effective within 8-10 hours of ingestion but has benefit up to 24+ hours.",
 an:"Tylenol overdose is like a factory producing toxic waste (NAPQI) faster than the cleanup crew (glutathione) can handle it. NAC airlifts in fresh cleanup crews AND raw materials to make more crews on-site. The sooner the reinforcements arrive, the less toxic waste damages the factory (liver). After 8 hours, some damage is already done, but NAC still helps limit the destruction.",
 pearl:"Rumack-Matthew nomogram guides treatment decisions. Most effective <8 hrs but give at any time if concern for toxicity. Anaphylactoid reactions common â€” slow infusion, treat with antihistamines.",at:"21-hour IV protocol is standard. Consider PO if IV unavailable."},

{n:"Sodium Thiosulfate",g:"Nithiodote",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Cyanide Poisoning",a:"12.5 g IV over 10-20 min",p:"400 mg/kg (max 12.5 g)",m:"12.5 g"}],
 ci:"None in life-threatening cyanide poisoning.",adr:"Nausea, vomiting, hypotension (if given too rapidly).",
 ph:"Cyanide inhibits cytochrome c oxidase (Complex IV) in the mitochondrial electron transport chain, halting aerobic metabolism and causing rapid cellular energy failure and lactic acidosis. Sodium thiosulfate provides sulfur atoms to the enzyme rhodanese (thiosulfate sulfurtransferase), which converts cyanide (CN-) to thiocyanate (SCN-), a much less toxic compound that is renally excreted. Thiosulfate has a slower onset than hydroxocobalamin, so it is often used as adjunctive therapy.",
 an:"Cyanide is like a plug shoved into every cell's power outlet â€” no electricity (ATP) can flow. Sodium thiosulfate hands the body extra sulfur 'adaptors' that convert the poisonous plugs into harmless ones (thiocyanate) that the kidneys can flush away. It works, but slowly â€” think of it as the backup generator while hydroxocobalamin is the emergency power restore.",
 pearl:"Often used in combination with hydroxocobalamin for severe cyanide poisoning. Slower onset than hydroxocobalamin. Part of the classic cyanide antidote kit."},

{n:"Dimercaprol (BAL)",g:"BAL in Oil",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IM"],
 d:[{i:"Heavy Metal Poisoning (Lead/Mercury/Arsenic)",a:"3-5 mg/kg IM q4-6h",p:"Same as adult",m:"5 mg/kg/dose"}],
 ci:"Hepatic insufficiency (except arsenic-related), peanut allergy (contains peanut oil).",adr:"Hypertension, tachycardia, nausea/vomiting, injection site pain, nephrotoxicity.",
 ph:"Dimercaprol (British Anti-Lewisite, BAL) is a dithiol chelating agent originally developed as an antidote for the arsenical chemical warfare agent Lewisite. Its two sulfhydryl groups compete with and displace heavy metals (lead, mercury, arsenic, gold) from binding sites on essential enzymes and proteins. The resulting metal-BAL chelate complex is water-soluble and excreted renally. BAL is formulated in peanut oil for IM injection only â€” it is too toxic for IV use.",
 an:"Heavy metals are like burglars that break into your enzyme 'houses' and refuse to leave, wrecking everything. Dimercaprol is like a locksmith with two master keys (sulfhydryl groups) â€” it lures the metals out of the houses by offering them a more attractive place to bind, then escorts them out through the kidneys.",
 pearl:"IM ONLY â€” contains peanut oil. Ask about peanut allergy. Causes pain at injection site. Keep patient well-hydrated. Often used with calcium EDTA for lead poisoning."},

{n:"Fomepizole",g:"Antizol",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Methanol/Ethylene Glycol Poisoning",a:"15 mg/kg loading, then 10 mg/kg q12h Ã—4 doses",p:"Same as adult",m:"15 mg/kg loading"}],
 ci:"None absolute in life-threatening poisoning.",adr:"Headache, nausea, dizziness, injection site reactions.",
 ph:"Methanol and ethylene glycol are themselves relatively non-toxic â€” their danger comes from toxic metabolites produced by alcohol dehydrogenase (ADH). Methanol â†’ formaldehyde â†’ formic acid (causes blindness, metabolic acidosis). Ethylene glycol â†’ glycolaldehyde â†’ glycolic acid â†’ oxalic acid (causes renal failure, calcium oxalate crystals). Fomepizole competitively inhibits ADH with 8,000Ã— greater affinity than ethanol, blocking formation of these toxic metabolites while the parent compound is renally excreted or removed by dialysis.",
 an:"Methanol and ethylene glycol are like raw ingredients that the body's 'oven' (alcohol dehydrogenase) cooks into poison. Fomepizole slams the oven door shut and locks it â€” the raw ingredients sit around harmlessly until the kidneys can sweep them out. It's much cleaner than the old method of running a competing recipe through the same oven (ethanol drip).",
 pearl:"Preferred over ethanol drip â€” more predictable, fewer side effects. Does NOT treat already-formed toxic metabolites â€” if significant acidosis, patient still needs dialysis."},

{n:"Physostigmine",g:"Antilirium",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV","IM"],ha:true,
 d:[{i:"Anticholinergic Toxicity",a:"0.5-2 mg slow IVP over 2-5 min; may repeat q10-30min",p:"0.02 mg/kg slow IVP",m:"2 mg/dose"}],
 ci:"Asthma, GI/GU obstruction, cardiovascular disease, gangrene, concurrent TCA/depolarizing NMB.",adr:"Bradycardia, seizures, bronchospasm, cholinergic crisis.",
 ph:"Physostigmine is a reversible carbamate acetylcholinesterase inhibitor that crosses the blood-brain barrier (unlike neostigmine). By inhibiting AChE, it increases acetylcholine levels at both muscarinic and nicotinic receptors centrally and peripherally, directly reversing the anticholinergic toxidrome (agitation, delirium, mydriasis, tachycardia, urinary retention, absent bowel sounds, dry flushed skin). Its ability to cross the BBB is what makes it effective for central anticholinergic delirium.",
 an:"Anticholinergic poisoning is like someone turned OFF all the 'calm and function' switches in the body (blocked acetylcholine). Physostigmine floods the system with acetylcholine by preventing its breakdown â€” turning all those switches back ON. Unlike neostigmine, physostigmine can cross into the brain to flip the central switches too, which is why it fixes the delirium and agitation.",
 pearl:"Only cholinesterase inhibitor that crosses BBB. SLOW IVP â€” rapid push can cause seizures/bradycardia. Mnemonic for anticholinergic toxidrome: 'Hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.'",at:"Push SLOWLY over 2-5 min. Have atropine at bedside for cholinergic overshoot."},

{n:"Digoxin Immune Fab",g:"DigiFab / Digibind",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Digoxin Toxicity",a:"Dose based on digoxin level or ingested amount; empiric: 10-20 vials for acute life-threatening toxicity",p:"Same calculation as adult",m:"20 vials empiric"}],
 ci:"None absolute in life-threatening digoxin toxicity.",adr:"Hypokalemia (as dig effect reverses), worsening heart failure, allergic reaction (sheep-derived).",
 ph:"Digoxin Immune Fab consists of antibody fragments (Fab) derived from sheep immunized against digoxin. These Fab fragments bind free digoxin molecules in the blood with extremely high affinity, forming antibody-antigen complexes too large to distribute into tissues. This rapidly reduces the free (active) digoxin concentration. Bound digoxin is trapped intravascularly and eventually excreted renally. As digoxin is pulled away from Na+/K+-ATPase, normal pump function resumes â€” potassium re-enters cells, which can cause sudden hypokalemia.",
 an:"Digoxin toxicity is like having too many wrenches jammed into your cells' sodium-potassium pumps. DigiFab antibodies are like tiny magnets that grab every loose wrench floating in the blood, wrapping around them so they can't jam into any more pumps. As wrenches get pulled out of pumps, potassium rushes back into cells â€” monitor K+ closely.",
 pearl:"Monitor K+ closely after administration â€” hypokalemia can occur rapidly as digoxin's effect on Na+/K+-ATPase reverses. Total serum digoxin levels become unreliable after Fab (measures both bound and free)."},

{n:"Cyproheptadine",g:"Periactin",c:"toxicology",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO","NG"],
 d:[{i:"Serotonin Syndrome",a:"12 mg PO/NG initially, then 4-8 mg q1-4h",p:"0.25 mg/kg q6h",m:"32 mg/day"}],
 ci:"Narrow angle glaucoma, urinary retention, concurrent MAOI use.",adr:"Sedation, dry mouth, increased appetite, weight gain.",
 ph:"Serotonin syndrome occurs from excessive serotonergic stimulation of 5-HT1A and 5-HT2A receptors, causing the classic triad of altered mental status, autonomic instability, and neuromuscular hyperactivity (clonus, hyperreflexia, rigidity). Cyproheptadine is a first-generation antihistamine with potent 5-HT2A receptor antagonist properties. By blocking 5-HT2A receptors, it directly counteracts the excess serotonin stimulation responsible for the syndrome's most dangerous features.",
 an:"Serotonin syndrome is like someone cranked the brain's 'activity' dial (serotonin) way past maximum â€” everything is overheating, twitching, and unstable. Cyproheptadine turns that dial back down by blocking the serotonin receptors that are being overstimulated, like putting a cap on a fire hydrant that's spraying out of control.",
 pearl:"PO/NG only â€” no IV form. Crush and give via NG if patient cannot swallow. Only specific antiserotonergic therapy for serotonin syndrome. Classic triad: clonus + agitation + diaphoresis."},

{n:"IV Fat Emulsion (ILE)",g:"Intralipid 20%",c:"toxicology",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Local Anesthetic Systemic Toxicity (LAST)",a:"1.5 mL/kg bolus, then 0.25 mL/kg/min drip Ã—30-60 min",p:"Same as adult",m:"10 mL/kg over first 30 min"}],
 ci:"None absolute in LAST. Relative: egg/soy allergy, severe hyperlipidemia.",adr:"Fat overload syndrome, pancreatitis, allergic reaction.",
 ph:"Local anesthetic systemic toxicity (LAST) occurs when lipophilic local anesthetics (especially bupivacaine) accumulate in cardiac tissue, blocking sodium channels and causing refractory cardiac arrest. ILE works through multiple proposed mechanisms: (1) 'lipid sink' â€” fat droplets absorb and sequester lipophilic drug molecules from cardiac tissue; (2) direct cardiotonic effects â€” fatty acids provide energy substrate for poisoned myocardium; (3) enhanced drug redistribution from affected organs. ILE has also shown benefit in other lipophilic drug toxicities.",
 an:"When a fat-loving poison like bupivacaine gets stuck in your heart tissue, ILE is like pouring grease into the bloodstream â€” the poison is much more attracted to the fat droplets than to heart cells, so it lets go of the heart and dissolves into the fat instead. It's essentially creating a more appealing parking spot for the drug to move to.",
 pearl:"Part of LAST rescue kit â€” should be immediately available wherever regional anesthesia is performed. Can repeat bolus Ã—2. Also studied for other lipophilic drug overdoses (beta-blockers, calcium channel blockers)."},

{n:"Ipecac Syrup",g:"Ipecac",c:"toxicology",e:"ğŸ’Š",s:["emt","aemt","paramedic"],r:["PO"],
 d:[{i:"(Historical â€” Rarely Used) Gastric Decontamination",a:"15-30 mL PO followed by water",p:"15 mL (>1 yr) PO",m:"30 mL"}],
 ci:"Caustic ingestion, hydrocarbons, altered mental status, seizure risk, infants <6 months.",adr:"Protracted vomiting, aspiration risk, Mallory-Weiss tear, myocardial toxicity (chronic abuse).",
 ph:"Ipecac contains the alkaloids emetine and cephaeline which stimulate emesis through both local gastric irritation (stimulating vagal afferents) and central chemoreceptor trigger zone (CTZ) activation. However, evidence shows ipecac does not improve clinical outcomes and can worsen them by causing prolonged vomiting, aspiration risk, and delaying definitive treatment (activated charcoal or whole bowel irrigation). AAP and AACT/EAPCCT recommend AGAINST routine use.",
 an:"Ipecac is like pulling a fire alarm in a building to get everyone out â€” it forces everything in the stomach to come back up. But in practice, the alarm goes off too late (poison is already absorbed), causes chaos (prolonged vomiting, aspiration risk), and delays the actual firefighters (charcoal, antidotes) from doing their job. That's why it's been essentially retired.",
 pearl:"NO LONGER RECOMMENDED by AAP, AACT, or AHA. Historical inclusion only. Activated charcoal is preferred when GI decontamination is indicated."},

// ==================== OB/GYN (ADDITIONAL) ====================
{n:"Misoprostol",g:"Cytotec",c:"obstetric",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO","SL","PR"],
 d:[{i:"Postpartum Hemorrhage (uterine atony)",a:"800-1000 mcg PR/SL",p:"N/A",m:"1000 mcg"}],
 ci:"None absolute in life-threatening PPH.",adr:"Diarrhea, abdominal cramps, fever/chills, nausea.",
 ph:"Misoprostol is a synthetic prostaglandin E1 (PGE1) analog that binds to EP2/EP3 receptors on uterine smooth muscle cells, increasing intracellular calcium and stimulating rhythmic myometrial contractions. In postpartum hemorrhage from uterine atony, the uterus fails to contract adequately after delivery, leaving spiral arteries at the placental site open and bleeding. Misoprostol causes sustained uterine contraction that compresses these vessels, achieving hemostasis.",
 an:"After delivering a baby, the uterus is supposed to clamp down like a fist to squeeze off the bleeding vessels where the placenta was attached. When the uterus stays relaxed (atony), it's like an open faucet gushing blood. Misoprostol is the chemical signal that tells the fist to SQUEEZE â€” compressing those open vessels shut.",
 pearl:"Can be given rectally if patient is vomiting or obtunded. Shelf-stable without refrigeration â€” advantage over oxytocin. Common side effect: shivering/fever."},

// ==================== GI (ADDITIONAL) ====================
{n:"Promethazine",g:"Phenergan",c:"gi",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM","PO","PR"],
 d:[{i:"Nausea/Vomiting",a:"12.5-25 mg IV/IM/PO/PR q4-6h",p:">2 yrs: 0.25-1 mg/kg",m:"25 mg/dose"}],
 ci:"Children <2 yrs, intra-arterial injection, severe respiratory depression.",adr:"Sedation, respiratory depression, tissue necrosis (IV extravasation), dystonic reactions.",
 ph:"Promethazine is a phenothiazine derivative with potent H1 antihistamine, anticholinergic, and anti-dopaminergic properties. Its antiemetic effect comes from blocking dopamine (D2) and histamine (H1) receptors in the CTZ and vestibular apparatus. It also has significant anticholinergic activity which reduces vagal stimulation to the GI tract. The combination of these three receptor blockades makes it a broad-spectrum antiemetic.",
 an:"Nausea has multiple alarm systems â€” histamine, dopamine, and vestibular signals all trigger the vomiting center. Promethazine is like muting three different alarm speakers at once. Very effective, but all that muting also makes you very sleepy and can cause some nasty tissue damage if it leaks out of the vein.",
 pearl:"BLACK BOX: IV push can cause severe tissue necrosis â€” dilute and give slowly. IM preferred route. CONTRAINDICATED <2 yrs (fatal respiratory depression). Causes significant sedation.",at:"Preferred route is IM. Deep IM injection. Never give SubQ or intra-arterial."},

{n:"Metoclopramide",g:"Reglan",c:"gi",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Nausea/Vomiting",a:"10 mg IV over 1-2 min",p:"0.1-0.2 mg/kg IV",m:"10 mg/dose"}],
 ci:"GI obstruction/perforation, pheochromocytoma, seizure history.",adr:"Drowsiness, restlessness, dystonic reactions, tardive dyskinesia (chronic use).",
 ph:"Metoclopramide is a dopamine (D2) receptor antagonist that acts both centrally at the CTZ (antiemetic effect) and peripherally in the GI tract (prokinetic effect). Peripherally, it enhances acetylcholine release from the myenteric plexus, increasing gastric motility, LES tone, and gastric emptying rate. It also has mild 5-HT3 antagonist and 5-HT4 agonist activity. The prokinetic action makes it uniquely useful when nausea is related to gastroparesis or delayed gastric emptying.",
 an:"Metoclopramide works from both ends: it blocks the nausea alarm in the brain AND pushes the food conveyor belt (stomach/intestines) to move faster. It's like silencing a 'food backup' alarm while simultaneously clearing the traffic jam that caused it.",
 pearl:"Dystonic reactions (especially in young patients) â€” treat with diphenhydramine or benzodiazepine. Useful for diabetic gastroparesis. Give slow IVP."},

{n:"Prochlorperazine",g:"Compazine",c:"gi",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM","PO","PR"],
 d:[{i:"Nausea/Vomiting",a:"5-10 mg IV/IM; 25 mg PR",p:">2 yrs: 0.1-0.15 mg/kg",m:"10 mg IV, 25 mg PR"}],
 ci:"CNS depression, bone marrow suppression, <2 yrs.",adr:"Sedation, dystonic reactions, akathisia, orthostatic hypotension, QT prolongation.",
 ph:"Prochlorperazine is a phenothiazine antipsychotic/antiemetic that primarily blocks dopamine D2 receptors in the CTZ and vomiting center of the medulla. It also has antihistaminic and anticholinergic properties. Its potent D2 blockade at the CTZ makes it highly effective for chemotherapy-induced nausea and other causes of emesis. Like other phenothiazines, nigrostriatal D2 blockade can cause extrapyramidal symptoms.",
 an:"The vomiting center in the brain has a dopamine-powered trigger (CTZ). Prochlorperazine blocks that trigger directly â€” like putting tape over a doorbell so it can't ring, even when someone pushes it. Very effective, but blocking dopamine in other brain areas can cause uncomfortable muscle stiffness and restlessness.",
 pearl:"Very effective for migraine-associated nausea. Watch for akathisia (inner restlessness). Dystonic reactions more common in young patients â€” have diphenhydramine ready."},

{n:"Dimenhydrinate",g:"Dramamine",c:"gi",e:"ğŸ’Š",s:["emt","aemt","paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Motion Sickness/Nausea",a:"50 mg IV/IM/PO q4-6h",p:"1.25 mg/kg q6h (>2 yrs)",m:"300 mg/day"}],
 ci:"Neonates, patients on ototoxic antibiotics.",adr:"Drowsiness, dry mouth, blurred vision, urinary retention.",
 ph:"Dimenhydrinate is a combination of diphenhydramine and 8-chlorotheophylline. The antiemetic effect comes primarily from diphenhydramine's H1 antihistaminic and anticholinergic blockade in the vestibular system and CTZ. The theophylline component was originally added to counteract drowsiness (mild CNS stimulant), though in practice, sedation remains prominent. It is particularly effective for vestibular-mediated nausea (motion sickness, vertigo, Meniere's disease).",
 an:"Dimenhydrinate is basically Benadryl (diphenhydramine) bundled with a tiny bit of caffeine-like stimulant to try to keep you awake. It quiets the inner ear's 'motion alarm' and blocks the nausea trigger. Think of it as putting noise-canceling headphones on your balance system.",
 pearl:"OTC medication. Essentially diphenhydramine + mild stimulant. Most effective for vestibular/motion-related nausea. Give IV slowly."},

{n:"Pantoprazole",g:"Protonix",c:"gi",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","PO"],
 d:[{i:"GI Bleeding/Ulcer Prophylaxis",a:"40-80 mg IV over 15 min; or 8 mg/hr drip",p:"1-2 mg/kg IV",m:"80 mg bolus"}],
 ci:"Hypersensitivity to proton pump inhibitors.",adr:"Headache, diarrhea, nausea, hypomagnesemia (chronic).",
 ph:"Pantoprazole is a proton pump inhibitor (PPI) that irreversibly inhibits the hydrogen/potassium ATPase (H+/K+-ATPase) enzyme system â€” the 'proton pump' â€” on the luminal surface of gastric parietal cells. This is the final common pathway for gastric acid secretion, regardless of the stimulus (histamine, acetylcholine, or gastrin). By blocking this pump, pantoprazole reduces gastric acid production by >95%. In GI bleeding, acid inhibition raises gastric pH above 6, promoting platelet aggregation and clot stability over bleeding ulcers.",
 an:"Stomach acid is produced by tiny pumps on the stomach wall. Pantoprazole permanently shuts down these pumps â€” not just turning down the volume like antacids, but actually unplugging the speakers. For bleeding ulcers, this is critical: acid dissolves blood clots, so by stopping acid production, you let the body's clots actually stick and stop the bleeding.",
 pearl:"IV bolus then drip for active GI bleed. Onset 15-30 min IV. Full acid suppression takes 2-3 days (need to inactivate enough pumps). More effective than H2 blockers for GI bleeding."},

{n:"Magnesium Citrate",g:"Citroma",c:"gi",e:"ğŸ’Š",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Bowel Prep/Constipation",a:"150-300 mL PO (full bottle)",p:"2-4 mL/kg (>2 yrs)",m:"300 mL"}],
 ci:"Renal failure, bowel obstruction, ileus, appendicitis.",adr:"Diarrhea, abdominal cramps, electrolyte imbalances, dehydration.",
 ph:"Magnesium citrate is an osmotic laxative that works by drawing water into the intestinal lumen through osmotic gradient. The magnesium ions are poorly absorbed and create a hyperosmolar environment in the bowel, pulling water across the intestinal mucosa. The increased intraluminal volume stimulates peristalsis via stretch receptors and hastens intestinal transit. Additionally, magnesium stimulates cholecystokinin (CCK) release, which further promotes bowel motility.",
 an:"Magnesium citrate is like turning on a faucet inside your intestines â€” the magnesium pulls water into the bowel, filling it up until the stretch sensors trigger 'time to move!' It's essentially a flood that washes everything downstream.",
 pearl:"OTC medication. Store in refrigerator for palatability. Ensure adequate hydration. Avoid in renal impairment â€” magnesium can accumulate. Onset: 30 min-6 hrs."},

{n:"Polyethylene Glycol",g:"MiraLAX / GoLYTELY",c:"gi",e:"ğŸ’Š",s:["emt","aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Whole Bowel Irrigation (Poisoning)",a:"GoLYTELY: 1-2 L/hr PO/NG until clear rectal effluent",p:"500 mL/hr (child); 1 L/hr (adolescent)",m:"Until clear effluent"},{i:"Constipation",a:"MiraLAX: 17 g in 8 oz liquid daily",p:"0.5-1.5 g/kg/day",m:"17 g/day"}],
 ci:"Bowel obstruction, ileus, GI perforation, toxic megacolon.",adr:"Nausea, bloating, abdominal cramps, electrolyte disturbances (large volumes).",
 ph:"PEG is a large, non-absorbable, osmotically active polymer that passes through the GI tract without being absorbed or metabolized. In whole bowel irrigation (WBI), the PEG-electrolyte solution (GoLYTELY) flushes the entire GI tract mechanically, physically pushing ingested toxins through before they can be absorbed. WBI is indicated for sustained-release drug ingestions, body stuffing/packing, iron or lithium overdose, and other ingestions where charcoal is ineffective.",
 an:"GoLYTELY is basically a pressure washer for your intestines â€” it sends a massive flood of non-absorbable liquid through the entire GI tract, physically pushing everything out the other end. Unlike charcoal (which absorbs poison), GoLYTELY just mechanically flushes it out. Think of it as the 'nuclear option' for GI decontamination.",
 pearl:"WBI is indicated when charcoal won't work: iron, lithium, lead, sustained-release pills, body packers. Continue until rectal effluent is clear. Requires NG tube for adequate volume delivery."},

// ==================== IV FLUIDS (ADDITIONAL) ====================
{n:"Dextrose 5% in Water (D5W)",g:"D5W",c:"iv-fluid",e:"ğŸ’§",s:["aemt","paramedic","rn","lpn"],r:["IV"],
 d:[{i:"TKO/Medication Dilution",a:"Rate varies per indication",p:"Same",m:"Per protocol"},{i:"Hypoglycemia (mild)",a:"100-250 mL bolus (5-12.5 g glucose)",p:"N/A",m:"Per protocol"}],
 ci:"Hyperglycemia (relative), cerebral edema, hyponatremia.",adr:"Hyperglycemia, hyponatremia (free water), cerebral edema.",
 ph:"D5W is an isotonic solution in the bag (252 mOsm/L) but becomes hypotonic in vivo because dextrose is rapidly metabolized, leaving free water that distributes throughout total body water (â…” intracellular, â…“ extracellular). Only ~8% of infused D5W remains in the intravascular space. This makes it a poor volume expander but useful for providing free water, maintaining IV access (TKO), and diluting IV medications. In hypoglycemia, it provides modest glucose supplementation.",
 an:"D5W is like sugar water that 'disappears' once inside the body â€” the sugar gets burned up immediately, leaving only plain water behind. That water then leaks out of blood vessels and into cells everywhere. So while it looks like a blood-volume filler in the bag, it's really just a hydration delivery system and a vehicle for medications.",
 pearl:"NOT a volume resuscitator â€” minimal intravascular expansion. Do NOT use in trauma, stroke, or brain injury (worsens cerebral edema). Primarily used as med diluent or free water replacement."},

{n:"Albumin 5%",g:"Albuminar / Albutein",c:"iv-fluid",e:"ğŸ’§",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Volume Expansion/Burns",a:"250-500 mL IV; titrate to response",p:"0.5-1 g/kg",m:"6 g/kg/day"}],
 ci:"Severe anemia, CHF (relative).",adr:"Fluid overload, allergic reactions, pulmonary edema, hypotension (if infused too quickly).",
 ph:"Albumin is the most abundant plasma protein, responsible for approximately 75-80% of plasma oncotic pressure. When infused, albumin molecules are too large to cross intact capillary membranes and therefore remain in the intravascular space, drawing water from the interstitial space via osmotic gradient (Starling forces). Unlike crystalloids (NS, LR), nearly 100% of albumin stays intravascular initially, making it a potent volume expander â€” 5% albumin is iso-oncotic and expands plasma volume approximately 1:1.",
 an:"Crystalloid fluids (NS, LR) are like pouring water on a sponge â€” most of it leaks out of the blood vessels into surrounding tissue. Albumin is like pouring honey into the bloodstream â€” it's too thick (large protein molecules) to leak out through the vessel walls, AND it actually pulls water back in from the tissues. Much more stays where you need it.",
 pearl:"Iso-oncotic â€” expands plasma volume approximately equal to volume infused. Expensive compared to crystalloids. Indicated when crystalloid resuscitation is inadequate. Useful in burns after first 24 hrs."},

{n:"Hetastarch (HES)",g:"Hespan / Hextend",c:"iv-fluid",e:"ğŸ’§",s:["paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Volume Expansion",a:"500-1000 mL IV",p:"10-20 mL/kg",m:"1500 mL/day (20 mL/kg)"}],
 ci:"Severe bleeding disorders, renal failure, critically ill septic patients (FDA warning), severe CHF.",adr:"Coagulopathy, renal injury (AKI), pruritus, anaphylactoid reactions, hyperamylasemia.",
 ph:"Hetastarch is a synthetic colloid (hydroxyethyl starch) derived from amylopectin. Like albumin, its large molecules remain in the intravascular space and expand plasma volume through oncotic pressure. However, multiple studies (VISEP, 6S, CHEST) demonstrated increased acute kidney injury and mortality in critically ill patients, leading to FDA boxed warnings. HES molecules are phagocytosed by the reticuloendothelial system and can cause persistent pruritus. HES also interferes with coagulation by diluting clotting factors and impairing platelet function and fibrin polymerization.",
 an:"Hetastarch was designed as a cheaper alternative to albumin â€” synthetic 'big molecules' that stay in blood vessels and hold water in. But studies showed it's like using cheap pipe sealant that damages the plumbing (kidneys) and makes the blood thinner (coagulopathy). Albumin is the real deal; hetastarch is the knockoff that backfired.",
 pearl:"âš  FDA BLACK BOX: Increased mortality and renal injury in critically ill/septic patients. Many EMS systems have removed it. If stocked, use only for acute hypovolemia, NOT in sepsis or critical illness."},

// ==================== ANTICOAGULANTS (ADDITIONAL) ====================
{n:"Enoxaparin",g:"Lovenox",c:"anticoagulant",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["SQ"],
 d:[{i:"ACS/STEMI",a:"30 mg IV bolus then 1 mg/kg SQ q12h; or 1 mg/kg SQ q12h",p:"N/A",m:"100 mg first SQ dose"},{i:"DVT/PE Prophylaxis",a:"40 mg SQ daily; or 30 mg SQ q12h",p:"N/A",m:"Per protocol"}],
 ci:"Active major bleeding, HIT, epidural/spinal anesthesia (relative).",adr:"Bleeding, injection site hematoma, thrombocytopenia (HIT), hyperkalemia.",
 ph:"Enoxaparin is a low-molecular-weight heparin (LMWH) that preferentially inhibits Factor Xa through antithrombin III (AT-III) activation. Unlike unfractionated heparin which equally inhibits both Factor Xa and thrombin (IIa), enoxaparin's shorter chain length means it primarily catalyzes AT-III-mediated inhibition of Factor Xa (anti-Xa:anti-IIa ratio ~3.8:1). Factor Xa is a key enzyme in the common coagulation pathway, converting prothrombin to thrombin. By blocking this step, enoxaparin prevents new thrombin generation and clot propagation.",
 an:"The clotting cascade is like a row of dominoes. Unfractionated heparin catches the dominoes at two points, but enoxaparin is more targeted â€” it mainly catches one specific critical domino (Factor Xa) before it can trigger the biggest one (thrombin). More predictable, more precise, and doesn't need as much monitoring.",
 pearl:"Predictable dose-response â€” no routine aPTT monitoring needed (unlike heparin). SQ injection in abdominal wall. Partially reversed by protamine (60% reversal). Renal dosing for CrCl <30."},

{n:"Alteplase (tPA)",g:"Activase",c:"anticoagulant",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Acute Ischemic Stroke",a:"0.9 mg/kg (max 90 mg): 10% bolus over 1 min, remainder over 60 min",p:"N/A",m:"90 mg"},{i:"STEMI (if PCI >120 min)",a:"15 mg bolus, 50 mg over 30 min, 35 mg over 60 min",p:"N/A",m:"100 mg"},{i:"Massive PE",a:"100 mg IV over 2 hrs; or 50 mg bolus for arrest",p:"N/A",m:"100 mg"}],
 ci:"Active internal bleeding, recent (3 mo) CVA/head trauma, intracranial neoplasm, suspected aortic dissection, uncontrolled severe HTN.",adr:"Major bleeding, ICH (intracranial hemorrhage), angioedema, reperfusion dysrhythmias.",
 ph:"Alteplase is a recombinant tissue plasminogen activator (tPA) that converts plasminogen to plasmin, the enzyme responsible for dissolving fibrin clots. It is 'fibrin-selective' â€” it preferentially activates plasminogen bound to fibrin in an existing clot, theoretically limiting systemic fibrinolysis. In ischemic stroke, dissolving the occluding thrombus restores cerebral blood flow to the ischemic penumbra (salvageable brain tissue surrounding the infarct core). In STEMI and PE, it dissolves thrombus in coronary or pulmonary arteries respectively.",
 an:"A blood clot blocking a brain artery is like a dam in a river â€” the land downstream (brain tissue) is drying up. Alteplase is a precision demolition charge that dissolves the dam from the inside, restoring flow. But if the charge is too strong or placed wrong, it can cause flooding elsewhere (bleeding). The window to use it is narrow â€” the longer the dam stays, the more permanent the damage downstream.",
 pearl:"Stroke: 4.5-hr window from symptom onset. STEMI: prefer PCI if <120 min. PE: consider in massive PE with hemodynamic instability. Most serious risk: ICH. Two large-bore IVs before administration.",at:"Strict inclusion/exclusion criteria. Two RNs verify dose. No anticoagulants for 24 hrs post-stroke tPA."},

{n:"Clopidogrel",g:"Plavix",c:"anticoagulant",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO"],
 d:[{i:"ACS/STEMI",a:"300-600 mg loading dose PO",p:"N/A",m:"600 mg loading"},{i:"Maintenance",a:"75 mg PO daily",p:"N/A",m:"75 mg/day"}],
 ci:"Active pathological bleeding, severe hepatic impairment.",adr:"Bleeding, bruising, GI upset, TTP (rare).",
 ph:"Clopidogrel is a thienopyridine prodrug that requires hepatic CYP2C19 conversion to its active metabolite. The active form irreversibly blocks the P2Y12 ADP receptor on platelet surfaces for the platelet's lifespan (~7-10 days). ADP (adenosine diphosphate) is a key platelet activator â€” when blocked, platelet aggregation and activation of the GPIIb/IIIa receptor are significantly reduced. This provides antiplatelet action through a completely different pathway than aspirin (COX-1), which is why dual antiplatelet therapy (DAPT) is synergistic.",
 an:"If aspirin is a traffic cop stopping cars from one direction (COX-1 pathway), clopidogrel is a cop on a different street corner blocking traffic from another direction (ADP pathway). Together, they block platelet clumping from both angles â€” that's why they're given together in heart attacks. The catch: clopidogrel is a 'prodrug' â€” the body has to activate it first, so there's a delay.",
 pearl:"Prodrug â€” requires CYP2C19 metabolism (genetic variability). Onset of loading dose: 2-6 hrs. Irreversible â€” effects last 7-10 days after stopping. Check if PCI is planned before giving (may delay surgery)."},

{n:"Ticagrelor",g:"Brilinta",c:"anticoagulant",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["PO"],
 d:[{i:"ACS",a:"180 mg loading dose PO",p:"N/A",m:"180 mg loading"}],
 ci:"Active pathological bleeding, history of ICH, severe hepatic impairment, concurrent strong CYP3A4 inhibitors.",adr:"Bleeding, dyspnea, bradycardia, hyperuricemia.",
 ph:"Ticagrelor is a cyclopentyl-triazolopyrimidine that directly and reversibly binds to the P2Y12 ADP receptor on platelets (no hepatic activation required). Unlike clopidogrel, ticagrelor does not require CYP2C19 conversion â€” it is active as the parent compound, providing faster, more consistent, and more potent platelet inhibition. It also inhibits cellular adenosine reuptake, increasing plasma adenosine levels â€” this contributes to its side effects of dyspnea and bradycardia but may also provide cardioprotective effects.",
 an:"If clopidogrel needs to be 'assembled' by the liver before it can work (like IKEA furniture), ticagrelor comes ready-to-use right out of the box. It blocks the same platelet switch (P2Y12) but faster, stronger, and more predictably. The downside is it can make you feel short of breath â€” that's the adenosine effect, not a heart attack.",
 pearl:"Faster onset than clopidogrel (30 min vs 2-6 hrs). Reversible binding = shorter duration. Must be taken BID (unlike clopidogrel QD). Dyspnea side effect is benign but may alarm patients."},

{n:"Eptifibatide",g:"Integrilin",c:"anticoagulant",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"ACS/PCI",a:"180 mcg/kg IV bolus, then 2 mcg/kg/min drip",p:"N/A",m:"Per protocol"}],
 ci:"Active bleeding, recent surgery/trauma (<30 days), severe HTN, thrombocytopenia, renal dialysis.",adr:"Bleeding (major and minor), thrombocytopenia.",
 ph:"Eptifibatide is a synthetic cyclic peptide that reversibly blocks the glycoprotein IIb/IIIa (GPIIb/IIIa) receptor on platelet surfaces. GPIIb/IIIa is the final common pathway of platelet aggregation â€” it binds fibrinogen, which cross-links adjacent platelets together. By blocking this receptor, eptifibatide prevents fibrinogen-mediated platelet cross-linking regardless of the activation stimulus. This represents the most potent level of antiplatelet therapy available.",
 an:"All the different platelet activation signals (thromboxane, ADP, thrombin, collagen) eventually converge on one final handshake: the GPIIb/IIIa receptor grabs fibrinogen to link platelets together. Eptifibatide blocks that final handshake â€” like putting mittens on every platelet so they can't grip anything. It's the most aggressive way to prevent clotting, which is also why bleeding risk is high.",
 pearl:"Most potent antiplatelet â€” blocks final common pathway. Short half-life (~2.5 hrs). Check platelets at baseline and 6 hrs. Reversible once discontinued. Renally cleared â€” adjust in renal impairment."},

{n:"Protamine Sulfate",g:"Protamine",c:"anticoagulant",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV"],ha:true,
 d:[{i:"Heparin Reversal",a:"1 mg per 100 units UFH (given in last 2-3 hrs); max rate 5 mg/min",p:"Same as adult",m:"50 mg/dose"}],
 ci:"Allergy to protamine, fish, or prior protamine exposure (relative).",adr:"Hypotension, bradycardia, anaphylaxis/anaphylactoid reactions, pulmonary hypertension, bleeding rebound.",
 ph:"Protamine is a strongly positively charged protein (derived from salmon sperm) that forms a stable ionic complex with negatively charged heparin molecules, neutralizing heparin's anticoagulant activity. The protamine-heparin complex has no anticoagulant effect and is cleared by the reticuloendothelial system. Protamine reverses ~100% of UFH effect but only ~60% of LMWH (enoxaparin) because LMWH's anti-Xa activity is less susceptible to protamine neutralization than its anti-IIa activity.",
 an:"Heparin is like a negatively charged magnet that sticks to clotting factors and disables them. Protamine is a positively charged magnet â€” when you bring them together, they snap onto each other and neutralize, leaving the clotting factors free to work again. The key is getting the ratio right â€” too much protamine and IT can cause its own bleeding and hemodynamic problems.",
 pearl:"SLOW IV push â€” rapid administration causes severe hypotension and anaphylactoid reactions. Fish/seafood allergy and prior protamine exposure increase reaction risk. 1 mg reverses ~100 units UFH.",at:"Administer slowly IV at max 5 mg/min. Have epinephrine available."},

{n:"Vitamin K (Phytonadione)",g:"AquaMEPHYTON",c:"anticoagulant",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IV","IM","PO","SQ"],
 d:[{i:"Warfarin Reversal (serious bleeding)",a:"10 mg slow IV over 10-20 min",p:"1-5 mg depending on age",m:"10 mg"},{i:"Warfarin Reversal (elevated INR, no bleeding)",a:"2.5-5 mg PO",p:"N/A",m:"10 mg"},{i:"Neonatal Prophylaxis",a:"N/A",p:"0.5-1 mg IM at birth",m:"1 mg"}],
 ci:"None absolute in life-threatening bleeding.",adr:"Anaphylactoid reactions (IV), flushing, pain at injection site.",
 ph:"Vitamin K (phytonadione) is an essential cofactor for hepatic gamma-carboxylation of clotting factors II, VII, IX, and X (plus proteins C and S). Warfarin inhibits vitamin K epoxide reductase, preventing recycling of vitamin K to its active form and depleting functional clotting factors. Exogenous Vitamin K bypasses the blocked recycling pathway, providing fresh cofactor for clotting factor synthesis. Full effect takes 6-24 hours because the liver must synthesize NEW clotting factors â€” for immediate reversal, FFP or PCC (prothrombin complex concentrate) is needed.",
 an:"Warfarin shuts down the recycling plant that reactivates vitamin K, and without active vitamin K, the liver can't stamp clotting factors with their 'approved for use' seal. Giving vitamin K is like airlifting fresh raw materials to the factory â€” the liver can start stamping new clotting factors again. But the factory needs time to produce them, which is why Vitamin K isn't instant.",
 pearl:"IV must be slow (anaphylactoid risk). Full effect takes 6-24 hrs â€” for immediate reversal, give PCC or FFP concurrently. IM route avoided in coagulopathic patients (hematoma risk). Neonatal dose is standard of care at birth."},

// ==================== OTHER (ADDITIONAL) ====================
{n:"Bumetanide",g:"Bumex",c:"other",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","IM","PO"],
 d:[{i:"Pulmonary Edema/CHF",a:"0.5-1 mg IV over 1-2 min; may repeat q2-3h",p:"0.015-0.1 mg/kg",m:"10 mg/day"}],
 ci:"Anuria, severe electrolyte depletion, hepatic coma.",adr:"Hypotension, dehydration, hypokalemia, hyponatremia, ototoxicity.",
 ph:"Bumetanide is a potent loop diuretic that inhibits the Na+/K+/2Cl- cotransporter (NKCC2) in the thick ascending limb of the loop of Henle â€” the same mechanism as furosemide but approximately 40Ã— more potent on a mg-per-mg basis. By blocking sodium, potassium, and chloride reabsorption, it causes massive diuresis and natriuresis. The resulting fluid loss reduces plasma volume, decreasing preload and pulmonary congestion in CHF. It also has minor venodilation effects that provide early preload reduction before diuresis begins.",
 an:"Bumetanide works the same way as furosemide (Lasix) â€” blocking the kidney's water recycling dam â€” but it's 40 times more potent per milligram. If Lasix is a garden hose, bumetanide is a fire hose. Used when patients are resistant to furosemide or need a stronger push.",
 pearl:"40Ã— more potent than furosemide (1 mg bumetanide â‰ˆ 40 mg furosemide). Useful in furosemide-resistant patients. Monitor K+, Mg2+, and volume status closely."},

{n:"Acetazolamide",g:"Diamox",c:"other",e:"ğŸ’Š",s:["paramedic","rn","lpn"],r:["IV","PO"],
 d:[{i:"Altitude Sickness",a:"125-250 mg PO BID",p:"2.5 mg/kg q12h",m:"1000 mg/day"},{i:"Increased ICP/Glaucoma",a:"250-500 mg IV",p:"5-10 mg/kg",m:"1 g/dose"}],
 ci:"Severe hepatic/renal disease, severe electrolyte imbalances, sulfonamide allergy, adrenal failure.",adr:"Metabolic acidosis, paresthesias, drowsiness, kidney stones, hypokalemia.",
 ph:"Acetazolamide is a carbonic anhydrase inhibitor that blocks the enzyme carbonic anhydrase (CA) in the proximal convoluted tubule of the nephron and in the choroid plexus. In the kidney, CA inhibition prevents reabsorption of bicarbonate, causing urinary bicarbonate wasting and mild metabolic acidosis â€” this acidosis stimulates the respiratory center to increase ventilation (beneficial at altitude). In the eye/brain, CA inhibition reduces aqueous humor and CSF production, lowering intraocular pressure and ICP.",
 an:"Carbonic anhydrase is like a recycling machine for bicarbonate in the kidneys. Acetazolamide breaks this machine â€” bicarbonate pours out in the urine, making the blood slightly acidic. The body responds by breathing faster to blow off CO2 (helpful at altitude). It also slows the faucet that makes fluid in the brain and eyes, reducing pressure in both.",
 pearl:"Sulfonamide derivative â€” cross-reactivity with sulfa allergy is possible (low risk). Causes tingling/paresthesias (numbness in fingers/toes) â€” warn patients. Induces metabolic acidosis."},

{n:"Prednisone",g:"Deltasone",c:"other",e:"ğŸ’Š",s:["aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Asthma Exacerbation",a:"40-60 mg PO daily Ã—5-7 days",p:"1-2 mg/kg/day (max 60 mg)",m:"60 mg"},{i:"Allergic Reaction/Croup",a:"1-2 mg/kg PO",p:"1-2 mg/kg",m:"60 mg"}],
 ci:"Systemic fungal infections, live vaccines (relative).",adr:"Hyperglycemia, immunosuppression, mood changes, GI upset, adrenal suppression (chronic).",
 ph:"Prednisone is a synthetic corticosteroid prodrug that is hepatically converted to prednisolone (active form). Corticosteroids bind to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modifies gene transcription. This upregulates anti-inflammatory proteins (lipocortin-1, IL-10) and downregulates pro-inflammatory mediators (cytokines, prostaglandins, leukotrienes, histamine). In asthma, this reduces airway inflammation, edema, and mucus production. Effects take 4-6 hours to manifest.",
 an:"Inflammation is like a fire alarm that won't stop ringing â€” immune cells, chemicals, and swelling keep amplifying. Prednisone goes into the cell's control room (nucleus) and reprograms the alarm system: turning down the 'inflammation' genes and turning up the 'calm down' genes. It's a powerful reset, but it takes a few hours because reprogramming genes isn't instant.",
 pearl:"Oral equivalent of methylprednisolone. Takes 4-6 hrs for clinical effect â€” give early. Short courses (5-7 days) don't need taper. PO alternative when IV steroids unavailable."},

{n:"Prednisolone",g:"Orapred / Prelone",c:"other",e:"ğŸ’Š",s:["aemt","paramedic","rn","lpn"],r:["PO"],
 d:[{i:"Croup/Asthma (Pediatric)",a:"1-2 mg/kg PO",p:"1-2 mg/kg (max 60 mg)",m:"60 mg"},{i:"Allergic Reaction",a:"1 mg/kg PO",p:"1-2 mg/kg",m:"60 mg"}],
 ci:"Systemic fungal infections.",adr:"Same as prednisone â€” hyperglycemia, GI upset, mood changes.",
 ph:"Prednisolone IS the active form of prednisone â€” it does not require hepatic conversion. This is clinically significant in patients with liver dysfunction and especially in young children whose hepatic enzyme systems may be immature. The mechanism is identical to prednisone: glucocorticoid receptor binding â†’ nuclear translocation â†’ anti-inflammatory gene modulation. Liquid formulations (Orapred) make it the preferred pediatric oral steroid.",
 an:"Prednisolone is prednisone that's already 'activated' â€” no assembly required by the liver. For kids, this matters because their livers may not convert prednisone efficiently. Plus, it comes as a liquid (Orapred) which is much easier to give a toddler than a pill. Same fire-alarm reprogramming, just pre-loaded.",
 pearl:"Preferred over prednisone in pediatrics â€” available as palatable liquid (Orapred). No hepatic conversion needed. Dose equivalent: prednisolone 5 mg = prednisone 5 mg."},


// ==================== ADDITIONAL TO REACH 143 ====================
{n:"Ziprasidone",g:"Geodon",c:"neuro",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IM"],
 d:[{i:"Acute Agitation/Psychosis",a:"10-20 mg IM",p:"N/A",m:"40 mg/day IM"}],
 ci:"Known QT prolongation, concurrent QT-prolonging drugs, uncontrolled heart failure.",adr:"QT prolongation, sedation, orthostatic hypotension, dystonic reactions.",
 ph:"Ziprasidone is an atypical (second-generation) antipsychotic with combined D2 dopamine and 5-HT2A serotonin receptor antagonism. The D2 blockade reduces psychotic symptoms and acute agitation while the 5-HT2A blockade provides anxiolytic effects and reduces extrapyramidal side effects compared to typical antipsychotics. It also has moderate affinity for histamine H1, alpha-1 adrenergic, and 5-HT1A receptors. Compared to haloperidol, it has lower risk of EPS but higher risk of QT prolongation.",
 an:"Ziprasidone is like a more sophisticated version of haloperidol â€” it calms agitation by blocking both the excitement signal (dopamine) AND the anxiety signal (serotonin), giving a smoother sedation with less muscle stiffness. The trade-off is it can mess with the heart's electrical timing more than haloperidol.",
 pearl:"IM onset 15-30 min. Requires QTc monitoring. Lower EPS risk than haloperidol. Many EMS systems use it as primary chemical restraint for excited delirium."},

{n:"Olanzapine",g:"Zyprexa",c:"neuro",e:"ğŸ’‰",s:["paramedic","rn","lpn"],r:["IM","PO"],
 d:[{i:"Acute Agitation",a:"5-10 mg IM; or 10 mg ODT (sublingual dissolving tab)",p:"N/A",m:"30 mg/day"}],
 ci:"Concurrent IM benzodiazepines (respiratory depression risk), hemodynamic instability.",adr:"Sedation, orthostatic hypotension, anticholinergic effects, metabolic effects.",
 ph:"Olanzapine is an atypical antipsychotic with broad receptor affinity: D2 dopamine antagonist, 5-HT2A serotonin antagonist, muscarinic M1 antagonist, histamine H1 antagonist, and alpha-1 adrenergic antagonist. This multi-receptor profile provides effective sedation through multiple pathways simultaneously. The IM formulation provides reliable absorption even in agitated patients. Importantly, concurrent IM benzodiazepines and IM olanzapine carry risk of respiratory depression, hypotension, and death.",
 an:"Olanzapine is like muting five different alarm systems at once â€” dopamine, serotonin, histamine, acetylcholine, and adrenaline all get turned down. This broad silencing effect makes it very effective for agitation, but the ODT form that dissolves on the tongue is particularly clever for patients who won't swallow pills.",
 pearl:"âš  Do NOT give IM olanzapine within 1 hour of IM benzodiazepine â€” respiratory depression/death risk. ODT tab is useful for cooperative-but-agitated patients.",at:"Avoid concurrent IM benzodiazepines."},

{n:"Dexmedetomidine",g:"Precedex",c:"sedation",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV","IN"],ha:false,
 d:[{i:"Procedural Sedation/Post-Intubation",a:"0.5-1 mcg/kg IV over 10 min; then 0.2-0.7 mcg/kg/hr drip",p:"1-2 mcg/kg IN",m:"1 mcg/kg loading"}],
 ci:"Advanced heart block (without pacemaker), severe ventricular dysfunction.",adr:"Bradycardia, hypotension, dry mouth.",
 ph:"Dexmedetomidine is a highly selective alpha-2 adrenergic agonist that produces sedation by activating alpha-2 receptors in the locus coeruleus (the brain's 'alertness center'). This produces a unique 'cooperative sedation' â€” patients appear to be sleeping but can be easily aroused to follow commands, then return to sleep when unstimulated. Unlike benzodiazepines and propofol, it does not cause clinically significant respiratory depression. It also has analgesic properties via spinal cord alpha-2 receptors and reduces sympathetic outflow.",
 an:"Most sedatives work by shutting down the whole brain â€” dexmedetomidine just turns off the alertness switch (locus coeruleus) while leaving everything else running. It's like putting the brain in sleep mode rather than powering it off completely. Patients breathe on their own, and if you tap them on the shoulder, they wake up, answer your question, and go right back to sleep.",
 pearl:"'Cooperative sedation' â€” arousable without agitation. No respiratory depression â€” game-changer for procedural sedation. Loading dose can cause brief hypertension then sustained hypotension/bradycardia. Increasingly used in prehospital care via IN route."},

{n:"Clevidipine",g:"Cleviprex",c:"cardiac",e:"ğŸ’‰",s:["paramedic","rn"],r:["IV"],
 d:[{i:"Hypertensive Emergency",a:"1-2 mg/hr IV; double q90sec until target BP; maintenance 4-6 mg/hr",p:"0.5 mcg/kg/min",m:"32 mg/hr (21 mg/hr avg)"}],
 ci:"Soy/egg allergy (lipid emulsion vehicle), defective lipid metabolism, severe aortic stenosis.",adr:"Headache, nausea, reflex tachycardia, atrial fibrillation.",
 ph:"Clevidipine is an ultra-short-acting IV dihydropyridine calcium channel blocker with a half-life of approximately 1 minute. It selectively relaxes arteriolar smooth muscle by blocking L-type calcium channels, reducing SVR and BP. It is rapidly metabolized by blood and tissue esterases (not hepatic/renal), making it safe in organ dysfunction. The lipid emulsion vehicle provides 2 kcal/mL (0.2 g fat/mL). Its extremely short half-life allows precise BP titration minute-to-minute.",
 an:"Clevidipine is the esmolol of calcium channel blockers â€” ultra-short acting, wears off in about a minute if you stop it. It opens up arteries instantly by blocking calcium, and if BP drops too much, just slow the drip and it corrects within minutes. It's dissolved in a milky lipid emulsion, which is why egg/soy allergies matter.",
 pearl:"1-min half-life â€” most titratable antihypertensive available. Lipid emulsion â€” contributes ~0.5 g fat/hr. No refrigeration needed. Ideal for precise BP control in aortic dissection, stroke."},

{n:"Tetracaine Ophthalmic",g:"Pontocaine",c:"analgesic",e:"ğŸ‘",s:["aemt","paramedic","rn","lpn"],r:["Ophthalmic"],
 d:[{i:"Eye Pain / Examination",a:"1-2 drops in affected eye",p:"Same as adult",m:"2 drops per application"}],
 ci:"Known hypersensitivity to ester-type local anesthetics.",adr:"Transient stinging, corneal epithelial toxicity (repeated use), allergic reaction.",
 ph:"Tetracaine is an ester-type local anesthetic that blocks sodium channels in corneal sensory nerve fibers, preventing depolarization and transmission of pain signals. It penetrates the corneal epithelium rapidly, providing topical anesthesia within 30 seconds that lasts 15-20 minutes. Single application for examination is safe; however, repeated use delays corneal epithelial healing by inhibiting mitosis and migration of epithelial cells, which is why it should never be prescribed for ongoing pain management.",
 an:"The cornea has the highest density of pain nerves anywhere in the body â€” that's why even a tiny scratch feels excruciating. Tetracaine drops temporarily silence those nerves by blocking their sodium channels, like putting the cornea on 'mute.' But if you keep using it, you prevent the cornea from healing â€” it's a diagnostic tool, not a treatment.",
 pearl:"Single application for exam/foreign body removal. NEVER send patient home with bottle â€” repeated use causes corneal melting. Onset <30 sec, lasts 15-20 min."},

{n:"Proparacaine",g:"Alcaine",c:"analgesic",e:"ğŸ‘",s:["aemt","paramedic","rn","lpn"],r:["Ophthalmic"],
 d:[{i:"Eye Pain / Examination / Tonometry",a:"1-2 drops in affected eye",p:"Same as adult",m:"2 drops"}],
 ci:"Hypersensitivity to ester-type local anesthetics.",adr:"Transient stinging (less than tetracaine), corneal toxicity with repeated use.",
 ph:"Proparacaine is an ester-type topical ophthalmic anesthetic similar to tetracaine but with less initial stinging on application, making it better tolerated. It blocks sodium channels in corneal sensory nerves, providing anesthesia within 20 seconds lasting 15-20 minutes. The reduced stinging is attributed to its lower pH and different chemical structure which causes less disruption of the corneal epithelium on initial contact.",
 an:"Same 'mute button' concept as tetracaine, but proparacaine is the gentler version â€” it doesn't sting as much going in. For a patient who's already in pain from an eye injury, this matters. Same rules apply though: one-time use for examination, never for ongoing pain.",
 pearl:"Preferred over tetracaine in many EMS systems due to less stinging. Same precautions: single application only. Don't prescribe or send home with patient."},

{n:"Erythromycin Ophthalmic",g:"Ilotycin",c:"other",e:"ğŸ‘",s:["emt","aemt","paramedic","rn","lpn"],r:["Ophthalmic"],
 d:[{i:"Neonatal Ophthalmia Prophylaxis",a:"N/A",p:"0.5-1 cm ribbon in each eye at birth",m:"Single application"},{i:"Bacterial Conjunctivitis",a:"0.5-1 cm ribbon q6h Ã—5-7 days",p:"Same",m:"Per protocol"}],
 ci:"Known macrolide allergy.",adr:"Minor irritation, blurred vision (temporary, ointment-based).",
 ph:"Erythromycin is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking translocation of amino acids during translation. The ophthalmic ointment form provides sustained contact time with the conjunctival surface. Neonatal prophylaxis targets Neisseria gonorrhoeae and Chlamydia trachomatis, which can be transmitted during vaginal delivery and cause ophthalmia neonatorum â€” a sight-threatening infection if untreated.",
 an:"Erythromycin ointment is like applying a thin layer of antibiotic 'paint' to the baby's eyes right after birth. It kills bacteria that could have been picked up during delivery and prevents infection that could cause blindness. The ointment sticks around longer than drops, giving better coverage.",
 pearl:"Standard of care for all newborns within 1 hour of birth. Applied as thin ribbon in lower conjunctival sac. May cause temporary blurred vision. Must document administration."},

{n:"Silver Sulfadiazine",g:"Silvadene",c:"other",e:"ğŸ”¥",s:["aemt","paramedic","rn","lpn"],r:["Topical"],
 d:[{i:"Burn Wound Care (2nd/3rd degree)",a:"Apply 1/16 inch layer to burn area BID",p:"Same as adult",m:"Per protocol"}],
 ci:"Sulfonamide allergy, pregnancy (near term), premature infants/neonates <2 months.",adr:"Leukopenia (transient), skin discoloration, pain at application site, rare allergic reaction.",
 ph:"Silver sulfadiazine combines two antimicrobial mechanisms: silver ions disrupt bacterial cell membranes and denature proteins, while sulfadiazine (a sulfonamide) inhibits bacterial dihydropteroate synthase, blocking folic acid synthesis needed for DNA replication. This dual mechanism provides broad-spectrum coverage against gram-positive, gram-negative, and yeast organisms â€” particularly Pseudomonas aeruginosa, a common burn wound pathogen. The cream also maintains a moist wound environment that promotes healing.",
 an:"Burns create a perfect breeding ground for bacteria â€” warm, moist, no skin barrier. Silver sulfadiazine is like a two-pronged security system: the silver physically destroys bacteria on contact (like a chemical force field), while the sulfa drug blocks their ability to reproduce (cuts off their supply chain). Together they keep the burn wound sterile while it heals.",
 pearl:"Apply with sterile gloves. Reapply BID. Transient leukopenia is common at 2-3 days â€” usually resolves spontaneously. Sulfa allergy is a contraindication. Some burn centers prefer alternative dressings (aquacel Ag, mepilex Ag)."},

{n:"Dextrose 25% (D25)",g:"Dextrose 25%",c:"metabolic",e:"ğŸ’‰",s:["aemt","paramedic","rn","lpn"],r:["IV"],
 d:[{i:"Pediatric Hypoglycemia",a:"N/A",p:"2-4 mL/kg IV (0.5-1 g/kg)",m:"25 g"}],
 ci:"None in hypoglycemia.",adr:"Hyperglycemia, phlebitis, tissue necrosis if infiltrated.",
 ph:"Dextrose 25% provides an intermediate concentration between D50 (too concentrated for pediatrics) and D10 (requires large volumes). Its osmolarity (~1,260 mOsm/L) is more appropriate for pediatric peripheral veins than D50 (~2,525 mOsm/L) while still delivering adequate glucose in a manageable volume. Many EMS systems prepare D25 by diluting D50 1:1 with sterile water or NS. The glucose directly enters glycolysis to restore cellular energy production in hypoglycemic states.",
 an:"D25 is the 'Goldilocks' concentration for pediatric hypoglycemia â€” D50 is too strong for small veins (can burn and damage tissue), D10 requires too much volume, but D25 is just right. It delivers enough sugar to rescue brain cells from glucose starvation without destroying the tiny blood vessels.",
 pearl:"Prepare by diluting D50 1:1 with NS. Preferred over D50 for pediatrics and neonates (less vein damage). D10 is becoming more common as the universal concentration. Check BGL q5min after administration."},

{n:"Norepinephrine Infusion",g:"Levophed Drip",c:"vasopressor",e:"ğŸ“ˆ",s:["paramedic","rn"],r:["IV"],ha:true,
 d:[{i:"Septic Shock (First-Line)",a:"0.1-0.5 mcg/kg/min IV; titrate to MAP â‰¥65",p:"0.05-0.1 mcg/kg/min",m:"3 mcg/kg/min (typical max)"},{i:"Neurogenic Shock",a:"0.1-0.3 mcg/kg/min IV",p:"Same",m:"Titrate to MAP"}],
 ci:"Mesenteric/peripheral vascular thrombosis (relative), concurrent halothane/cyclopropane anesthesia.",adr:"Hypertension, reflex bradycardia, tissue necrosis (extravasation), dysrhythmias, limb ischemia.",
 ph:"Norepinephrine is a potent endogenous catecholamine with strong alpha-1 agonism and moderate beta-1 agonism but minimal beta-2 activity. The predominant alpha-1 effect causes significant arteriolar vasoconstriction, increasing SVR and MAP. The beta-1 component maintains cardiac output without excessive tachycardia. In septic shock, the pathologic vasodilation from inflammatory mediators (NO, cytokines) causes distributive shock â€” norepinephrine directly counteracts this vasodilation. It is first-line per Surviving Sepsis Campaign guidelines because it improves perfusion pressure with less tachycardia than dopamine.",
 an:"In septic shock, blood vessels are wide open and floppy â€” like a garden hose with no water pressure because the hose itself expanded to twice its size. Norepinephrine squeezes those floppy vessels back to normal diameter, restoring pressure so blood can reach organs. It does this mainly through alpha receptors (vessel squeeze) with enough beta to keep the heart pumping efficiently.",
 pearl:"First-line vasopressor for septic shock (SSC guidelines). Target MAP â‰¥65 mmHg. Central line preferred â€” extravasation causes severe tissue necrosis. Phentolamine is antidote for extravasation.",at:"Central line preferred. Treat extravasation immediately with phentolamine."},

// ==================== NURSING â€” CARDIAC/VASCULAR ====================
{n:"Warfarin",g:"Coumadin",c:"anticoagulant",e:"ğŸ©¸",s:["rn","lpn"],r:["PO"],
 d:[{i:"DVT/PE/AFib Anticoagulation",a:"2-10 mg PO daily (per INR)",p:"Rarely used in peds",m:"Per INR target"}],
 ci:"Active bleeding, hemorrhagic stroke, pregnancy, severe hepatic disease, recent surgery.",adr:"Bleeding, bruising, skin necrosis (rare), purple toe syndrome, alopecia.",
 ph:"Warfarin inhibits vitamin K epoxide reductase (VKORC1), blocking the recycling of vitamin K from its epoxide form back to its active form. Without active vitamin K, the liver cannot complete gamma-carboxylation of clotting factors II, VII, IX, and X â€” making them non-functional. Factor VII has the shortest half-life (~6 hours), so PT/INR rises first, but full anticoagulation takes 3-5 days as the other factors deplete.",
 an:"Imagine a factory that makes four types of armor (clotting factors II, VII, IX, X). The factory needs a special tool (vitamin K) to finish each piece. Warfarin steals the tool, so the factory keeps producing armor that falls apart â€” it looks right but can't actually protect you. The old armor already made still works until it wears out (3-5 days), which is why warfarin doesn't work immediately.",
 pearl:"Monitor INR â€” therapeutic range typically 2.0-3.0 (mechanical valve: 2.5-3.5). Vitamin K is the reversal agent. Numerous food and drug interactions. Educate on consistent vitamin K intake.",at:"INR monitoring required. Many drug/food interactions."},

{n:"Apixaban",g:"Eliquis",c:"anticoagulant",e:"ğŸ©¸",s:["rn","lpn"],r:["PO"],
 d:[{i:"DVT/PE Treatment",a:"10 mg PO BID Ã— 7 days, then 5 mg BID",p:"Not established",m:"10 mg BID"},{i:"AFib Stroke Prevention",a:"5 mg PO BID (2.5 mg if â‰¥2: age â‰¥80, wt â‰¤60 kg, Cr â‰¥1.5)",p:"N/A",m:"5 mg BID"}],
 ci:"Active pathological bleeding, severe hepatic impairment, prosthetic heart valves.",adr:"Bleeding, bruising, nausea, anemia.",
 ph:"Apixaban is a direct Factor Xa inhibitor. Factor Xa sits at the convergence of both intrinsic and extrinsic coagulation cascades â€” it converts prothrombin to thrombin. By selectively blocking Factor Xa, apixaban reduces thrombin generation without directly affecting existing thrombin, providing predictable anticoagulation without routine monitoring.",
 an:"The clotting cascade is like a relay race with two teams (intrinsic and extrinsic pathways) that merge at one runner (Factor Xa) before the final sprint (thrombin â†’ fibrin clot). Apixaban tackles that one critical runner at the merge point, so it doesn't matter which team started the race â€” neither can finish.",
 pearl:"No routine INR monitoring needed. Reversal agent: andexanet alfa (Andexxa). Dose-reduce for age, weight, renal criteria in AFib. Fewer dietary restrictions than warfarin.",at:"No reliable lab monitoring. Reversal: andexanet alfa."},

{n:"Amlodipine",g:"Norvasc",c:"cardiac",e:"ğŸ’Š",s:["rn","lpn"],r:["PO"],
 d:[{i:"Hypertension",a:"5-10 mg PO daily",p:"0.1-0.3 mg/kg/day (max 5 mg)",m:"10 mg/day"},{i:"Chronic Stable Angina",a:"5-10 mg PO daily",p:"N/A",m:"10 mg/day"}],
 ci:"Severe aortic stenosis, cardiogenic shock, unstable angina (without beta-blocker).",adr:"Peripheral edema, dizziness, flushing, headache, fatigue, palpitations.",
 ph:"Amlodipine is a dihydropyridine calcium channel blocker that selectively inhibits L-type calcium channels in vascular smooth muscle. By blocking calcium influx, it prevents the actin-myosin cross-bridging needed for smooth muscle contraction, causing peripheral arteriolar vasodilation. This reduces systemic vascular resistance (afterload), lowering blood pressure. Its long half-life (30-50 hours) provides smooth 24-hour coverage.",
 an:"Blood vessels have tiny muscles that squeeze when calcium floods in â€” like making a fist when you grip something. Amlodipine blocks the calcium doors, so the muscles can't squeeze as hard. The vessels stay relaxed and open, like an unclenched fist, letting blood flow with less pressure.",
 pearl:"Long half-life = once daily dosing. Ankle edema is most common side effect. Unlike diltiazem/verapamil, minimal effect on heart rate/conduction. Takes 7-10 days for full effect."},

{n:"Atorvastatin",g:"Lipitor",c:"cardiac",e:"ğŸ’Š",s:["rn","lpn"],r:["PO"],
 d:[{i:"Hyperlipidemia",a:"10-80 mg PO daily",p:"10-20 mg/day (age â‰¥10)",m:"80 mg/day"},{i:"ACS/Post-MI",a:"80 mg PO daily (high-intensity)",p:"N/A",m:"80 mg/day"}],
 ci:"Active liver disease, unexplained persistent transaminase elevations, pregnancy, breastfeeding.",adr:"Myalgia, elevated LFTs, GI upset, headache, rhabdomyolysis (rare), new-onset diabetes.",
 ph:"Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol biosynthesis. As liver cholesterol production drops, hepatocytes upregulate LDL receptors to capture more LDL-C from blood, lowering circulating LDL levels. Beyond lipid lowering, statins stabilize atherosclerotic plaques, reduce vascular inflammation, and improve endothelial function.",
 an:"Your liver is like a cholesterol factory with one main assembly line (HMG-CoA reductase). Atorvastatin shuts down that assembly line. Now the liver is hungry for cholesterol, so it puts up more 'help wanted' signs (LDL receptors) on its surface, pulling bad cholesterol out of the bloodstream like vacuum cleaners.",
 pearl:"Take at any time (long half-life). High-intensity (40-80 mg) for ACS, post-MI, established ASCVD. Monitor LFTs at baseline. CK if myalgia. Grapefruit interaction at high doses."},

// ==================== NURSING â€” METABOLIC ====================
{n:"Metformin",g:"Glucophage",c:"metabolic",e:"ğŸ’Š",s:["rn","lpn"],r:["PO"],
 d:[{i:"Type 2 Diabetes",a:"500 mg PO BID, titrate to 2000-2550 mg/day",p:"â‰¥10 yr: 500 mg BID, max 2000 mg/day",m:"2550 mg/day"},{i:"Prediabetes Prevention",a:"500-1700 mg PO daily",p:"N/A",m:"1700 mg/day"}],
 ci:"eGFR <30, metabolic acidosis, DKA, IV contrast within 48 hrs (hold), severe hepatic impairment.",adr:"GI upset (diarrhea, nausea), lactic acidosis (rare), B12 deficiency (long-term), metallic taste.",
 ph:"Metformin suppresses hepatic glucose production (gluconeogenesis) by activating AMP-activated protein kinase (AMPK). Secondary effects include increasing peripheral insulin sensitivity and decreasing intestinal glucose absorption. It does NOT stimulate insulin secretion, so it rarely causes hypoglycemia alone.",
 an:"In Type 2 diabetes, the liver is like a sugar factory that ignores the 'CLOSED' sign and keeps producing glucose 24/7. Metformin is the factory manager who enforces the shutdown order â€” it makes the liver obey. It also helps the warehouse workers (muscles) unload sugar faster. Because it never tells the pancreas to make more insulin, it almost never causes a sugar crash.",
 pearl:"First-line for Type 2 DM (ADA guidelines). Hold 48 hours before/after IV contrast. GI side effects improve with food and slow titration. ER formulation better tolerated. Check B12 annually with long-term use.",at:"Hold for IV contrast procedures. Check renal function regularly."},

{n:"Levothyroxine",g:"Synthroid",c:"metabolic",e:"ğŸ’Š",s:["rn","lpn"],r:["PO","IV"],
 d:[{i:"Hypothyroidism",a:"1.6 mcg/kg/day PO (start 25-50 mcg in elderly/cardiac)",p:"Neonates: 10-15 mcg/kg/day",m:"200-300 mcg/day"},{i:"Myxedema Coma",a:"200-500 mcg IV load, then 50-100 mcg IV daily",p:"Per endocrine consult",m:"500 mcg IV load"}],
 ci:"Uncorrected adrenal insufficiency (give hydrocortisone first), acute MI (relative), thyrotoxicosis.",adr:"Tachycardia, palpitations, tremor, insomnia, weight loss, heat intolerance.",
 ph:"Levothyroxine is synthetic T4 (thyroxine). After absorption, T4 is converted to the more active T3 by deiodinase enzymes in peripheral tissues. T3 enters cell nuclei and binds thyroid hormone receptors, activating gene transcription that increases basal metabolic rate, oxygen consumption, and thermogenesis across virtually every organ system. Long half-life (~7 days) provides stable levels.",
 an:"Your thyroid is like a thermostat that controls the speed of every process in your body. In hypothyroidism, the thermostat is broken and set too low â€” everything runs in slow motion. Levothyroxine is like installing a new thermostat set to the right temperature. You take the same hormone your body would make, so everything gradually speeds back up to normal.",
 pearl:"Take on empty stomach 30-60 min before food. Monitor TSH 6-8 weeks after dose changes. Narrow therapeutic index â€” brand consistency recommended. In myxedema coma, give IV hydrocortisone BEFORE levothyroxine.",at:"Give hydrocortisone before levothyroxine in myxedema coma."},

{n:"Potassium Chloride",g:"KCl / K-Dur",c:"metabolic",e:"âš—ï¸",s:["rn","lpn"],r:["PO","IV"],ha:true,
 d:[{i:"Hypokalemia (Mild: K 3.0-3.5)",a:"40-80 mEq PO daily in divided doses",p:"1-2 mEq/kg/day PO",m:"200 mEq/day PO"},{i:"Hypokalemia (Severe: K <3.0)",a:"10-20 mEq/hr IV (max 40 mEq/hr central w/ monitoring)",p:"0.5-1 mEq/kg IV over 1 hr",m:"40 mEq/hr central"},{i:"Maintenance",a:"20-40 mEq PO daily",p:"1-2 mEq/kg/day",m:"Per levels"}],
 ci:"Hyperkalemia, severe renal impairment (GFR <10), untreated Addison's disease.",adr:"GI irritation, nausea, hyperkalemia, cardiac arrhythmias (if infused too fast), phlebitis, tissue necrosis.",
 ph:"Potassium is the primary intracellular cation, critical for maintaining resting membrane potential in excitable cells. The Na+/K+ ATPase maintains the ~-90 mV resting potential. In hypokalemia, the resting membrane becomes hyperpolarized, paradoxically making cardiac cells more susceptible to arrhythmias and delaying repolarization (prolonged QT). Severe hypokalemia can cause U waves, ST depression, VFib.",
 an:"Every cell in your body is like a tiny battery. Potassium keeps the battery charged to the right voltage. When potassium drops too low, the batteries in your heart get glitchy â€” they can't fire and reset properly, causing the electrical system to short-circuit (arrhythmias). Replacing KCl recharges all those cellular batteries back to correct voltage.",
 pearl:"NEVER IV push KCl â€” fatal arrhythmias. Max peripheral IV: 10 mEq/hr. Central line: up to 20-40 mEq/hr with cardiac monitoring. Always check Mg2+ â€” hypomagnesemia makes hypokalemia refractory. PO preferred when possible.",at:"NEVER IV PUSH. Max 10 mEq/hr peripheral. Cardiac monitoring for IV."},

{n:"Insulin Glargine",g:"Lantus / Basaglar",c:"metabolic",e:"âš—ï¸",s:["rn","lpn"],r:["SQ"],
 d:[{i:"Type 1 DM (Basal)",a:"~0.2 units/kg/day SQ, titrate per glucose",p:"Same as adult",m:"Per protocol"},{i:"Type 2 DM (Basal)",a:"10 units SQ at bedtime, titrate q3 days",p:"Per endocrine",m:"Per glucose targets"}],
 ci:"Hypoglycemia, hypersensitivity to insulin glargine.",adr:"Hypoglycemia, weight gain, injection site reactions, lipodystrophy.",
 ph:"Insulin glargine is a long-acting analog modified to precipitate at neutral subcutaneous pH, forming a depot that slowly dissolves over ~24 hours. This provides a peakless basal insulin profile mimicking the pancreas's continuous low-level secretion between meals.",
 an:"Your pancreas normally drips a small, steady amount of insulin all day â€” like a slow-dripping faucet. In diabetes, that faucet is broken. Insulin glargine replaces that slow drip: when injected, it forms a tiny depot under the skin that gradually dissolves over 24 hours, recreating the constant drip your pancreas can't provide.",
 pearl:"DO NOT mix with other insulins. Inject at same time daily. Clear solution (not cloudy â€” that's NPH). Does NOT cover meals. Rotate injection sites. Peakless = lower nocturnal hypoglycemia risk vs NPH.",at:"NEVER give IV. Do not mix with other insulins."},

{n:"Insulin Lispro",g:"Humalog",c:"metabolic",e:"âš—ï¸",s:["rn","lpn"],r:["SQ","IV"],
 d:[{i:"Mealtime Coverage",a:"Per sliding scale or carb ratio (typically 1 unit per 10-15g carbs)",p:"0.5-1 unit/kg/day total",m:"Per protocol"},{i:"Hyperglycemia Correction",a:"Per sliding scale (1 unit per 50 mg/dL above target)",p:"Per endocrine",m:"Per protocol"},{i:"DKA (IV Infusion)",a:"0.1 units/kg/hr IV",p:"0.1 units/kg/hr IV",m:"Per glucose/gap closure"}],
 ci:"Hypoglycemia.",adr:"Hypoglycemia, hypokalemia (shifts K+ intracellularly), weight gain, injection site reactions.",
 ph:"Insulin lispro is a rapid-acting analog where lysine and proline are swapped at B28-B29, preventing hexamer self-association. This allows rapid absorption as monomers/dimers from subcutaneous tissue. Onset is 15 minutes (vs 30-60 for regular insulin), matching mealtime glucose absorption.",
 an:"Regular insulin molecules are social â€” they link arms in groups of six (hexamers) and take a while to break apart. Insulin lispro was engineered to be antisocial â€” the molecules won't hold hands, so they absorb individually right away. That's why it works in 15 minutes instead of 30-60.",
 pearl:"Give within 15 min of meal. Onset 15 min, peak 1-2 hr, duration 3-5 hr. Monitor K+ in DKA. Store opened vials at room temp up to 28 days. Rotate sites.",at:"Monitor potassium closely in DKA."},

// ==================== NURSING â€” ANALGESIC ====================
{n:"Hydromorphone",g:"Dilaudid",c:"analgesic",e:"ğŸ’œ",s:["rn"],r:["PO","IV","IM","SQ"],ha:true,
 d:[{i:"Moderate-Severe Pain",a:"0.2-1 mg IV q2-3h; 2-4 mg PO q4-6h",p:"0.015 mg/kg IV q3-4h",m:"Per pain protocol"},{i:"PCA Dosing",a:"0.2 mg demand dose, 6-10 min lockout",p:"Per protocol",m:"Per 4-hr limit"}],
 ci:"Respiratory depression, severe asthma/COPD (unmonitored), paralytic ileus, MAOIs within 14 days.",adr:"Respiratory depression, sedation, constipation, nausea, pruritus, urinary retention, hypotension.",
 ph:"Hydromorphone is a semi-synthetic opioid ~5-7Ã— more potent than morphine. It binds mu-opioid receptors, activating inhibitory G-proteins that decrease cAMP, open potassium channels (hyperpolarizing neurons), and close calcium channels (preventing neurotransmitter release). This suppresses ascending pain transmission and activates descending inhibitory pathways.",
 an:"Pain signals travel through a relay chain of nerve cells. Hydromorphone cuts the power at multiple relay stations â€” it hyperpolarizes the nerves (harder to fire) and prevents them from releasing chemical messengers. The pain signal can't make it through the chain to reach your brain.",
 pearl:"5-7Ã— more potent than morphine mg-for-mg. IV onset 5 min, peak 10-20 min. ALWAYS have naloxone available. More predictable in renal impairment than morphine. PCA: independent double-check. Schedule II.",at:"5-7Ã— more potent than morphine. High alert â€” independent double check."},

{n:"Tramadol",g:"Ultram",c:"analgesic",e:"ğŸ’œ",s:["rn","lpn"],r:["PO"],
 d:[{i:"Moderate Pain",a:"50-100 mg PO q4-6h",p:"Not recommended <17 yrs",m:"400 mg/day (300 mg if >75 yrs)"},{i:"Chronic Pain (ER)",a:"100-300 mg ER daily",p:"N/A",m:"300 mg/day ER"}],
 ci:"Seizure disorder, concurrent MAOIs/SSRIs (serotonin syndrome), children <12, post-tonsillectomy <18.",adr:"Nausea, dizziness, constipation, seizures (dose-related), serotonin syndrome, respiratory depression.",
 ph:"Tramadol has dual mechanism: weak mu-opioid agonism AND serotonin/norepinephrine reuptake inhibition. The parent compound provides SNRI effects, while its active metabolite (O-desmethyltramadol via CYP2D6) provides most opioid effect â€” CYP2D6 polymorphisms significantly affect response.",
 an:"Tramadol is a two-in-one tool: one end works like a weak opioid, the other like an antidepressant (boosting serotonin/norepinephrine). Your liver converts it into a stronger opioid form, which is why some people respond dramatically (fast converters) while others barely feel it (slow converters).",
 pearl:"Schedule IV. Seizure risk >400 mg/day or with SSRIs/SNRIs. Serotonin syndrome risk with serotonergic drugs. CYP2D6 polymorphisms affect efficacy. Avoid in children <12. Taper to discontinue after chronic use.",at:"Seizure risk. Serotonin syndrome risk with SSRIs/SNRIs."},

// ==================== NURSING â€” ANTI-INFECTIVE ====================
{n:"Ceftriaxone",g:"Rocephin",c:"other",e:"ğŸ’Š",s:["rn","lpn"],r:["IV","IM"],
 d:[{i:"Pneumonia",a:"1-2 g IV/IM daily",p:"50-75 mg/kg/day (max 2 g)",m:"4 g/day"},{i:"Meningitis",a:"2 g IV q12h",p:"100 mg/kg/day divided q12h",m:"4 g/day"},{i:"UTI (Complicated)",a:"1-2 g IV daily",p:"50-75 mg/kg/day",m:"2 g/day"},{i:"Gonorrhea",a:"500 mg IM Ã— 1",p:"25-50 mg/kg IM (max 250 mg)",m:"500 mg"}],
 ci:"Cephalosporin allergy, neonates with hyperbilirubinemia, neonates receiving IV calcium.",adr:"Diarrhea, rash, elevated LFTs, biliary sludging, C. difficile colitis, IM site pain.",
 ph:"Ceftriaxone is a third-generation cephalosporin that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), blocking transpeptidation of peptidoglycan cross-linking. Bacteria lyse from osmotic pressure as they try to grow with compromised walls. Broad gram-negative and gram-positive coverage with excellent CNS penetration.",
 an:"Bacteria build walls for protection, like bricklayers adding mortar between bricks. Ceftriaxone jams the mortar gun (PBPs), so new bricks can't stick. As bacteria grow, their wall gets weaker until internal pressure blows them apart â€” like a balloon with thin spots expanding until it pops.",
 pearl:"Once-daily dosing (long half-life). DO NOT co-infuse with calcium (especially neonates â€” fatal precipitates). IM: mix with 1% lidocaine for pain. ~1-3% cross-reactivity with penicillin allergy. Biliary sludging is reversible."},

{n:"Vancomycin",g:"Vancocin",c:"other",e:"ğŸ’Š",s:["rn"],r:["IV","PO"],
 d:[{i:"MRSA / Serious Gram+ Infections",a:"15-20 mg/kg IV q8-12h",p:"15 mg/kg IV q6h",m:"Per trough/AUC levels"},{i:"C. difficile Colitis",a:"125 mg PO QID Ã— 10 days",p:"10 mg/kg PO QID (max 125 mg/dose)",m:"500 mg/dose PO"}],
 ci:"Vancomycin hypersensitivity. Caution in renal impairment.",adr:"Red Man Syndrome (rapid infusion), nephrotoxicity, ototoxicity, thrombophlebitis, neutropenia.",
 ph:"Vancomycin binds to the D-alanyl-D-alanine terminus of peptidoglycan precursors, physically blocking incorporation into the cell wall. Oral vancomycin is NOT absorbed systemically â€” it stays in the GI lumen, making it ideal for C. difficile.",
 an:"If ceftriaxone jams the mortar gun, vancomycin wraps itself around each individual brick before it reaches the wall, making it too bulky to fit. For C. difficile, oral vancomycin goes directly through the pipes (GI tract) â€” it never enters the bloodstream, just scrubs the infection right where it lives.",
 pearl:"Infuse over â‰¥60 min (â‰¥1 hr per gram) â€” prevents Red Man Syndrome. AUC/MIC-guided dosing (target 400-600). Oral = NOT for systemic infections. IV = NOT for C. diff. Dose by actual body weight.",at:"Infuse â‰¥60 min. Red Man Syndrome is rate-related, not allergy."},

{n:"Azithromycin",g:"Zithromax / Z-Pack",c:"other",e:"ğŸ’Š",s:["rn","lpn"],r:["PO","IV"],
 d:[{i:"Pneumonia / URI",a:"500 mg day 1, then 250 mg days 2-5",p:"10 mg/kg day 1, then 5 mg/kg Ã— 4 days",m:"500 mg/day"},{i:"Chlamydia",a:"1 g PO Ã— 1 dose",p:"N/A",m:"1 g single dose"}],
 ci:"Macrolide hypersensitivity, history of cholestatic jaundice with prior azithromycin.",adr:"Diarrhea, nausea, abdominal pain, QT prolongation, hepatotoxicity (rare).",
 ph:"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking peptide chain translocation. It concentrates in tissues at 10-100Ã— serum levels, with phagocytes carrying drug to infection sites for targeted delivery. Tissue half-life ~68 hours.",
 an:"Bacteria need protein factories (ribosomes) to survive. Azithromycin jams the conveyor belt (50S subunit), so half-built proteins pile up. The coolest part: your immune cells carry the drug like delivery trucks directly to the infection and dump it on the bacteria.",
 pearl:"Z-Pack: 500 mg day 1, then 250 mg days 2-5. Monitor QT interval. Long tissue half-life = keeps working 5-7 days after last dose. Avoid in myasthenia gravis."},

{n:"Ciprofloxacin",g:"Cipro",c:"other",e:"ğŸ’Š",s:["rn","lpn"],r:["PO","IV"],
 d:[{i:"UTI (Uncomplicated)",a:"250-500 mg PO BID Ã— 3-7 days",p:"Not first-line in peds",m:"1500 mg/day PO"},{i:"UTI/Pyelonephritis (Complicated)",a:"500 mg PO BID or 400 mg IV q12h",p:"6-10 mg/kg IV q8h",m:"800 mg/day IV"},{i:"Anthrax Post-Exposure",a:"500 mg PO BID Ã— 60 days",p:"15 mg/kg BID (max 500 mg/dose)",m:"1 g/day"}],
 ci:"Concurrent tizanidine, fluoroquinolone hypersensitivity, myasthenia gravis.",adr:"Tendon rupture/tendinitis, QT prolongation, peripheral neuropathy, C. difficile, CNS effects, photosensitivity.",
 ph:"Ciprofloxacin inhibits bacterial DNA gyrase (topoisomerase II) and topoisomerase IV â€” enzymes essential for DNA replication and repair. By blocking both, it prevents bacteria from copying DNA and dividing, leading to cell death. Excellent gram-negative coverage.",
 an:"Bacteria need to unwind and copy their DNA to reproduce. DNA gyrase is the enzyme that untwists the DNA. Ciprofloxacin locks the untwisting tool in place, creating permanent tangles and breaks. The bacterium can't read its own blueprint or make copies, so it dies.",
 pearl:"FDA Black Box: tendinitis/tendon rupture, peripheral neuropathy, CNS effects. Avoid >60 yrs, on corticosteroids. Do NOT take with dairy, calcium, iron, antacids (chelation). Reserve for appropriate indications.",at:"Black Box: tendon rupture, neuropathy. Avoid with dairy/antacids."},

// ==================== NURSING â€” GI ====================
{n:"Omeprazole",g:"Prilosec",c:"gi",e:"ğŸŸ¢",s:["rn","lpn"],r:["PO","IV"],
 d:[{i:"GERD",a:"20-40 mg PO daily before breakfast",p:"1 mg/kg/day (max 20 mg)",m:"40 mg/day"},{i:"Gastric/Duodenal Ulcer",a:"20-40 mg PO daily Ã— 4-8 weeks",p:"Same",m:"40 mg/day"},{i:"GI Bleed Prophylaxis (ICU)",a:"40 mg IV daily or 8 mg/hr drip",p:"1 mg/kg IV daily",m:"8 mg/hr drip"}],
 ci:"PPI hypersensitivity, concurrent rilpivirine or nelfinavir.",adr:"Headache, diarrhea, C. difficile risk, hypomagnesemia, B12 deficiency, bone fracture risk (long-term), rebound acid.",
 ph:"Omeprazole irreversibly inhibits H+/K+ ATPase (proton pump) on gastric parietal cells â€” the final common pathway for acid secretion. By permanently disabling the pump, it blocks ~95% of acid output. New pumps must be synthesized (3-5 days) to resume acid production.",
 an:"Your stomach has millions of tiny acid pumps. No matter what signal turns them on, they all flow through the same hydrant. Omeprazole permanently welds each hydrant shut. Your stomach has to build entirely new hydrants, which takes days. That's why one pill controls acid all day.",
 pearl:"Take 30-60 min before first meal. Not for long-term use >8-12 weeks without reassessment. Long-term risks: Mg/B12/Ca malabsorption, C. diff, fractures. Taper after chronic use."},

{n:"Docusate Sodium",g:"Colace",c:"gi",e:"ğŸŸ¢",s:["rn","lpn"],r:["PO"],
 d:[{i:"Stool Softener / Constipation Prevention",a:"100-300 mg PO daily in 1-3 doses",p:"<3 yr: 10-40 mg/day; 3-6: 20-60 mg; 6-12: 40-150 mg",m:"500 mg/day"}],
 ci:"Intestinal obstruction, undiagnosed acute abdominal pain, concurrent mineral oil.",adr:"Mild cramping, diarrhea, throat irritation (liquid).",
 ph:"Docusate is an anionic surfactant that lowers surface tension at the oil-water interface in stool, allowing water and lipids to penetrate. This softens the stool without stimulating peristalsis. Also stimulates intestinal fluid secretion via cAMP effects.",
 an:"Hard stool is like a dry sponge that repels water. Docusate works like dish soap â€” it breaks surface tension so water soaks in, turning the dry sponge into a soft, moist one. It doesn't push things along (that's a stimulant laxative), just makes what's there softer.",
 pearl:"Works best to PREVENT hard stools (especially with opioid use). Takes 1-3 days for effect. Often paired with senna for opioid-induced constipation. Give with full glass of water."},

// ==================== NURSING â€” DVT PROPHYLAXIS ====================
{n:"Heparin (SQ Prophylaxis)",g:"Heparin SQ",c:"anticoagulant",e:"ğŸ©¸",s:["rn","lpn"],r:["SQ"],
 d:[{i:"DVT Prophylaxis",a:"5,000 units SQ q8-12h",p:"Not routine in peds",m:"5,000 units/dose"},{i:"DVT Prophylaxis (Higher Risk)",a:"7,500 units SQ q8h",p:"N/A",m:"7,500 units/dose"}],
 ci:"Active uncontrolled bleeding, severe thrombocytopenia, HIT.",adr:"Injection site bruising, HIT (type II â€” monitor platelets), bleeding.",
 ph:"Subcutaneous prophylactic heparin potentiates antithrombin III at low levels, primarily inhibiting Factor Xa to prevent DVT formation in immobilized patients without achieving full systemic anticoagulation. Does not significantly prolong aPTT at prophylactic doses.",
 an:"When you're lying in bed after surgery, blood flow slows in your legs like a lazy river barely moving. Stagnant blood starts to clot. Prophylactic heparin adds just enough anti-freeze to keep the river from icing over â€” not enough to thin everything out, but enough to prevent the dangerous freeze-up.",
 pearl:"Rotate injection sites (abdomen preferred). Do NOT rub injection site. Monitor platelets for HIT. This is PROPHYLACTIC â€” different from therapeutic heparin drip. No aPTT monitoring needed.",at:"Monitor platelets for HIT. Do not rub injection site."},
];

/* â•â•â•â•â•â•â• STATE â•â•â•â•â•â•â• */
let curCat='all',curScope='all',filtered=[],shIdx=-1;

/* â•â•â•â•â•â•â• CHIPS â•â•â•â•â•â•â• */
function buildChips(){
  const w=document.getElementById('chips');
  w.innerHTML=CATS.map(c=>`<button class="chip${c.id==='all'?' on':''}" data-c="${c.id}" onclick="pickChip(this)">${c.i} ${c.l}<span class="cc" id="cc_${c.id}"></span></button>`).join('');
}
function pickChip(el){
  document.querySelectorAll('.chip').forEach(c=>c.classList.remove('on'));
  el.classList.add('on');curCat=el.dataset.c;render();
  // sync tab bar
  document.querySelectorAll('.tb-item').forEach(t=>{
    t.classList.toggle('on',t.dataset.f===curCat||(curCat==='all'&&t.dataset.f==='all'));
  });
}

/* â•â•â•â•â•â•â• TAB BAR â•â•â•â•â•â•â• */
function tabFilter(el){
  document.querySelectorAll('.tb-item').forEach(t=>t.classList.remove('on'));
  el.classList.add('on');curCat=el.dataset.f;render();
  // sync chips
  document.querySelectorAll('.chip').forEach(c=>c.classList.toggle('on',c.dataset.c===curCat));
  window.scrollTo({top:0,behavior:'smooth'});
}

/* â•â•â•â•â•â•â• SCOPE â•â•â•â•â•â•â• */
function toggleScope(){
  document.getElementById('scopeWrap').classList.toggle('show');
}
function pickScope(el){
  document.querySelectorAll('.scope-seg button').forEach(b=>b.classList.remove('on'));
  el.classList.add('on');curScope=el.dataset.s;render();
}

/* â•â•â•â•â•â•â• SEARCH â•â•â•â•â•â•â• */
function onSearch(){
  const v=document.getElementById('sBar').value;
  document.getElementById('sX').classList.toggle('show',v.length>0);
  render();
}
function clearSearch(){
  document.getElementById('sBar').value='';
  document.getElementById('sX').classList.remove('show');
  render();document.getElementById('sBar').focus();
}

/* â•â•â•â•â•â•â• FILTER & RENDER â•â•â•â•â•â•â• */
function getFiltered(){
  const q=document.getElementById('sBar').value.toLowerCase().trim();
  return D.filter(m=>{
    if(curCat!=='all'&&m.c!==curCat)return false;
    if(curScope!=='all'&&!m.s.includes(curScope))return false;
    if(q){
      const hay=(m.n+' '+m.g+' '+(m.c||'')+' '+m.r.join(' ')+' '+(m.d||[]).map(x=>x.i).join(' ')).toLowerCase();
      return hay.includes(q);
    }
    return true;
  });
}

function render(){
  filtered=getFiltered();
  const grid=document.getElementById('grid');
  document.getElementById('sCnt').textContent=document.getElementById('sBar').value?filtered.length:'';
  document.getElementById('navBadge').textContent=`${filtered.length} medication${filtered.length!==1?'s':''}`;

  // Chip counts
  CATS.forEach(c=>{
    const el=document.getElementById('cc_'+c.id);
    if(el){
      const cnt=c.id==='all'?D.filter(m=>curScope==='all'||m.s.includes(curScope)).length
        :D.filter(m=>m.c===c.id&&(curScope==='all'||m.s.includes(curScope))).length;
      el.textContent=cnt;
    }
  });

  if(!filtered.length){
    grid.innerHTML=`<div class="empty"><div class="empty-ico">ğŸ”</div><h3>No Results</h3><p>Try a different search or category</p></div>`;
    return;
  }

  // Group by category
  const groups={};
  filtered.forEach(m=>{
    if(!groups[m.c])groups[m.c]=[];
    groups[m.c].push(m);
  });

  let html='';
  const catOrder=CATS.filter(c=>c.id!=='all').map(c=>c.id);
  catOrder.forEach(cid=>{
    if(!groups[cid])return;
    const cat=CATS.find(c=>c.id===cid);
    if(curCat==='all') html+=`<div class="section-hd">${cat.i} ${cat.l} Â· ${groups[cid].length}</div>`;
    html+=`<div class="card-group">`;
    groups[cid].forEach(m=>{
      const idx=D.indexOf(m);
      const clr=CLR[m.c]||'blue';
      const routes=m.r.slice(0,3).join(' Â· ');
      html+=`<div class="card c-${m.c}" onclick="openSheet(${idx})">
        <div class="card-bar"></div>
        <div class="card-emo">${m.e}</div>
        <div class="card-body">
          <div class="card-name">${m.n}</div>
          <div class="card-gen">${m.g}</div>
          <div class="card-pills">
            <span class="cpill ct">${CATS.find(c=>c.id===m.c)?.l||m.c}</span>
            ${m.ha?'<span class="cpill ha">âš  High Alert</span>':''}
          </div>
        </div>
        <div class="card-right">
          <span class="card-route">${routes}</span>
          <span class="card-chev">â€º</span>
        </div>
      </div>`;
    });
    html+=`</div>`;
  });
  grid.innerHTML=html;
}

/* â•â•â•â•â•â•â• SHEET â•â•â•â•â•â•â• */
function openSheet(idx){
  shIdx=idx;
  document.getElementById('ov').classList.add('open');
  document.getElementById('sheet').classList.add('open');
  document.body.style.overflow='hidden';
  // Reset to Learn tab
  document.querySelectorAll('.sh-tab').forEach(t=>t.classList.toggle('on',t.dataset.t==='dose'));
  populateSheet();
}

function populateSheet(){
  const d=filtered[filtered.indexOf(D[shIdx])]?D[shIdx]:D[shIdx];
  const fi=filtered.indexOf(d);
  document.getElementById('shPrev').disabled=fi<=0;
  document.getElementById('shNext').disabled=fi>=filtered.length-1;
  document.getElementById('shPos').textContent=`${fi+1}/${filtered.length}`;
  document.getElementById('shEmo').textContent=d.e;
  document.getElementById('shName').textContent=d.n;
  document.getElementById('shGen').textContent=d.g;
  const clr=CLR[d.c]||'blue';
  const cat=CATS.find(c=>c.id===d.c);
  document.getElementById('shTags').innerHTML=`
    <span class="cpill ct" style="background:var(--${clr}-fill);color:var(--${clr})">${cat?.l||d.c}</span>
    ${d.r.map(r=>`<span class="cpill" style="background:var(--fill4);color:var(--label2)">${r}</span>`).join('')}
    ${d.s.map(s=>`<span class="cpill sc">${s.toUpperCase()}</span>`).join('')}
    ${d.ha?'<span class="cpill ha">âš  High Alert</span>':''}`;

  const activeTab=document.querySelector('.sh-tab.on')?.dataset.t||'dose';
  const body=document.getElementById('shBody');

  let html='';
  // LEARN TAB
  html+=`<div class="tpanel${activeTab==='learn'?' on':''}" data-p="learn">`;
  if(d.ph){
    html+=`<div class="patho"><div class="sec-hd">ğŸ”¬ PATHOPHYSIOLOGY</div><div class="sec-txt">${d.ph}</div></div>`;
  }
  if(d.an){
    html+=`<div class="analog"><div class="sec-hd">ğŸ§© SIMPLE ANALOGY</div><div class="an-text">${d.an}</div></div>`;
  }
  if(!d.ph&&!d.an){html+=`<div class="sec"><div class="sec-txt" style="color:var(--label3)">No pathophysiology or analogy available for this medication.</div></div>`;}
  html+=`</div>`;

  // DOSE TAB
  html+=`<div class="tpanel${activeTab==='dose'?' on':''}" data-p="dose">`;
  if(d.d&&d.d.length){
    d.d.forEach(dose=>{
      html+=`<div class="dcard">
        <div class="dcard-hd">${dose.i}</div>
        <div class="drow"><span class="drow-lbl lbl-adult">Adult</span><span class="drow-val" onclick="copyDose(this)">${dose.a}</span></div>
        ${dose.p?`<div class="drow"><span class="drow-lbl lbl-peds">Peds</span><span class="drow-val peds" onclick="copyDose(this)">${dose.p}</span></div>`:''}
        ${dose.m?`<div class="drow"><span class="drow-lbl lbl-max">Max</span><span class="drow-val mx" onclick="copyDose(this)">${dose.m}</span></div>`:''}
      </div>`;
    });
  } else {
    html+=`<div class="sec"><div class="sec-txt" style="color:var(--label3)">No dosing information available.</div></div>`;
  }
  html+=`</div>`;

  // SAFETY TAB
  html+=`<div class="tpanel${activeTab==='safe'?' on':''}" data-p="safe">`;
  if(d.at){html+=`<div class="alert-box">${d.at}</div>`;}
  if(d.ci){html+=`<div class="sec"><div class="sec-hd">ğŸš« CONTRAINDICATIONS</div><div class="ci-item">${d.ci}</div></div>`;}
  if(d.adr){html+=`<div class="sec"><div class="sec-hd">âš¡ ADVERSE EFFECTS</div><div class="adr-item">${d.adr}</div></div>`;}
  if(!d.at&&!d.ci&&!d.adr){html+=`<div class="sec"><div class="sec-txt" style="color:var(--label3)">No safety information available.</div></div>`;}
  html+=`</div>`;

  // TIPS TAB
  html+=`<div class="tpanel${activeTab==='tips'?' on':''}" data-p="tips">
      <div class="pearl-box">${d.pearl||'No clinical pearls available.'}</div>
    </div>`;

  body.innerHTML=html;
  body.scrollTop=0;
}

function prevSh(){
  const d=D[shIdx];
  const fi=filtered.indexOf(d);
  if(fi>0){shIdx=D.indexOf(filtered[fi-1]);populateSheet();}
}
function nextSh(){
  const d=D[shIdx];
  const fi=filtered.indexOf(d);
  if(fi<filtered.length-1){shIdx=D.indexOf(filtered[fi+1]);populateSheet();}
}
function closeSheet(){
  document.getElementById('ov').classList.remove('open');
  const sh=document.getElementById('sheet');
  sh.classList.remove('open');sh.style.transform='';
  document.body.style.overflow='';shIdx=-1;
}
function pickTab(el){
  document.querySelectorAll('.sh-tab').forEach(t=>t.classList.remove('on'));
  el.classList.add('on');
  const tab=el.dataset.t;
  document.querySelectorAll('.tpanel').forEach(p=>p.classList.toggle('on',p.dataset.p===tab));
}
function copyDose(el){
  navigator.clipboard.writeText(el.textContent).then(()=>{
    const t=document.getElementById('toast');t.classList.add('show');
    setTimeout(()=>t.classList.remove('show'),1200);
  }).catch(()=>{});
}

/* â•â•â•â•â•â•â• SCROLL BEHAVIOR â•â•â•â•â•â•â• */
let lastScroll=0,scrollStart=0;
window.addEventListener('scroll',()=>{
  const y=window.scrollY;
  const nav=document.getElementById('nav');
  nav.classList.toggle('scrolled',y>4);
  nav.classList.toggle('mini',y>60);
  // Dismiss keyboard on scroll
  if(Math.abs(y-scrollStart)>30){document.activeElement?.blur?.();}
  lastScroll=y;
},{passive:true});
window.addEventListener('touchstart',()=>{scrollStart=window.scrollY},{passive:true});
document.getElementById('sBar').addEventListener('keydown',e=>{
  if(e.key==='Enter'){e.target.blur();}
});

/* â•â•â•â•â•â•â• SWIPE GESTURES â•â•â•â•â•â•â• */
let sy0=0,sy1=0,dragging=false;const shEl=document.getElementById('sheet');
document.getElementById('shGrab').addEventListener('touchstart',e=>{
  sy0=e.touches[0].clientY;dragging=true;shEl.style.transition='none';
},{passive:true});
document.addEventListener('touchmove',e=>{
  if(!dragging)return;sy1=e.touches[0].clientY;
  const d=sy1-sy0;
  if(d>0){const isD=window.innerWidth>=700;
    shEl.style.transform=isD?`translate(-50%,${d}px)`:`translateY(${d}px)`;}
},{passive:true});
document.addEventListener('touchend',()=>{
  if(!dragging)return;dragging=false;shEl.style.transition='';
  if(sy1-sy0>80)closeSheet();else shEl.style.transform='';
  sy0=0;sy1=0;
});

/* Swipe left/right on body */
let sx0=0,sx1=0,swiping=false;
document.getElementById('shBody').addEventListener('touchstart',e=>{
  sx0=e.touches[0].clientX;sx1=sx0;swiping=true;
},{passive:true});
document.getElementById('shBody').addEventListener('touchmove',e=>{
  if(!swiping)return;sx1=e.touches[0].clientX;
},{passive:true});
document.getElementById('shBody').addEventListener('touchend',()=>{
  if(!swiping)return;swiping=false;
  const dx=sx1-sx0;
  if(Math.abs(dx)>80){
    if(dx<0)nextSh();
    else prevSh();
  }
  sx0=0;sx1=0;
});

/* Keyboard nav */
window.addEventListener('keydown',e=>{
  if(e.key==='Escape'&&shIdx>=0)closeSheet();
  if(e.key==='ArrowLeft'&&shIdx>=0)prevSh();
  if(e.key==='ArrowRight'&&shIdx>=0)nextSh();
});

/* â•â•â•â•â•â•â• INIT â•â•â•â•â•â•â• */
buildChips();render();
</script>
</body>
</html>
